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Abstract
Abstract
Chiral aldehydes are useful building blocks in asymmetric synthesis. This thesis describes 
the development of a new way o f combining chiral auxiliaries and substrate-directable 
reactions for the synthesis of enantiopure chiral aldehydes. This methodology relies on 
generation o f a temporary hydroxyl stereocentre via an asymmetric aldol reaction, which is 
then used to direct the formation of a new methyl stereocentre via a hydrogenation 
reaction. The chiral aldehyde is then generated via an anionic retro-aldol reaction which 
destroys the hydroxyl stereocentre and regenerates the chiral auxiliary for recycling (see 
Scheme I).
> 90% e.e.





LHM DS, 0 °C
toluene
O 0  OH 
O ^ N '  '  ' 'C 5H 11
Ph
17.5 mol%  
R h(P P h3)CI
4 .5  bar H 2, D C M .2 4  hrs
O Q OH
O N "  'Y ' 'vc 5h 11
Ph
100% conversion, 96% d.e.
Schem e I. Strategy for the synthesis o f chiral aldehydes
The hydrogenation reaction may be applied to different syn- and anti-aldol substrates using 
different catalysts to allow access to both enantiomers o f the chiral aldehyde in excellent 
enantiomeric excess, which can then be derivatised in situ to afford a range of stable chiral 
synthons. A novel palladium catalysed isomerisation reaction has been developed which 
allows easy access to tri-substituted alkenes in excellent yield (see Scheme II).
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>95% conversion, 85% d.e.
> 95% d.e. after chromatography
> 90% e.e
Scheme II. Novel palladium catalysed isomerisation reaction to allow access to the alternate enantiomer o f  
chiral aldehyde
By contrast Evans’ auxiliary derived aldols did not undergo the same retro-aldol cleavage 
reaction and instead it was found that a competing cyclisation-elimination reaction could 
occur. This reaction pathway was exploited to synthesise a range o f chiral 1,3-oxazinane- 
2,4-diones by treatment with 10 mol% diethylzinc, as well as a series of semiplenamide 
natural products by treatment with potassium /er/-butoxide (see Scheme III).
5 examples 
35 - 94% yield, > 90%  d.e.
Semiplenamides C - G
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Chapter 1: Introduction
1.1 Common methods in asymmetric synthesis
Asymmetric synthesis is the mainstay of organic synthesis. Nearly all natural products 
contain chiral centres and synthesis of drugs often requires control of absolute 
stereochemistry as receptors in the body often only recognise a single enantiomer, whilst 
the opposite enantiomer can sometimes produce unwanted side effects. In order to 
synthesize a single enantiomer of product from a prochiral precursor, the enantiotopic 
faces o f the substrate must be discriminated so that addition to one face occurs at a faster 
rate than the other. There are several methods that are commonly used to achieve this, 
including the use o f chiral pool reagents, chiral catalysis, kinetic resolutions, and chiral 
auxiliaries.
The chiral pool approach to asymmetric synthesis relies on using natural products as 
building blocks for more complicated molecules. A recent example o f this is the successful 
synthesis o f the C (l)-C (ll) fragment of antitumour macrolide peloruside A, starting from 
D-glucose, using the strategy shown in Scheme 1





key precursor for C(1)-C(11) fragment
D -G lu cose
Schem e 1. Retrosynthetic analysis o f  C( 1 )-C( 11) fragment o f peloruside A
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Chiral catalysts induce chirality by generating diastereomeric transition states of differing 
energies. Ideally, reaction leading to the lower energy transition state should occur much 
faster, leading to a enantiopure product. A recent example o f this is the enantioselective 
synthesis of cyclopropylphosphonates 1 that contain a quaternary chiral centre catalysed by 
the /^-symmetric chiral catalyst Rh2((5)-biTISP)2 (see Scheme 2).[2]





76 - 92% e.e.
Rh2((S)-biTISP)2
R = S 0 2-2,4,6-tri‘PrC6H2
Scheme 2. Catalytic asymmetric synthesis o f  cyclopropylphosphonates 1 with Rh2((5)-biTISP)2
Catalytic kinetic resolutions operate by reacting an enantiomerically pure reagent with a 
racemic substrate. One of the two enantiomers reacts more quickly allowing the 
enantiopure starting material and product to be separated. Masaguer recently reported the 
oxidative kinetic resolution o f  3-hydroxymethylbenzocycloalkanols 2 by selective 
asymmetric hydrogen-transfer oxidation with a Noyori type ruthenium complex 3 (see 
Scheme 3).[3]
Scheme 3. Kinetic resolution by asymmetric oxidation using a Noyori type ruthenium complex
2
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Chiral auxiliaries are enantiomerically pure compounds that are attached to prochiral 
functional groups so that the two faces of the substrate react at different rates, with the 
products being diastereomers rather than enantiomers. The main requirements for a 
compound to act as a chiral auxiliary are that it must be readily available in an 
enantiomerically pure form, be easily attached to the required functional group, induce 
good stereocontrol and must be easily removable, preferably so that it can be recycled. 
This is demonstrated by the work of Davies et al. who reported the use o f Superquat 




Schem e 4. Chiral auxiliary approach to the asymmetric synthesis o f  carboxylic acids containing a- 
stereocentres
This thesis reports the development of novel methodology which combines chiral 
auxiliaries and substrate-directable hydrogenation reactions for the asymmetric synthesis 
o f chiral aldehydes. Therefore, a brief report on some recent examples describing how 
chiral auxiliaries can be employed as powerful tools for asymmetric synthesis now follows.
1.2 Recent examples of chiral auxiliaries in asymmetric synthesis
A number of examples published in recent years serve to demonstrate the synthetic utility 
and efficiency of the chiral auxiliary approach for the asymmetric synthesis o f  chiral 
building blocks for natural product synthesis or drug discovery purposes.
Dixon et al. used a 6-methyltetrahydropyran (THP*) auxiliary 4 to control the 
stereochemistry of oxy-Michael additions to nitroalkenes, allowing access to 
enantiomerically enriched 1,2-amino alcohols 5.[5] The 1,2-amino alcohol motif is very
3
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common in bioactive compounds but there are relatively few methods for it’s asymmetric 
synthesis, particularly for examples that afford products containing a stereogenic 
secondary alcohol centre. The alkoxide functionality o f  the THP* auxiliary acts as a chiral 
water equivalent in the reaction and directs the stereochemistry of the addition as shown in 
Scheme 5.
a) 1 eq. KHMDS
b) 1 eq. 18-crown-6
a) 2 eq . NiCI2.6H20 ,  
6 eq . NaBH4
OH c ) 0 67  ecl- n o 2 NHBoc
4
THP*







Schem e 5. Asymmetric synthesis o f  1,2-amino alcohols by oxy-M ichael reaction with THP* auxiliary 4
The addition of the auxiliary was shown to always favour the cis-THP* isomer. The 
process is applicable to a range of (£)-nitroalkenes and produces good yields and high 
enantioselectivity, especially with aryl, heteroaryl or alkyl R groups. This work has been 
further extended to allow highly stereoselective oxy-Michael additions to a,(3-disubstituted 
nitroalkenes in good yield (66 -  99%) and excellent diastereoselectivity (> 95% at 
(3-centre).
Camphor derived auxiliaries have been widely used in asymmetric synthesis. Aggarwal et 
al. reported the use o f a camphor derived sulfonium amide salt 6 in an enantioselective 
Darzens reaction to yield glycidic amides 7.[7] This is particularly useful as it is one of the 
few direct routes to glycidic amides with almost complete diastereocontrol and 







8 8 % yield
6
98% e.e
Schem e 6. Asymmetric synthesis o f (2R,3S)-2,3-epoxyamides via a camphor derived sulfonium salt
The reaction was found to proceed well with a range o f aldehydes including aromatic, 
heteroaromatic and tertiary and mono-substituted aliphatic aldehydes, although secondary 
substituted aldehydes gave low selectivity. The diastereocontrol was found to be always in 
favour of the trans isomer and the sulfide auxiliary could be isolated and reused at the end 
of the reaction. The group have demonstrated the utility of this reaction by carrying out 
further selective transformations on epoxyamides (see Scheme 7) and used the strategy in 
the short synthesis o f SK&F 104353, a leukotriene D4 antagonist implicated in the 
treatment of bronchial asthma (see Scheme 8).
NEt;
R = Cl, CH3, H
PhSH or TMSN3
R' = Ph, Me
Schem e 7. Further selective transformations o f  epoxyamides
Ph
OH
KOH, -30°C, 24 hrs.
SK&F 104353
Schem e 8. Short synthesis o f  SK&F 104353
5
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A more unusual auxiliary has been reported by Carretero for the asymmetric 
intermolecular Pauson-Khand reactions of unstrained olefins.[8] This approach used a 
cobalt coordinating 2-(iV,Ar-dimethylamino)phenyl vinyl sulfoxide to react with a variety o f 
alkyne di-cobalt complexes under mild conditions with good levels o f regio- and 
stereocontrol (see Scheme 9).
| |— Co2(CO)6 +
H
(fi)-vinyl sulfoxide 5(S), S(R)
6 8 % yield 
96% e.e.
Schem e 9. Asymmetric Pauson-Khand reaction o f  2-(Ar,A-dimethylamino)phenyl vinyl sufoxide with alkyne 
di-cobalt complexes
The vinyl sulfoxide is easily synthesised in enantiomerically pure form and although the 
yields o f cycloadduct are only moderate (49 -  74 %) the enantioselectivity was high (> 
93% e.e.). The reactions were completely regioselective leading only to 2,5-disubstituted 
cyclopentenones, unlike many Pauson-Khand reactions of mono-substituted alkenes with 
terminal alkynes. The process is applicable to a range of terminal alkynes, including 
primary-, benzyl- and tertiary alkyl-substituted, in addition to aryl acetylenes and 
functionalised alkynes. The conditions are relatively mild, allowing for alkynes with a 
primary bromoalkyl chain to be used. However, reactions with internal alkynes such as 2- 
butyne, needed to be carried out at high pressure (10 Kbar) to afford any product, although 
stereoselectivity remains high. The versatility of this approach was illustrated by the 
efficient four step enantioselective synthesis of (-)-pentenomycin I antibiotic shown in 
Scheme 10.




O 0 s 0 4, TMEDACH3CN
TIPSO
|— Co2(CO)6 + |
NMO, 0°C
5 S, S R
O O
TIPSO
'H nK Toluene, reflux
S .
Ar




Scheme 10. Short asymmetric synthesis o f (-)-pentenomycin 1
Hitchcock et al. have reported the synthesis of chiral (3-hydroxy acids via a chiral relay
norephedrine 8 with acetone and sodium borohydride afforded derivative 9 in good yield. 
This amine was transformed to nitrosamine 10 in quantitative yield via treatment with 
sodium nitrate and hydrochloric acid, before reduction to p-hydroxy hydrazine 11 in good 
yield. Cyclisation to give chiral auxiliary 12 was affected using lithium hydride and diethyl 
carbonate followed by N-acylation to give 13 (see Scheme 11). The acylated auxiliary 13 
can undergo a titanium mediated aldol reaction with a range of aldehydes to give aldol 
products such as 14 in good yield (45 -  98%) and high diastereoselectivity (> 90%). 
Hydrolysis o f 14 to give chiral P-hydroxy acid 15 and the recovered auxiliary 12 was 
carried out by refluxing in 6 M sulfuric acid with milder hydrolysis conditions proving 
unsuccessful. The configuration of the resultant P-hydroxy acid 15 confirmed that the 
preceding aldol reaction had afforded the non-Evans syn product which was proposed to 
arise via a Zimmerman-Traxler transition state involving a chelated Z(0)-titanium enolate. 
It was proposed that the chirality o f the norephedrine fragment is not directly responsible 
for the diastereoselectivity o f the aldol reaction, but rather that the stereochemistry o f the 
methyl group at the C5 position is relayed and inverted through the conformation o f the 
achiral isopropyl group on the adjacent nitrogen which serves to control the facial 
selectivity of the aldol reaction and formation o f the new stereocentres.
approach from a norephedrine derived chiral auxiliary .R eductive alkylation o f (\R,2S)~
1
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OH OH OH NO
T (CH3)2CO T H NaN 0 2 T I
Ph'AY Nh2  ►    P h ^ v " -i NaBH4 1 I HCI i




OH NH2 1 II 2
LiAIH4 I E t02C 0  O ^ N H  LiH O ^ N ^ O
►  P h T V '  e l  J ,3  I I
UH P K ''V '« V ' C2H=C0CI DkA ^ N .Me I 5 j  4 j Ph*










c) benzaldehyde | J = '//(,
Me 1
14 15 12
78% yield 56% yield 46% yield
> 98% d.e. > 96% e.e.
Schem e 11. Synthesis o f chiral P-hydroxy acids via chiral relay from norephedrine derived auxiliary 12
Asymmetric rearrangements are useful reactions in asymmetric synthesis due to the atom 
efficiency and ordered transition state o f the process. Recently Sweeney et al. have 
reported the stereoselective [2,3] rearrangement of allyldimethyl ammonium ylids 
controlled by a camphorsultam auxiliary 18.[l0] Thus, a range of allyldimethyl ammonium 
sultam ylids 16 can undergo rearrangement to afford allyl glycine derivatives 17 in good 
yield and excellent selectivity (see Scheme 12). The reaction proceeds well with a range of 
substitution patterns on the ylid including terminal alkenes which allowed access to allyl 
glycines which are not easily accessible by other methods.
NaH, DME
16 (2’f?)-17 
8 6 % yield 
> 96:4 2'R:2'S
18
Schem e 12. [2,3] Rearrangement o f allyldimethyl ammonium sultam ylids
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Interestingly the auxiliary could be attached to the allylic side of the ylid to give 19 which 
also underwent [2,3] rearrangement with high levels of stereocontrol to afford 20 (see 
Scheme 13). This is exemplified by the stereoselective synthesis of (ft)-allyl glycine in 












Scheme 13. [2,3] Rearrangement controlled by camphorsultam auxiliary 18
One of the most common chiral auxiliaries used in asymmetric synthesis is the Evans 
oxazolidin-2-one auxiliary, which Glorius et al. employed for the asymmetric 
hydrogenation o f substituted pyridines.[I1] This enables the stereoselective formation of 
piperidines with up to four new chiral centres in a single operation, as shown in Scheme 




"NT 'X  
X = Br, Cl
HIM Me
Cul, ligand, K2C 0 3










Scheme 14. Synthesis and asymmetric hydrogenation o f oxazolidinone-substituted pyridines
This asymmetric hydrogenation reaction occurs in good yields (63 -  100 %) and generally 
excellent enantioselectivity (mostly > 95% e.e.). The process uses fairly mild conditions, 
with no need for special precautions to exclude air or moisture, and is tolerant to a range o f 
substituents on the pyridine, although selectivity is low with a methyl substituent in the R3 
position. Another advantage of this process is that traceless cleavage of the auxiliary
9
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occurs under the hydrogenation conditions, thereby combining chirality transfer and 
release of the auxiliary into a single step. Addition o f hydrochloric acid allows separation 
of the more soluble auxiliary from the piperidine salt so that it can be easily recycled. This 
method describes an efficient and easy transformation for the asymmetric hydrogenation of 
heteroaromatic compounds, which has previously proved difficult. The versatility o f the 
process was demonstrated for the formation o f (5)-A-ethylpiperidines 21 as shown in 
Scheme 15.
H2, AcOH, Pd(0H)2/C
M eC H O o rA c2 0 (4 eq .) N
Et
21
87%  yield 
95% e.e.
Schem e 15. Synthesis o f  (5)-7V-ethylpiperidines via asymmetric hydrogenation
Another interesting transformation involving the Evans type auxiliary has been reported by 
Hsung et al. for the tandem epoxidation/cycloaddition of nitrogen-stabilised chiral oxyallyl 
cations.[12] Allenamide 23 is synthesised from oxazolidinone 22 by alkylation followed by 
isomerisation with potassium ter/-butoxide,[13] and is then converted into a-tethered 
allenamide 25 by treatment with two equivalents of furan 24. Subsequent treatment with 
dimethyl dioxirane (DMDO) facilitated epoxidation followed by the intramolecular [4+3] 


























2 - 5 eq. DMDO
-►
30 min




Scheme 16. Tandem epoxidation/cycloaddition o f a-tethered allenamide 25
This reaction has also been extended to a range of y-tethered allenamides. For example, 
allenamide 28 has been synthesised as a single diastereomer from 27 according to 
procedures developed by Seebach et a/..[14] Removal o f the trimethylsilyl group led to 
scrambling o f the allenic axial stereocentre to give 29 as a 1:1 mixture of P and M  isomers 
after protection of the hydroxyl group with chlorotriethylsilane (see Scheme 17). However, 
these isomers could be cleanly separated and subsequent treatment with DMDO afforded 
the same isomer of cyclic product 30 regardless of the axial stereochemistry, indicating 
that the chirality o f the allene does not govern the stereochemistry of the cycloaddition. 
This reaction could be extended to a range o f tether lengths in the chiral allenamide and 
could also be carried out successfully with butadienes in place of fiirans in the 
cycloaddition reaction. This process is a useful way to synthesise chirally complex tri­
cyclic compounds containing quaternary stereocentres in good yield, excellent 
diastereoselectivity and in very short reaction times.
11
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Scheme 17. Tandem epoxidation/cycloaddition with y-tethered allenamides 29
These examples clearly demonstrate how chiral auxiliaries can be used in a novel and 
efficient manner for the asymmetric synthesis o f chiral products containing one or more 
new stereocentres. My research has been directed towards developing an efficient strategy 
for combining chiral auxiliaries, temporary stereocentres and substrate-directable reactions 
for the asymmetric synthesis o f chiral aldehydes. Consequently, it is useful to consider 
existing methodology that is available for the asymmetric synthesis o f aldehydes, and a 
review of this area now follows.
1.3 Strategies for the asymmetric synthesis of chiral aldehydes
1.3.1 Introduction
Chiral aldehydes are useful building blocks in asymmetric synthesis due to the wide range 
of reactions they can undergo. Several one step transformations exist that can convert the 
aldehyde synthon into a range of other useful functionality that can be used to introduce 











Schem e 18. Some one step transformations o f aldehydes
These transformations allow chiral aldehydes to be used as key intermediates for the 
synthesis of natural products and biologically important compounds. For example, in 1999 
Mukaiyama et al. reported the use of chiral aldehyde 31 in the synthesis of anticancer 
compound Taxol® (see Scheme 19).tl6] The following year Shibasaki et al. reported the 
synthesis of natural products epothilones A and B from complex chiral aldehyde 32 (see 
Scheme 20),[l?] and in 2001 Paterson et al. reported the synthesis o f discodermolide using 
chiral aldehyde 33 as a key intermediate (see Scheme 21).[,8] Both of these natural 
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Schem e 21. Synthesis o f  discodermolide from chiral aldehyde 33
These examples highlight the utility o f  chiral aldehydes in synthesis and therefore the 
importance of developing effective methods for their asymmetric synthesis.
1.3.2 Oxidation, reduction and chiral pool strategies
Aldehydes are often synthesised by oxidation o f primary alcohols. For example, Solladie- 
Cavallo et al. exploited this approach in their synthesis o f a range of novel enantiopure 
( \R,2S)-erthro- and (1 S,2S)-threo- isomers of aryl-pyrrolidyl alcohols from (-)-(5)-proline 
(see Scheme 22).[19] The key aldehyde intermediate 35 was synthesised by oxidation of 
alcohol 34 in quantitative yield. It was found that application o f Swem oxidation 
conditions resulted in significant racemisation due to the acidity of the stereogenic a- 
proton. However, this problem was overcome by using SCVpyridine and triethylamine in a 
DMSO/DCM mixture, which allowed the oxidation reaction to proceed with no 
racemisation. Oxidations o f this type are widely used in synthesis as they prevent over 
oxidation of the aldehyde to its carboxylic acid.
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C 0 2H EtOCOCI, K2C 0 3 [ ^ > — C 0 2Me DIBAL-H CH2OH
u MeOH N\ _  THF _
H C 0 2Et C 0 2Et
(-)-(S)-proline 9 7 o/o  yie|d 3 4
8 8 % yield
S 0 3/pyridine, Et3N [ y - « CHo
C r
DCM:DMSO (1:1) 'I  "  OH ™ H
C 0 2Et R  R
35
Scheme 22. Synthesis o f  aryl-pyrrolidyl alcohols from (-)-(5)-proline via aldehyde 35
Takahashi et al. have exploited a “chiron approach”1201 for the synthesis of key aldehyde 38 
in their total synthesis o f anti tumour agent mucocin 39,[21] involving Swern oxidation o f 
alcohol 37 to give aldehyde 38 in almost quantitative yield (see Scheme 23). Although the 
chiron approach can be useful for asymmetric synthesis it is often inefficient due to the 
need to remove redundant functionality from the starting chiron.
MOMO/y, MOMO,
(COCI)2, DMSO






Scheme 23. Synthesis o f aldehyde 38, the key tetrahydropyran fragment o f mucocin 39
Another oxidative method for the synthesis of aldehydes involves periodate cleavage of a 
diol. In 2003 Ley et al. reported the use o f D-mannitol as a cheap and convenient starting 
material for the synthesis of chiral butane-1,2-diacetal-protected glyceraldehyde 42.[22] D- 
mannitol 40 was treated with butane-2,3-dione and trimethyl ortho formate in the presence 
of a catalytic amount of boron trifluoride tetrahydrofuran to yield the protected mannitol
16
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derivative 41. This diol was oxidatively cleaved with sodium metaperiodate to afford 
glyceraldehydes derivative 42 in 42% yield over two steps which can be used as a building 
block in natural product synthesis (see Scheme 24). Sugars have often been used as chiral 
synthons for the synthesis of chiral aldehydes in a similar way.[23]
HC(OMe)3, MeOH, 
BF3.THF
Scheme 24. Synthesis o f butane-1,2-diacetal-protected glyceraldehyde 42 from D-mannitol 40
Sharpless et al. have reported the use o f the osmium catalysed asymmetric dihydroxylation 
procedure to synthesise a range of chiral dihydroxyaldehydes 44 from acetal protected a,p- 
unsaturated aldehydes 43 in good yield and enantioselectivity as shown in Scheme 25.[24] 
The acetal protecting group could be easily removed by hydrogenolysis or acid hydrolysis 
without racemisation of the stereocentres and the resultant aldehydes could then be 
subjected to an enzyme catalysed aldol reaction to afford a range of carbohydrate products.
43
R = H, Me, Ph
AD-mix-p, 25  °C 
f-BuOH:H20  (1:1)
AD-mix-a, 2 5  °C 
f-BuOH:H20  (1:1)
Pd(OH)2, H2
u n  pH 1 buffer,
R = H, 90% yield, > 95% e.e. 65 °C 
R = Me, 96% yield, 82% e.e.
R = Ph, 91% yield, > 95% e.e.
OH
Pd(OH)2, H2 
MeOH, 25  °C
or
pH 1 buffer,
R = H, 93% yield, > 95% e.e. 65 °c  
R = Me, 100% yield, 79%  e.e.






Scheme 25. Synthesis o f  dihyroxyaldehydes by osmium catalysed asymmetric dihydroxylation
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A similar dihydroxylation strategy was used for polyunsaturated aldehyde 45 whose y,8- 













Scheme 26. Selective asymmetric dihydroxylation for the synthesis o f dihydroxyaldehyde 46
Aldehydes can also be synthesised by hydride reduction o f the corresponding ester, nitrile 
or amide. In a similar way to oxidations, care must be taken not to over reduce the resultant 
aldehyde to its parent alcohol. A recent paper from the Pattenden group uses a hydride 
reduction to form the key aldehyde 48 in their synthesis of (±)-Salinosporamide A (see 
Scheme 27).[26] Reduction of the malonate derivative 47 with “Super-hydride” (lithium 
triethylborohydride) was regioselective and proceeded in good yield with no racemisation. 
The regioselectivity was rationalised on steric grounds, with the bulky O-TMS group 
preventing hydride delivery to the sy/7-orientated ester functionality. It was also suggested 
that the same O-TMS group exerts an inductive electronic effect to activate the 
corresponding £w//'-orientated ester due to their antiperiplanar relationship.
18
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a) ethylene glycol, /  \
Q gn p-TSA, benzene dimethylaminomalonate.HCI
b) 2M NaOH, EtOH | HOBt, EDC.HCI, DCM, NMM
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Scheme 27. Reductive synthesis o f key aldehyde 48 in the synthesis o f  salinosporamide A
Tamura et al. have described the synthesis o f a number of peptidyl arginals such as 53, 
which are important synthetic targets as they exhibit activity as therapeutic agents for 
thrombotic vascular disease.[27] 7V-Boc-nitro-L-arginal 50 is synthesised from the 
corresponding L-arginine 49 via its Weinreb amide (see Scheme 28). This aldehyde was 
then converted to the key intermediate 51 which was coupled to fragment 52 followed by 
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O c o 2h
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H N - .N H 2 TFA
M e0 2Ca) H2, 10% Pd/C, EtOH, AcOH, H20
b) 60% HPF6> CH3CN, H20
53
41% overall yield
Scheme 28. Synthesis o f peptidyl arginal 53
An additional reductive method for the synthesis of chiral aldehydes involves the reduction 
of thioesters. For example, Feringa et al. have described the asymmetric conjugate addition 
of Grignard reagents to a,P-unsaturated thioesters such as 54 in good yield and 
enantiomeric excess (up to 96% e.e.) using chiral ligand 55.[28] Subsequent reduction of 
thioester 56 with Pd/C afforded chiral aldehyde 57 in excellent yield and with no loss of 
enantiomeric excess (see Scheme 29). These aldehydes could also easily undergo a Wittig
2 0
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reaction to yield a,|3-unsaturated aldehyde 58 and by an iterative process thioester 59 could 
be synthesised in good yield and with good diastereoselectivity. This protocol has been 
exploited for the synthesis of natural product (-)-lardolure.
0  1.2 eq. MeMgBr, 1.2 mol% 55  ■ O 10% Pd/C, Et3SiH ■ O
B u ^ ^ S E t  1 moi% CuBr.SMe2> - 75  °C B u ^ ^ S E t  DCM B u ' ^ ^ H
54 56 57
93% yield 92%  yield
95%  e.e.
Ph3PCHCOSEt ■ O 1 .2 e q . MeMgBr, 1.2 mol% 55 l  |  O





Fe " P P h 2 Prj u u a OCHO
(-)-lardolure
55 = (f?,S)-JOSIPHOS 26% overall yield
Scheme 29. Asymmetric addition o f Grignard reagents to thioesters and subsequent reduction to afford chiral 
aldehydes
Another common method used to synthesise chiral aldehydes involves chiral auxiliaries. 
For example, in 2000 Evans et al. reported the use o f their oxazolidin-2-one auxiliary to 
synthesise aldehyde 65 which was a key component in the synthesis o f phorboxazole B.[29] 
An aldol reaction between aldehyde 60 and the acylated Evans’ auxiliary 61 gave p- 
hydroxy-A-acyl oxazolidin-2-one 62 in good yield with high diastereocontrol. Subsequent 
removal of the chloro functionality and protection of the free alcohol gave 63 in good 
yield. The desired chiral aldehyde 65 was obtained by reductive cleavage of the auxiliary 
with lithium borohydride to give alcohol 64, followed by Swem oxidation to aldehyde 65 
































Scheme 30. Synthesis o f key aldehyde 65 in the synthesis o f  phorboxazole B using Evans’ auxiliary 
methodology
Modification o f the Evans auxiliary to give the gem-dimethyl Superquat analogue allows 
for direct conversion o f the auxiliary adduct to the chiral aldehyde.[30] For example, the 
enolate of A-acylated Superquat auxiliary 66 can be alkylated with benzyl bromide to give 
A-a-benzyl-butyryl oxazolidin-2-one 67 in good yield and diastereoselectivity. Subsequent 
treatment with DIBAL-H affords the chiral aldehyde 68 directly in good yield with no 
racemisation o f the new chiral centre (see Scheme 31).
o o





BnBr / % rn  ^
Ph
Ph'
6 6   6 8
94% yield 95% yield
94% d.e. 94% e.e.
Scheme 31. Synthesis o f chiral aldehydes by reductive cleavage o f  alkylated Superquat auxiliaries
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Direct reductive cleavage of chiral auxiliaries with DIBAL-H to yield chiral aldehydes has 
also been demonstrated for L-valinol and L-phenylalaninol derived 2-phenylamino-2- 
oxazoline auxiliaries^31] a benzopyrano-isoxazolidine auxiliary[32] and a sultam 
auxiliary,[33] whilst lithium triethoxyaluminium hydride has been used for the reduction o f 
a pseudoephedrine derived auxiliary.[34]
One o f the most widely used strategies for the synthesis of chiral aldehydes is the use o f 
hydrazone methodology, which has already been comprehensively reviewed.[35] For 
example the SAMP auxiliary 69, first developed by Enders et al. in 1976,[36] can react with 
prochiral aldehydes to yield hydrazone 70 and 71 in excellent yield. Subsequent 
deprotonation with LDA followed by alkylation with organohalides yields chiral 
hydrazones 72 in almost quantitative yield with good diastereoselectivityJ35] Oxidative 
cleavage of the chiral hydrazone 73 with ozone yields aldehyde XX in good yield and 
enantiomeric excess. A useful feature of this methodology is that both enantiomers o f 
aldehyde can easily be synthesised using a single enantiomer o f auxiliary depending on the 
sequence of reactions, as shown in Scheme 32.
h 3c
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Schem e 32. Use o f  SAMP 69 auxiliary in hydrazone based synthesis o f chiral aldehydes1351
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The use of hydrazones can also be successfully applied using heteroatom electrophiles 
which can lead to the synthesis o f benzyl-protected a-hydroxyaldehydes,[37] a-thiolated 
aldehydes,[38] a-silylated aldehydes[39] and a-phosphinylaldehydes[40] in good yields and 
enantiomeric excesses. In addition to alkylation reactions, aldehyde derived chiral 
hydrazones can take part in aldol reactions, Michael additions and rearrangements to form 
chiral aldehyde products.[35]
These strategies depend on manipulation of the oxidation state or substitution pattern of a 
chiral substrate which obviously adds steps to the synthetic procedure. Therefore, the 
remaining examples in this review will concentrate on asymmetric methods that directly 
synthesise chiral aldehydes without the need for either oxidation or reduction to generate 
the aldehyde functionality.
1.3.3 Asymmetric hydroformylation
Discovered in 1938 by Roelen,[41] hydroformylation is an atom efficient process for the 
conversion of an alkene to an aldehyde. The challenge in asymmetric hydroformylation is 
not only control o f enantioselectivity but also of chemoselectivity (hydroformylation vs. 
hydrogenation) and regioselectivity (branched vs. linear aldehyde).[42] For mono­
substituted alkenes formation o f the linear aldehyde does not result in a stereogenic centre, 
whereas for more highly substituted alkenes enantioselectivity can arise by formation of 




C O /H 2
branched linear
Schem e 33. Possible products arising from hydroformylation
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Asymmetric hydroformylation is an important tool in the synthesis of nonsteriodal anti­
inflammatory agents based on the preparation of functionalised 2-arylpropanoic acids, as 
well as the synthesis o f optically active a-amino acids (see Scheme 34).[421
C O /H 2 H, X H O  oxidation H, .C 0 2H
^  "  A r ^
Ar = p -((CH3)2 CHCH 2 )C6 H4 = Ibuprofen
Ar = p-(C6H5CO)C6H4 = Ketoprofen
Ar = 2-(6-MeO-2-naphtyl) = Naproxen
O




-  C O / H 2  H *  ^ C H O  | H 2
A c ° ^   *• Ac0X .  -  > y V H
O H  O  
D-Threonine
D-Alanine
Scheme 34. Chiral drug intermediates and amino acids that have been synthesised by asymmetric 
hydroformylation1421
Preliminary work into catalyst systems capable o f affecting asymmetric hydroformylation 
were carried out using rhodium and platinum systems containing phosphine ligands. Prior 
to 1992, rhodium catalysis achieved only moderate enantioselectivities, whilst competing 
hydrogenation and regioselectivity issues were often a problem with platinum systems.[43] 
The best example for a rhodium(I) catalyst was 60% enantiomeric excess for the 
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Schem e 35. Asymmetric hydroformylation o f methyl a-acetamidoacrylate catalysed by Rh(I)-DIOP
In 1993 Takaya et al. reported the development of the BINAPHOS ligand 74, a chiral 
phosphinephosphite ligand which affords a highly efficient catalyst for asymmetric 
hydroformylation when complexed to rhodium (I) (see Scheme 36).[45]
Scheme 36. Synthesis o f  (R,S)- BINAPHOS ligand 74
The rhodium complex was used for the asymmetric hydroformylation of a range o f 
arylethenes and lunctionalised olefins including vinyl acetate and A-vinylphthalimide in 
good yields (> 90%), and with good enantioselectivity (75 -  94% e.e.) and regioselectivity. 
The best results were obtained for the hydroformylation of hept-l-ene which proceeded in 
greater than 99% conversion, 94% enantiomeric excess and a branched to linear ratio of
’PPh2
OH
NEt3 / EtO 






The group further extended the use of their catalyst system to allow for the asymmetric 
hydroformylation o f 1,2-disubstituted olefins in excellent regioselectivity (up to 98:2) and 
enantioselectivity (up to 97%)/461 and to the asymmetric hydroformylation of conjugated 
dienes, an area where previous efforts had been disappointing (see Scheme 37)/471 In this 
case hydroformylation was highly selective for the terminal alkene, and ratios of branched 
to linear products were high (up to 95:5). However, very high pressures of hydrogen and 
carbon monoxide (100 atm.) and long reaction times (up to 108 hours) were required to 
achieve these results. This protocol has also been extended to allow highly regio- and 
enantioselective hydroformylation without organic solvents/481 and more recently a 
polymer supported version of the BINAPHOS ligand has been developed which exhibits 
regio- and enantioselectivity comparable to the solution phase version/49,501




H2 / CO (1:1 , 100atm), benzene, 
substrate/catalyst = 200
96% e.e.
78%  conversion (at 40 °C )
88:12 branched:linear
Scheme 37. Rh(I)-BINAPHOS catalysed asymmetric hydroformylation o f conjugated dienes
Having studied the structures of the most common phosphine ligands used for asymmetric 
hydroformylation, Masdeu-Bulto et al. concluded that simple diphosphines such as BDPP 
75 should be effective at influencing enantioselectivity in the hydroformylation reaction/511 
They reported the use of a [Rh(p-OMe)(COD)]2 / (+)-BDPP catalyst precursor system to 
affect the hydroformylation o f styrene in good yield, regioselectivity and reasonable 
enantioselectivity (see Scheme 38). Although the enantioselectivity was disappointing in 
comparison with BINAPHOS, much milder conditions and shorter reaction times were 
used in this reaction, combined with the use of a much more easily prepared ligand.
CHO
[Rh(OMe)(COD)]2 / (+)-BDPP (1 :4) I .CHO
CO/H2 (1:1, 10 bar), 65  °C, THF 
substrate/precursor = 200
56% e.e. (S)
92%  conversion (7 hours) 
(+)-BDPP — 94:6 branchedilineer
PPh2 ^Ph2
Scheme 38. Asymmetric hydroformylation o f styrene with (+)-BDPP 75
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Subsequent ligands developed for the rhodium catalysed asymmetric hydroformylation 
reaction include BINAP,[52] NAPHOS,[53] BIPHLOPHOS,[54] and the ribafuranose 
derivative 76 (see Figure 1).[55] However in all these cases no major improvements were 
observed with the best enantioselectivities obtained being around 60%, and whilst 












Figure 1. Examples o f ligands developed for the rhodium catalysed asymmetric hydroformylation reaction
Herrmann et al. describe the use of a variety of chiral ferrocenylethyl diphosphines 77 with 
rhodium(I) precursors for the asymmetric hydroformylation of styrene.[56] The presence o f 
an ortho-anisyl substituent on phosphorus allowed enantioselectivities up to 76% e.e., with 
good levels of regiocontrol (see Scheme 39). However conversions in these reactions were 





[Rh(CO)2(acac)] /  77 (1:2)
CO/H2 (1:1, 10 MPa), 4 0  °C, 16 hours 
substrate/precursor = 300
76% e.e. (S)
r , 3% conversion
77 =
* * &
R = P(o-Anis), R-) = PPh2
Schem e 39. Chiral ferrocenylethyl diphosphines as ligands for the rhodium catalysed asymmetric 
hydroformylation o f  styrene
Improvements to the platinum catalysed asymmetric hydroformylation have also been 
described. Hegedis et al. reported the use of a novel chiral phosphine-phosphole ligand 78 
which can be used with a platinum precursor to affect the hydroformylation of styrene with 
excellent levels o f regio- and enantiocontrol (see Scheme 40).[57] Furthermore, high 
enantioselectivities could be achieved using relatively short reaction times, under lower 
pressures of syngas and at ambient temperatures.
CHO
[Pt(PhCN)2Cl2] / SnCI2 / 78 (1:1:1.1)
CO/H2 (1:1, 70 atm), 24 °C, toluene 
substrate/precursor = 200
89% e.e. (S) 





Scheme 40. Novel phosphine-phosphole ligand for the platinum catalysed asymmetric hydroformylation o f  
styrene
More recently several new ligands have been developed for the asymmetric 
hydroformylation reaction.[58,59] These include (5,5)-kelliphite which affords 
enantioselectivities in up to 88% e.e. with excellent regioselectivity for the 
hydroformylation o f allyl cyanide and vinyl acetate,[60] (2/?,4i?)-chiraphite which displays 
enantioselectivities up to 90% e.e. for hydroformylation of styrene,[6,] (S^-ESPHOS
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which exhibits high enantioselectivities for the hydroformylation o f vinyl acetate[62] and 
(J/?rR)-Ph-BPE and the bis-3,4-diazaphospholone 79 which show high catalyst activity and 
excellent regio- and stereocontrol (up to 96%) for the hydroformylation o f styrene, allyl 
cyanide and vinyl acetate (see Figure 2).[63,64]
(S.S)-kelliphite (2f?,4R)-chiraphite
I
.N ^ / Ph Ph"
(S,S)-ESPHOS ^ jT * 0  {R,R)-Ph-BPE
Figure 2. Recent examples o f  chiral ligands used for asymmetric hydroformylation
In 2006, Zhang et al. reported that a small modification to the (/?,5)-BINAPHOS ligand 
allowed for very high enantioselectivities (up to 99% e.e.) for the asymmetric rhodium 
catalysed hydroformylation of styrene derivatives and vinyl acetate.[65] For example the 
hydroformylation of para-methoxy styrene with ligand 80 was achieved with excellent 
98% enantiomeric excess compared to the 88% e.e. reported for BINAPHOS and with 




Rh(acac)(CO)2/ (R,S)-80  









Rh(acac)(CO)2/  (S,R)-BINAPHOS 
CO/H2 (50 atm), 60  °C, 34 h




Scheme 41. Rhodium catalysed hydroformylation ofp-m ethoxy styrene using ligand 80
Nozaki et al. have exploited the rhodium catalysed asymmetric hydroformylation reaction 
for the synthesis of p-lactam 84 which is a key intermediate in the synthesis o f 1(3- 
methylcarbapenem antibiotics^661 Chiral p-lactam aldehyde 83 was synthesised by 
asymmetric hydroformylation from 4-vinyl-p-lactam 81 using the 2-Nap-BIPNITE-p-F 
ligand 82 in good yield and enantioselectivity (see Scheme 42) Subsequent oxidation 
afforded the key compound 84 with no epimerization.
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Schem e 42. Synthesis o f  P-lactam 84 by asymmetric hydroformylation
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Although the control o f enantioselectivity using these types o f ligands has provided a 
significant advancement in the area o f asymmetric hydroformylation, the range of 
substrates that can be used in these reactions is still relatively limited. One method that 
may overcome this is the use o f a substrate-bound catalyst directing group (CDG) which 
allows for diastereoselective hydroformylation of substrates. Breit et al. have developed 
this strategy for the desymmetrising hydroformylation of prochiral dialkenylcarbinols 85 
and diallylcarbinols using a planar -chiral catalyst-directing group.[67‘69] Desymmetrisation 
of these compounds is achieved by coordination of the hydroxyl group of the carbinol 
substrate to form an or//?o-diphenylphosphanyl ferrocene adduct 86. This species then 
directs the hydroformylation reaction to one of the enantiotopic alkenes with excellent 
enantio- and diastereoselectivity (see Scheme 43). Removal o f the directing group is 
achieved by saponification of the ester functionality with ethanolic potassium hydroxide 




















Scheme 43. Desymmetrising hydroformylation using a planar-chiral catalyst-directing group
1.3.4 Catalytic asymmetric isomerisation
The catalytic asymmetric isomerisation o f prochiral ally lie amines has been shown to be an 
effective method for the synthesis of chiral aldehydes via chiral enamines. In 1978 Otsuka 
et al. reported the use of a chiral cobalt complex catalyst to affect the asymmetric 
isomerisation o f geranyl- and nerylamine derivatives, however the enantioselectivity o f the 
cobalt catalysts investigated was too low to be synthetically useful (approximately 
30% e.e.).[70] Later the development of a rhodium (I) BINAP complex catalyst was found
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to be successful for the asymmetric isomerisation of ally lie amines,[71] which subsequently 
led to it’s development for the industrial scale preparation of (-)-menthol and other related 
terpenes from geranylamine.[72] The prochiral allylic amine 87 is isomerised with [Rh((-)- 
BINAP)(COD)]ClC>4 to give chiral enamine 88 in excellent yield and enantioselectivity. 
Subsequent hydrolysis with dilute sulfuric acid affords (+)-citronellal 89 which can then be 
stereoselectively cyclised and reduced to /-menthol 90 in good yield and enantioselectivity 
(see Scheme 44).
[Rh((-)-BINAP)(C0D)]CI04 f  T | H+
MEt2 100 C, THF, 7 hours NEt2
8 8  89
98% e.e. 98% e.e.






Scheme 44. Catalytic asymmetric isomerisation o f  allylic amines
The reaction is thought to proceed by a 1,3-hydride shift involving a rj-allyl 
intermediate.[73J Interestingly, the resulting chiral enamine was found to always possess 
(is)-alkene geometry regardless o f the geometry of the prochiral allylamine. Also there are 
no chemoselectivity issues in isomerisation o f allylic amines such as 87 which contain two 
different types of alkene functionality. The complex is stable, maintaining high levels o f 
stereocontrol through several catalyst turnovers.
Although the isomerisation o f allylic amines has proved to be a synthetically useful 
process, isomerisation o f allylic alcohols would have the advantage that it is a completely 
atom economic process, however this area has been much less studied. In 2000 Fu et al. 
reported the use of a planar-chiral phosphaferrocene 91 to affect the asymmetric 
isomerisation of (Z)-allylic alcohols with good enantioselectivity (64 -  86% e.e.) and
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reasonable yield (55 -  91%) (see Scheme 45).t74] This was a considerable breakthrough as 
previously the highest enantioselectivity achieved was 53% e.e. for the asymmetric 
isomerisation of (£)-3-phenyl-but-2-en-l-ol with a rhodium(I) BINAP catalyst in 47%
Scheme 45. Asymmetric isomerisation o f allylic alcohols with planar-chiral phosphaferrocene ligand 91
This procedure was further developed in 2001 by modification o f the phosphine substituent 
to an ortho-tolyl group in place of the phenyl groups. This allowed access to a much more 
robust ligand 92, which was not only more air stable but also significantly improved the 
scope, enantioselectivity (57 -  93% e.e.) and yield (60 -  98%) of these reactions (see
Scheme 46. Asymmetric isomerisation o f  allylic alcohol with modified planar-chiral phosphaferrocene 
ligand 92
Interestingly it was discovered that use o f the air stable, crystalline [Rh(COD)(92)]BF4 
complex was found to give higher enantioselectivity than the previously used [Rh(92)]BF4
yield.174'751
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which was made via hydrogenation of [Rh(COD)(92)]BF4 as a precatalyst. This simplifies 
the reaction procedure and also allows for the catalyst to be easily recyclable without 
significant loss of enantioselectivity or yield. It was also found that the highest 
enantioselectivities were obtained with (£)-allylic alcohols in contrast to previous reports. 
Mechanistic studies have shown that this reaction is likely to proceed via an intramolecular 
1,3-migration pathway analogous to the pathway found tor asymmetric isomerisation o f 
allylic amines.
Recently Crevisy et al. reported the first use of a rhodium phosphoramidite complex to 
catalyse the enantioselective isomerisation of allylic alcohols. This uses ligand 93 to effect 
asymmetric isomerisations of a range o f allylic alcohols in high yield (84 -  89%) with 
moderate to good enantioselectivities (38 -  70%) as shown in Scheme 47J77] In 
concordance with Fu’s work it was found that isomerisations o f (£)-allylic alcohols 
proceeded with higher stereoselectivities than those starting from (Z)-allylic alcohols, and 
that a 1,3-hydride shift is involved in this reaction.
Scheme 47. Asymmetric isomerisation o f allylic alcohols catalysed by a rhodium(I) phosphoramidite 
complex
Although the enantioselectivities achieved in this reaction are not as high as those reported 
by Fu, it serves to highlight that further research should be directed towards development 
of novel, easily accessible ligands to affect these transformations.
7 mol% Rh/ligand








Kinetic resolution o f racemic compounds is a useful strategy for the synthesis o f chiral 
molecules.[78] In 1989 Oguni et al. reported the use of diethyl zinc in the presence of small 
amounts of chiral (3-amino alcohols for the kinetic resolution of racemic aldehydes by 
enantioselective alky lat ion.[79] It was found that when the (/?)-enantiomer of the |3-amino 
alcohol ligand was used, the (^)-enantiomer of the aldehyde reacted faster affording the 
(/?)-alcohol and the enantiomerically enriched (5)-aldehyde. This reaction has been adapted 
to a range of aldehydes using various (3-amino alcohols with moderate success and has 
been exploited for the synthesis o f styrene oxide 95 from resolved 

















p h ^ J ^  1.2 eg. BH3SM e2  ^ P h ^ ^ 0H  1 3 ^  NaH  ^ Ph„. ^
Cl
(S)-94 (S)-alcohol {R}- 95
Scheme 48. Kinetic resolution o f aldehydes by enantioselective alkylation for the synthesis o f styrene oxide
More recently Kosmrlj et al. have reported the crystallization-induced dynamic resolution 
of a number racemic ketones and aldehydes.[8,] For example, racemic aldehyde 96 was 
reacted with chirally pure amine 97 to afford four rapidly equilibrating diastereomers of 
aldimine 98 in quantitative yield. Subsequent stirring and concentration resulted in 
continuous precipitation of the most crystalline aldimine which was then hydrolysed to 













Scheme 49. Crystallisation-induced dynamic resolution o f  racemic aldehyde 96
Fu et al. have developed a new method for the rhodium catalysed synthesis of 
cyclopentenones from 4-alkynals,[82] and have exploited the asymmetric variant of this 
reaction to allow for the kinetic resolution o f racemic alkynals as shown in Scheme 50.[83] 
This reaction has been applied to a range of alkynal substrates resulting in excellent levels 
of enantiomeric excess in the unreacted alkynal (93 -  99% e.e.). For substrates with a 
tertiary stereocentre at the (3- carbon, DUPHOS was used as a chiral ligand, whilst 
Tol-BINAP was used for substrates where the J3- carbon was a quaternary centre. The 
difference in rate between the faster and slower reacting enantiomers was different enough 
for either the enantiomerically enriched aldehyde or the chiral cyclopentenone to be 









Scheme 50. Rhodium catalysed kinetic resolution o f  racemic 4-alkynals
Another important resolution strategy is the use of enzymes as catalysts for stereocontrol. 
Yamazaki et al. reported the use of horse liver alcohol dehydrogenase (HLADH) for the
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kinetic resolution of formyl-substituted derivatives of tricarbonyl(cyclopentadienyl) 
manganese and (benzene)tricarbonyl chromium.[84] Racemic 1-formyl-2-methyl 
tricarbonyl(cyclopentadienyl) manganese 99 was reduced with HLADH and NADH to 
yield alcohol 100 and unreacted (5)-aldehyde 99. Once separated the alcohol could be 
oxidised back to its enantiomerically pure (7?)-aldehyde 99 using manganese dioxide in 
good yield (see Scheme 51). The same procedure was used to obtain both enantiomers of 
tricarbonyl(2-methylbenzaldehyde) chromium 101, which allowed easy access to both 
enantiomers of the tricarbonyl complexes in 100% enantiomeric excess.
OHC^  ^Me
V
M e^ ^CHO Mnocr i "co
CO
CO
O C 'T 'C O  (1S M *H >9
HLADH 31% yield
O H C . Me NADH M e . . C H z O H  M e . . C H O
MnO? i
Mn Mn  ► ______ ^Mn____
OC" k "CO OC" 1 "CO O C ' k "CO
CO CO CO
(rac)-99 (-)-100 (1R)-(-)-99
35%  yield 78% yield











Schem e 51. HLADH mediated kinetic resolution o f chiral metallocenic aldehydes
This approach has been extended by Jaouen et al. for the resolution o f a range of other 
ortho- and /weta-substituted tricarbonylchromium benzaldehydes using bakers yeast.[85] 
£>//zo-substituted methoxy, methyl, chloro, fluoro and trimethylsilyl benzaldehydes 102 
were reduced with bakers yeast to their (l/?)-alcohols 103 and the unchanged (15)- 
aldehyde 102 which could be isolated with good enantioselectivity (see Scheme 52). 
Reduction of the meta-substituted methoxy and methyl benzaldehydes 104 resulted in the 
opposite selectivity yielding the (15)-alcohol 105 and unchanged (l/?)-aldehyde 104 under 
the same conditions. After isolation the compounds could be recrystallised to give chiral
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(rac)-104
Scheme 52. Resolution o f  ortho- and meta-substituted tricarbonylchromium benzaldehydes by bakers yeast
Smonou et al. developed an enzymatic resolution of more simple aldehydes using Candida 
rugosa lipase (CRL).[86] Racemic 2-phenyl-propanal 106 was converted to its acylal 107 
and then enantioselectively hydrolysed back to a mixture o f the enantiomerically enriched 
starting aldehyde (/?)-106 and unchanged acylal (S)-107 by CRL (see Scheme 53). A 
number o f different enzymes were tested for this hydrolysis reaction but it was found that 
CRL gave the best enantioselectivity over the shortest reaction time (70 minutes for 25% 
conversion).
O OAc O OAc
106 107 (R)-106 (S)-107
72% e.e. 62% e.e.
Scheme 53. Resolution o f protected 2-phenylpropanal with CRL
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Aoyagi et al. have reported the asymmetric synthesis of 2-formyl-l,r-binaphthyl (/?)-110 
using the lipase catalysed kinetic resolution o f acetyloxime 108, which was easily 
synthesised by a Suzuki cross c o u p l i n g . F o r  example using Pseudomonas species LIP, 
kinetic resolution of acetyloxime 108 was carried out in good yield and high 
enantioselectivity followed by acid hydrolysis to afford (R)-110 in excellent yield and 

















Scheme 54. Kinetic resolution o f racemic oxime 108 in the synthesis o f  chiral aldehyde 110
Although these types of kinetic resolution protocols can be an effective method in 
asymmetric synthesis, the major disadvantage is the limit to reaction yield, with even the 
most successful reactions producing a 50% yield of the desired chiral product.
1.3.6 Chiral masked aldehyde equivalents
Chiral sulfur compounds can be used as aldehyde equivalents in asymmetric synthesis, 
allowing access to umpolung reactivity o f carbonyl compounds. Scolastico et al. reacted 
the anion of sulfoxide 111, which is a chiral formyl anion equivalent, with benzaldehyde to
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give the sulfoxide adduct 112 as a mixture o f diastereomers.[88] This adduct was then O- 
methylated to overcome the instability of the hydroxyl adduct to give 113 in good yield. 
Subsequent reduction of the sulfoxide substituent of 113 and hydrolysis of the dithioacetal 
fragment of 114 affords the chiral a-methoxy aldehyde 115 in reasonable yield and greater 
than 70% e.e. (see Scheme 55).
OH OMe
CH2STol o  BuLi, THF JL Bu4NOH, Me2S 0 4 JL
A +  U ------------------- ► Ph CHSTol ---------------------------------- ► P h CHSTol
TolO* ^  P t T ^ H  g  H20 ,  DCM
u  Tol"Vb \ .  Tol">b \ .
O '  O '
111 112 113
91% yield 90% yield




68%  yield 67% yield
> 70% e.e. >70% e.e.
Scheme 55. Synthesis o f  a-methoxy aldehyde 115 using a formyl anion equivalent
Trost et al. developed this methodology further by using chiral a-acetoxysulfones derived 
from a,|3-unsaturated aldehydes.[89] Chiral a-acetoxysulfones are readily synthesised by 
palladium catalysed asymmetric allylic alkylation reactions o f allylic gem diesters 116 in 
good yield (73 -  94%) and excellent enantioselectivity (> 94% e.e.) as shown in Scheme 
56. Furthermore, either enantiomer o f chiral acetoxysulfone may be easily accessed 






2 mol% [(C3H5PdCI)2] 
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R S 0 2Ph
Ri
PPh2 Ph2P '
Schem e 56. Palladium catalysed asymmetric allylic alkylation for the synthesis o f chiral a-acetoxysulfones
A range of these a-acetoxysulfones have been synthesised and used to direct 
dihydroxylation reactions with osmium tetroxide and jV-methylmorpholine oxide to yield 
the corresponding diols 117 in good yield (57 -  94%) and with excellent diastereocontrol 
(mostly >90% de.). Since hydrolysis to the chiral aldehyde is difficult at this stage, the 
diol 117 is converted to the acetonide protected sulfone 118 which can then be employed 
as a masked “aldehyde equivalent” in reactions with nucleophiles, such as 
phenylmagnesium bromide (see Scheme 57). This avoids the need to handle 
configurationally unstable aldehydes and allows access to aldehyde equivalents that are 
acid-stable.
OAc
" S 0 2Ph
5% O s 0 4, NMO 









> 96% d.e. 
77% yield






0  0  OH
H - h K ;
Ph H F
118 > 96% d.e.
Schem e 57. Chiral sulfones as masked aldehyde equivalents
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Attempts to directly liberate the chiral aldehyde from the acetonide protected sulfone 118 
gave mixed results. Compounds derived from a di-substituted alkene led to epimerisation
compounds derived from tri- or tetra-substituted olefins such as 119 however, the use of 
potassium carbonate and methanol allowed hydrolysis to the a,(3-acetonide aldehyde 120 in 
excellent yield and without racemisation o f its stereocentres (see Scheme 58).
93% yield
Schem e 58. Liberation o f chiral aldehyde from a-acetoxysulfone
One o f the disadvantages o f using a chiral aldehyde equivalent is the need for an extra step 
in formation of the sulfone in comparison to a direct enantioselective reaction on the 
alkene. However, the recent development of a one-pot dihydroxylation, differential 
protection and aldehyde unmasking strategy overcomes this, allowing access to some diol 
products that cannot be synthesised by asymmetric dihydroxy lat ion o f the corresponding 
enals.[90] The a-acetoxysulfones 121 are treated with catalytic osmium tetroxide and NMO 
to affect the dihydroxylation as before, followed by addition o f 4-dimethylaminopyridine 
to facilitate 1,3-acyl migration, yielding the differentially protected aldehydes 122 as a 
single product in good yield and high diastereomeric excess (> 96% d.e.) as shown in 
Scheme 59.
o f the a-stereocentre or decomposition under a range of basic conditions.[90] For
K2C 0 3> MeOH
119 120
E t02C S 0 2Ph




Schem e 59. One-pot dihydroxylation-differential protection unmasking strategy
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Another class of chiral aldehyde equivalent are chiral y-aryloxybutenolides whose C-4 
stereocentre can direct either stepwise or concerted addition o f nucleophiles to yield 
products that are masked aldehyde-carboxylic acids (see Scheme 60).
stepwise addition
concerted addition
Scheme 60. Hydroxybutenolides as chiral aldehyde equivalents
These compounds were originally developed by Feringa et al. using menthol as a chiral 
auxiliary for their synthesis.t91] More recently, Trost et al. have introduced 
hydroxybutenolide 123 which is prepared using a palladium catalysed asymmetric allylic 
alkylation in a dynamic kinetic asymmetric transformation.[92] They showed that this 
lactone could undergo Michael additions (stepwise) and cycloadditions (concerted) with a 
range o f nucleophiles or dipolarophiles in good yield and high diastereoselectivity. The 
cycloaddition strategy was used for the synthesis of brefeldin A, a natural product with a 
range of biological activity, as shown in Scheme 61. The [3+2] cycloaddition of a 
trimethylenemethane precursor with chiral butenolide 123 gave bi-cyclopentene 124 which 
was then treated with catalytic osmium tetroxide and sodium periodate to give ketone 125. 
Ketone 125 was then chemo- and diastereoselectively reduced and silyl-protected to 
compound 126 which was ring opened to aldehyde/Weinreb amide 127 which was a key 



























Schem e 61. Use o f  hydroxybutenolide 123 as an aldehyde equivalent in the synthesis o f brefeldin A
Therefore, the use of hydroxybutenolides as aldehyde equivalents is complementary to the 
use o f acetoxysulfones, allowing both nucleophilic and electrophilic additions to 
functionalise chiral aldehydes.[90]
1.3.7 Chiral auxiliaries
Chiral auxiliaries are often used for the synthesis of chiral aldehydes due to the ability o f a 
masked aldehyde functionality to govern the diastereoselective transformation of a 
prochiral group within a substrate. Most of these strategies rely on cleavage of a 
transformed substrate to a chiral alcohol which is then oxidised to a chiral aldehyde, or 
reduction of an acid derivative to yield a chiral aldehyde, as described earlier. However, 
there are several examples o f the use o f chiral auxiliaries in the synthesis of chiral 
aldehydes which do not require oxidative or reductive methods. Eliel et al. have developed 
a chiral 1,3-oxathiane 128 which is converted to chirally pure 2-acyl derivatives by an 
aldol type reaction with an aldehyde, followed by oxidation o f the resultant alcohol with
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DMSO and (CF3CO)2 0 .[93] These chiral ketones 129 can then be reacted with a range o f 
Grignard reagents with high diastereoselectivity (generally > 90% d.e.) and then cleaved to 
give chiral tertiary a-hydroxy aldehydes 130 with good enantioselectivity (> 94% e.e.) via 
treatment with NCS and silver nitrate as shown in Scheme 62. The reaction also yields 
oxathiane-derived sultine 131 which can be recycled to the original oxathiane 128 in 
excellent yield. The chiral a-hydroxy aldehydes could be isolated, but were found to be 
very unstable and were therefore directly converted into either their corresponding chiral 
alcohol by reduction with sodium borohydride, or selectively oxidised to their 
corresponding a-hydroxy acid by treatment with iodine, potassium hydroxide and 
methanol, with no loss of enantiomeric excess. Both enantiomers o f chiral product could 
be obtained by either reversing the order of introduction of the R and Ri groups (see 
Scheme 62), or by using the opposite diastereomer of oxathiane 128.
p h  D M S O ,  ( C F 3 C 0 ) 2 0a )  B u L i
b )  P h C H O
O H
128 129
A g N 0 3
76% yield 130 131
99% d.e.
Schem e 62. Use o f  oxathiane 128 as a chiral auxiliary for the synthesis o f chiral a-hydroxy aldehydes
Colombo et al. have developed norephedrine and camphor derived 2-acyk/V-BOC- 
oxazolidines as chiral auxiliaries for the asymmetric synthesis o f chiral a- 
hydroxyaldehydes. [94 95] They may be converted into chiral aldehydes 132 which react with 
a range o f Grignard reagents or allyltributylstannanes in reasonable yield (54 -  90%) and 
excellent diastereoselectivity, especially in the presence o f strong Lewis acids to promote 
chelation (generally > 96% t/e.).[96] The resulting chiral alcohol 133 was 0-benzoyl 
protected before the chiral aldehyde 134 was released by hydrolysis with dilute acid and 
immediately reduced to the more stable chiral alcohol 135 with sodium borohydride in 
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134 135> 96% e.e.
Schem e 63. Camphor derived auxiliary for the synthesis o f a-hydroxy aldehydes
A similar piperidin-3-ol auxiliary 136 has been used Chung et al. for the synthesis of a- 
hydroxy aldehydes.[97] The chiral piperidine derived auxiliary was reacted with 
phenylglyoxal monohydrate to yield the bridged 2-acyl-1,3-oxazolidine 137 which was 
then treated with a range o f Grignard reagents or organolithiums to yield a diastereomeric 
mixture of chiral alcohols and (S ^ -IS S  in good yield (generally > 83%).
Interestingly, it was found that addition o f Grignard reagents favoured formation o f an 
(5)-configured alcohol 139 with high diastereoselectivity ( 8 6  -  96% d.e.), whereas use of 
organo lithiums resulted in formation o f the (/?)-alcohol 139 with lower stereoselectivity. 
Both enantiomers o f the chiral aldehyde could be released by treatment with silica gel in 
DCM in good enantiomeric excess, allowing for efficient and easy access to a range of 
a-hydroxy aldehydes (see Scheme 64).
h o HQ, R HO xSR
HO"”T 1 PhCOCHO^ RM w R h ^ Y H + P h ^ ^ H
1 3 6  137 (S)-138 (R)-138
silica gel
(S)-139 (f?)-139 136
Schem e 64. (/?)-Piperidin-3-ol as a chiral auxiliary for the synthesis o f  a-hydroxy aldehydes
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Another class of compounds often used as chiral auxiliaries for the synthesis of chiral 
aldehydes are acetals.[98] For example, Yamamoto et al. have used chiral diisopropyl 
tartrate and diethyltartrate to form enantiopure acetals 140 with a range of a,p-unsaturated 
aldehydes.[99] The tartrate ligand then controls a Simmons-Smith reaction to yield 
cyclopropane 141 in reasonable yield (50 - 95%) and high diastereoselectivity (85 - 94%). 
The chiral aldehyde 142 was released by simple hydrolysis with /wra-toluenesulfonic acid 
and water without any loss o f enantiopurity (see Scheme 65). Since both (R,R)- and (S,S)- 
enantiomers of tartaric acid are readily available, synthesis o f either enantiomer o f chiral 
aldehyde is easy and predictable.
EU .H
Me Me
Me a) HC(OEt)3, NH4NO3. \ K j
EtOH E t' ^ V r ^O CH2l2,E t2Zn
 ► I V - C 0 2/-Pr ------------------- ► I V - C 0 2/-Pr
b) L-(+)-DIPT O ^ y  o ^ y





TsOH, MeOH, H20 E K |> ^  M
142
89% e.e.
Schem e 65. Diisopropyl tartrate controlled asymmetric synthesis o f  cyclopropane aldehydes
Chiral imidazolidines are the nitrogen equivalents of chiral acetals which can also act as 
chiral auxiliaries for the synthesis o f chiral aldehydes. They have some advantages over 
acetals since imidazolidines are formed without the need for catalysts, and can be 
hydrolysed back to their parent aldehyde under mild conditions without racemisation.[IOOJ 
Chiral aminals have been used widely for the synthesis o f chiral aldehydes, with Alexakis 
et al. having reacted chiral diamine 143 with aqueous glyoxal to form aminal 144 in 90% 
crude yield, which was then used to direct several different transformations.[10IJ Reaction 
with organo lithiums, followed by acetyl protection of the hydroxyl group proceeded in 
good yield and forms a single diastereomer of aminal 145 which could be hydrolysed to a- 
acetoxy aldehyde 146 with no loss o f enantiomeric excess (see Scheme 6 6 ). Aminal 144 
also underwent a Wadsworth-Emmons olefination to yield (is)-a,j3-unsaturated ester 147 
followed by conjugate addition of cuprates to yield 148 with complete diastereocontrol. 
Hydrolysis o f this adduct 148 afforded chiral aldehyde 149 with no appreciable
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racemisation. The aminal could also be transformed into imine 150 via treatment with 
primary amines such as tritylamine, which reacted with organolithium reagents to afford a 
single diastereomer o f adduct 151 in good yield,[l02] whereas treatment with Grignard 
reagents led to formation of the opposite stereocentre in adduct 151 .[I03] Subsequent 
removal of the 7V-trityl group and N-Boc protection, followed by mild acid hydrolysis 
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Scheme 6 6 . Aminals as chiral auxiliaries in the synthesis o f chiral aldehydes
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More recently Normant et al. have developed a chiral lithium amide 153 which can be 
added to prochiral aldehydes such as cinnamaldehyde to form an aminoalkoxide 154.tl04] 
Addition of various organolithium reagents resulted in a regio- and stereoselective 
carbolithiation which can lead to the synthesis of a-mono 155, or a,|3-disubstituted 156 
aldehydes on quenching with either acid/water or methyl iodide in good yield and 
enantiomeric excess (see Scheme 67).
4 eq. n-BuLi
Schem e 67. Lithium amide 153 mediated carbolithiation for the synthesis o f  chiral aldehydes
Gawley et al. have developed a camphor-derived auxiliary 157 which can be lithiated and 
added to a range o f aldehydes to afford crystalline adducts 158 which simplifies the 
purification o f diastereomers.[,05] It was found that addition o f auxiliary 157 to 
benzaldehyde, cyclohexane and propanal resulted in attack at the Si face o f the aldehyde to 
yield adduct (R,R)~ 158 in good yield and diastereoselectivity, whereas addition to 
pivaldehyde occurred with lower selectivity to the Re face of the aldehyde to produce 
(R,S)-15S (see Scheme 6 8 ). Mercury assisted hydrolysis released both enantiomers o f 
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Scheme 6 8 . Camphor derived auxiliary 157 in the synthesis o f  a-hydroxyaldehydes
Seebach et al. have developed a novel thiomethyl oxazolidinone 160 which can be used for
followed by treatment with aldehydes, ketones or imines affords adducts 161, 162 and 163, 
in moderate to excellent yield and good diastereoselectivity. After selective protection o f 
the hydroxyl functionalities, these adducts could be hydrolysed to yield hemiaminal 
intermediate 164 which collapsed to chiral aldehyde 165 on treatment with DBU (see 
Scheme 69).
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R1 = H or alkyl 
X = O or N
Schem e 69. Methylthiomethyl oxazolidinone 160 as a chiral auxiliary for the synthesis o f chiral aldehydes
Although chiral auxiliaries have been widely used for the asymmetric synthesis o f chiral 
aldehydes, the range of functionalities that has been incorporated into these non- 
reductive/oxidative strategies is still fairly limited and there is still much potential for 
further work in this area.
1.3.8 Conjugate additions and cycloadditions to a,p-unsaturated aldehydes
Conjugate additions represent a useful carbon-carbon bond forming reaction in asymmetric 
synthesis, however one of the inherent difficulties associated with 1,4-conjugate additions 
to unsaturated aldehydes is the propensity o f the aldehyde functionality to undergo 
competing 1,2-addition pathways. Nakajima et al. have developed a cadmium complex of 
chiral A^V'-bis-pyridine-TV-oxide ligand 166 which can catalyse conjugate additions of 
thiophenol to enals in good yield and enantioselectivity, after reduction to their more stable 
chiral alcohols 167 in situ (see Scheme 70).tl07’108] The mildness of these conditions
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overcomes the usual lability of the aldehyde functionality allowing for the first reported 
enantioselective conjugate additions o f thiols to enals, in addition to being the first report 
o f a cadmium complex being used in an enantioselective reaction.
1 mol% Cdl2, 1 mol% (S)-166 NaBK
2 eq. PhSH, toluene, RT MeOH
(S )-1 6 6
Schem e 70. Enantioselective conjugate addition o f thiophenol to enals catalysed by Cdl2-166
Maruoka et al. have found that a chiral quaternary ammonium bifluoride complex 170 
could control the regio- and stereo-chemistry of fluorine catalysed Michael addition of silyl 
nitronates 168 to a,|3-unsaturated aldehydes 169 via formation of chiral ammonium 
nitronate intermediates in situ.[l09] Tuning of the ligand structure allowed conditions to be 
identified that afforded a highly selective 1,4-addition reaction (32:1, 1,4-: 1,2- 
addition).[1,0] The reaction yields stable enol silyl ethers 171 in excellent yield and 
enantioselectivity, which could be converted into chiral y-nitro aldehydes 172 via treatment 
with acid with no loss of enantiomeric excess. Another useful feature of this reaction is that 
protonation of enol silyl ether 171 containing an a-substituent can be carried out 
diastereoselectively by simple treatment with HC1 at 0 °C to exclusively furnish chiral 
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Schem e 71. Asymmetric Michael addition o f silyl nitronates to a,P-unsaturated aldehydes catalysed by chiral 
quaternary ammonium bifluoride 170
Motoyama et al. have reported the novel asymmetric Michael addition o f a- 
cyanopropionates to acrolein using the Phebox-derived 174 rhodium(III) catalyst.[lll] The 
best enantioselectivities were achieved with a-cyanopropionates containing bulky ester 
groups such as 173 affording chiral aldehyde 174 containing a y-stereocentre in excellent 
yield over short reaction times (see Scheme 72).
Me [{(o-octene)2RhCI}2] XX









Schem e 72. Michael addition o f a-cyanopropionates to acrolein
The tandem Michael addition-elimination of sulfur or tellurium ylides to electron deficient 
olefins is a useful strategy for the synthesis of fiinctionalised cyclopropanes. This reaction
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has been previously reported for the enantioselective cyclopropanation o f esters, amides, 
ketones and nitriles,[112114] however the reactivity of the aldehyde functionality makes the 
synthesis o f their corresponding cyclopropane aldehydes difficult due to the presence of a 
competing epoxidation mechanism. To overcome this problem, Tang et al. have used a,J3- 
unsaturated imines in enantioselective cyclopropanations with tellurium ylides.[115] Thus 
telluronium salt 176 undergoes deprotonation with NaHMDS followed by conjugate 
addition to imines 177, to afford an adduct which on exposure to damp silica gel afforded 
chiral cyclopropane aldehydes 178 in good yield and excellent selectivity (see Scheme 73).
- © B P h 4
TMS
a) NaHMDS







> 95% d.e. 
99%  e.e.
Schem e 73. Asymmetric cyclopropanation o f a, (3-un saturated imines 177 with tellurium ylide 176
Recently Hayashi et al. have reported the rhodium catalysed asymmetric 1,4-addition o f 
arylboronic acids to a,J3-unsaturated aldehydes mediated by a chiral diene ligand 181.[116] 
Optimisation of ligand and conditions maximised the yield o f the 1,4-addition pathway 
enabling a range of electron-rich and electron-deficient arylboronic acids 180 to be used 
for the synthesis of a range of chiral aldehydes 182 in excellent yield and enantiomeric 
excess (see Scheme 74). This reaction allowed access to both enantiomers of chiral 
aldehyde XX using the same enantiomer of chiral ligand 181, simply by altering the 
sequence of substituents on the aldehyde and boronic acid. The (S^-enantiom er of chiral 
diene ligand 181 was also used for the 1,4-addition o f arylboronic acids to a,p-unsaturated 
Weinreb amides in high yield (74 -  93%) and excellent enantioselectivity (80 -  
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Schem e 74. Asymmetric conjugate addition o f  arylboronic acids to a,(3-unsaturated aldehydes mediated by 
Rh/(/?^?)-181
In the same year Carreira et al. reported a related chiral diene ligand 184 to affect this type 
of rhodium catalysed addition o f electron rich and electron poor arylboronic acids to 
substituted cinnamaldehydes 183 in good yield (63 -  90%) and excellent enantioselectivity 
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90% yield
93% e.e.
Schem e 75. Asymmetric conjugate addition o f  arylboronic acids to substituted cinnamaldehydes mediated by 
Rh/184
The asymmetric 1,4-addition of organozinc reagents to a,(3-unsaturated aldehydes without 
the need for a metal catalyst has recently been reported by Brase et al.[U9] For example 
cinnamaldehyde 183 was treated with diethylzinc in the presence of chiral ligand 
(/?P,S)-186 to afford the corresponding 1,4-addition product 187 in excellent 98% e.e. (see 
Scheme 76). Unfortunately yields were moderate (43%) due to competing formation of the 








Schem e 76. Asymmetric 1,4-conjugate addition o f  diethyl zinc to cinnamaldehyde without the need for metal 
salts
Corey et al. have developed a cationic chiral catalyst for the enantioselective Diels-Alder 
reaction o f a,p-enals with cyclopentadiene.[120] Chiral amino phenol ligand 189 was 
complexed to boron to generate a chiral Lewis acid 190 in situ, which was used to control 
addition of dienes to the Si face of the dienophile through transition state 192. For 
example, addition of cyclopentadiene to aldehyde 191 proceeds in excellent yield and 
selectivity to give chiral aldehyde 192 (see Scheme 77) and chiral ligand 189 which can be 
recovered and reused. This type of Diels-Alder transformation has also been carried out 
successfully using chiral Lewis acid complexes o f ruthenium, [1211 iron,[122J indium,[123] and 
cobalt,[l24] as well as tartaric acid derived chiral (acyloxy)borane (CAB) catalysts,[125] 
Bronsted acid-assisted Lewis acid (BLA),[126] and Lewis acid-assisted Lewis acid (LLA) 
chiral catalysts.[l27]
O a) Et2Zn, 2 mol% 186 Et O
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Schem e 77. Chiral Lewis acid catalysed enantioselective Diels-Alder
Kanemasa et al. have developed a chiral DBFOX/Ph complex 196 which was effective in 
enantioselective nitrone cycloadditions with a,|3-unsaturated aldehydes.[l28] In reactions 
with a-alkyl and a-aryl acroleins with nitrone 194 the nickel (II) or magnesium complexes 
afforded isoxazolidine-5-carbaldehydes 197 by steric control. For example reaction o f 
methacrolein 195 with nitrone 194 at room temperature in the presence of nickel(II)196 
complex afforded a single diastereomer of aldehyde 197 which was reduced in situ to 
afford chiral alcohol 198 in good yield and enantioselectivity (see Scheme 78). However 
when a-bromoacrolein 199 was reacted with a range of nitrones 194 it was found that 
isoxazolidine-4-carbaldehydes 200 were successfully formed using a zinc (II) complex 
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Schem e 78. Enantioselective nitrone cycloaddition with methacrolein catalysed by Ni(II)/196 complex
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q o 10 mol% Zn/196,
4 Ph *  7 _ 0 \  7 7
Ph*'' ] H mol. sieves (4A) P h ^ \ /  P h ^ \ ^
Br Br V/CHO B r  ///CH2OH
194 199 200 201
94% yield 97% e.e.
96% d.e.
Schem e 79. Enantioselective nitrone cycloadditions to a-bromoacrolein catalysed by Zn(II)/196 complex
Similar enantioselective 1,3-dipolar cycloadditions have been reported using catalysts 
based on ketoiminato cobalt(III),[129] copper(I)-Fesulphos,[130] titanium-BINOLates,[131] and 
rhodium- and iridium-Prophos comp lexes. [1321
1.3.9 Aldol reactions
Wong et al. have developed a new strategy for the synthesis of pyranose synthons using 2- 
deoxyribose-5-phosphate aldolase (DERA) for stereoselective aldol reactions^ 1335 This 
enzyme has been shown to effectively catalyse sequential aldol reactions with a range of 
aldehyde donors and acceptors. [134 ,35] This strategy has been exploited for the aldol 
reaction of the enolate of acetaldehyde with a range of |3-hydroxyaldehydes 202 to afford 
chiral aldehyde 203 which immediately cyclises to form the more stable hemiacetal 204, 
thus driving the reaction towards condensation (see Scheme 80). These hemiacetals could 
be further oxidised to lactones 205 in good yield. Interestingly, it was found that the 
substituent at the C2 position of the acceptor aldehyde had a marked effect on the 
stereoselectivity o f the reaction allowing kinetic resolutions to be carried out. For example, 
when a polar group such as OH or N3 was present the aldolase reacted almost exclusively 
with the D-isomer (see Scheme 80-A), whereas when a hydrophobic residue, such as a 
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Schem e 80. Aldolase catalysed synthesis o f pyranose synthons via chiral aldehyde 203
In 2001, Denmark et al. reported the first catalytic enantioselective crossed-aldol reactions 
of aldehydes using a dimeric chiral Lewis base 207 as a catalyst. 11361 A range of 
trichlorosilyl enolates such as 206 were reacted with a range of aldehydes to afford 
crossed-aldol products such as 208 in high yield and moderate to high enantioselectivity, 
with syn or anti diastereoselectivity being governed by the (E)- or (Z)-conformation of the 
trichlorosilyl enolate. It is thought that these reactions overcome many of the usual 
problems associated with aldol reactions o f aldehydes by chelation o f  the aldehyde 
carbonyl to silicon which reduces the Lewis basicity of the aldol product.[137] The aldol 
products were immediately protected as their dimethyl acetals 209, however these could be 
converted to their TBS protected aldehydes 211 in two high yielding steps with no 
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Scheme 81. Enantioselective crossed-aldol reaction catalysed by 207
1.3.10 Rearrangement reactions
Epoxy silyl ethers are easily accessed from allylic alcohols via the Sharpless asymmetric 
epoxidation reaction. Yamamoto et al. have reported a novel stereocontrolled 
rearrangement of epoxy silyl ethers to yield p-siloxy aldehydes in good yield and 
stereocontrol using a bulky organoaluminium Lewis acid catalyst under mild 
conditions.[138] For example, Sharpless asymmetric epoxidation of allylic alcohol 212, 
followed by silylation gives rise to either enantiomer o f epoxide 213 in excellent 
enantioselectivity. Subsequent treatment of either enantiomer with methylaluminium bis(4- 
bromo-2,6-di-tert-butylphenoxide) (MABR) 215 afforded either enantiomer of chiral 
aldehyde 214 in good yield and with no loss of enantioselectivity (see Scheme 82). 
Although this reaction uses two equivalents of MABR it was possible to reduce the amount 
to catalytic quantities (up to 10 mol%) with no loss of enantioselectivity. However, the 
catalytic protocol was found to be less tolerant of a range o f substitution on the epoxide 
fragment. The development of a high valent metalloporphyrin chromium complex
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Scheme 82. Organoaluminium promoted rearrangement o f epoxides in the synthesis o f chiral aldehydes
In 2003 Nelson et al. reported the isomerisation-Claisen rearrangement (ICR) reaction 
catalysed by an iridium phosphine speciesJl40] The reaction was optimised to allow (-)- 
MIB 216 catalysed addition o f diethylzinc to cinnamaldehyde and subsequent Pd catalysed 
O-allylation to afford (5)-bis(allyl) ether 217. This ether subsequently underwent ICR 
reaction on treatment with iridium phosphine species 218 followed by triphenyl phosphine, 
which attenuates the Lewis acidity of the iridium complex to prevent epimerisation of the 
aldehyde stereocentre, to afford pentenal 219 in excellent syn.anti diastereoselectivity and 
high e.e. (see Scheme 83).tl41]
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a) 2 mol% 216 
EtjiZn, pentane, 0 °C



















Schem e 83. Isomerisation-Claisen rearrangement reaction catalysed by iridium phosphine species 218
Recently Cossy et al. have reported the rearrangement of homoallylic alcohols induced by 
diethylaminosulfur trifluoride (DAST).[I42] Treatment of (3,y-unsaturated monoprotected 
diols such as 220 with DAST allow the stereoselective formation of |3,y-unsaturated 
aldehydes in good yields and with good transfer of chirality (see Scheme 84). The reaction 
of homoallylic alcohol 220 with DAST affords homoallylic fluoride 221 which could be 
isolated and converted to p,y-unsaturated aldehyde 2 2 2  in good yield and enantiomeric 
excess on exposure to silica gel. The enantioselectivity and configuration of aldehyde 222 
was determined by reduction to the alcohol, transformation to the corresponding lactone 
and comparison to literature data.
TBDPSO OH
a) 5 eq. DAST. DCM,











Schem e 84. Rearrangement o f homoallylic alcohols by DAST
1.3.11 Organocatalysis
Organocatalysis, the acceleration o f chemical reactions using substoichiometric amounts of 
an organic compound that do not contain a metal atom, is one of the biggest areas o f 
current research in asymmetric synthesis. This area has recently been extensively and 
exhaustively reviewed[l43 I46] and therefore this section will only describe a few
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representative examples that highlight the synthetic utility o f organocatalysts for the 
asymmetric synthesis of chiral aldehydes.
Ha et al. have developed an organocatalytic Diels-Alder reaction o f a,p-unsaturated 
aldehyde 223 using a chiral 1,2-diamino-1,2-diphenylethane catalyst 224 in excellent yield 
and good enantioselectivity (see Scheme 85). It was proposed that the enantioselectivity of 
the reaction is governed via a hydrogen bonded intermediate 225.
Me o
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Schem e 85. Organocatalytic Diels-Alder reaction
Macmillan et al. have found that formation of an iminium ion conjugated with a double 
bond lowers the energy o f the olefin LUMO, which enables conjugate addition o f electron 
rich aromatic or heteroaromatic rings to a,|3-unsaturated aldehydes.[147‘149] For example, 
using chiral imidazolidinone catalyst 227, A(A-dimethylaniline could be added to 











Schem e 86. Organocatalytic conjugate addition
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The same imidazolidinone catalyst 227 has been used by Wang et al. for the 
enantioselective Mukaiyama-Michael addition reaction o f silyl ethers to a,P-unsaturated 
aldehydes to afford 5-keto aldehydes containing a |3-stereocentre in good yield (56 -  87%) 
and high enantioselectivities (85 -  97%).[150] For example silyl enol ether 228 was reacted 
with cinnamaldehyde in the presence o f chiral imidazolidinone 227 and acid additive 2,4- 
dinitrobenzene sulfonic acid (DNBA) to afford chiral 5-keto aldehyde 229 with excellent 
97% enantiomeric excess albeit in moderate yield (see Scheme 87).
OTMS O Ph O
MeO
Ph
O 30 mol% 227, 30 mol% DNBA





Schem e 87. Mukaiyama-Michael addition reaction for the synthesis o f  5-keto aldehydes
Asymmetric hydrogenation o f alkene bonds often requires expensive, substrate specific 
catalysts and high pressures, however List et al. have overcome these problems by 
developing an organocatalytic asymmetric conjugate reduction of a,P-unsaturated aldehyde 
230 to form chiral aldehyde 234.[l5l] It is thought that chiral amine 231 catalyses a metal- 
free transfer hydrogenation o f the iminium ion intermediate 233 using Hantzch ester 232 as 
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Scheme 8 8 . Organocatalytic transfer hydrogenation
Aldol reactions are extremely powerful carbon-carbon bond forming reactions that can 
generate two new stereocentres. One of the limitations o f this reaction when attempting to 
react two aldehydes, is that large amounts o f homo-coupled products are often formed due 
to the inherent reactivity of the aldehyde functionality. In 2002 MacMillan et al. reported 
the first direct and enantioselective aldol reaction between two non-equivalent aldehydes, 
catalysed by L-proline.[,52] It was found that addition o f the aldehyde donor to the aldehyde 
acceptor via a syringe pump was effective in suppressing dimerisation affording the 
p-hydroxy aldehyde 235 in high yields (75 -  87%) and enantiomeric excess (91 — 
99% e.e.), a reaction which had previously only been successful using enzymatic 
catalysis.[ 1341 A range of aldehyde donors and acceptors were tolerated, including those 
containing both alkyl and aromatic substituents. Although both aldehyde substrates contain 
enolisable protons only a single aw/z-diastereomer was formed in high enantiomeric excess 
(see Scheme 89). This strategy has been extended to the dimerisation o f 
a-oxyaldehydes,[153] whose aldol products a-oxyaldehydes did not undergo further 
condensation reactions and instead could be employed in the synthesis carbohydrates by a 
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Scheme 89. Proline catalysed direct enantioselective crossed aldol reaction
Tanaka et al. have developed this strategy further to allow for the formation o f aldol
condensation between a,a-dialkyl aldehyde 236 and electron deficient aryl aldehyde 237 
with moderate diastereoselectivity affording the anti-aldol in excellent e.e. (see Scheme 
90). The stereoselectivity is thought to be controlled by the hydrogen bonded transition 
state 239 which delivers the electron deficient aldehyde to one face o f the enamine 
intermediate.
Scheme 90. Organocatalytic crossed aldol condensation
In a similar way (S)-2-methoxymethylpyrrolidine (SMP) has been used to catalyse 
Mannich reactions with preformed imines to synthesise (3-amino aldehydes in reasonable 
yield and good selectivity (see Scheme 91)J,56]
products containing quaternary stereocentres.[155] Catalyst 238 affects a crossed aldol
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Schem e 91. SMP-catalysed Mannich reaction o f  aldehydes with PMP-protected a-imino ethyl glyoxylate
Another strategy for the synthesis o f chiral aldehydes is a-substitution. This allows the 
incorporation o f heteroatoms into aldehydes which can be further elaborated to form useful 
chiral synthons. An example of this is chiral amine 242 catalysed a-sulfenylation of 
prochiral aldehydes described by Jorgensen et a l.P 57] Alpha substitution of aldehyde 240 
with sulfenylating agent 241 affords a-sulfenyl aldehyde 242 with excellent yield and 




Scheme 92. Alpha suphenylation o f  prochiral aldehydes
This strategy has also been developed to successfully allow the direct enantioselective a- 
functionalisation of aldehydes with fluorine,1158] bromine, 1[1591 nitrogen and selenium,[144] 
and recently y-amination of a,|3-unsaturated aldehydes.C160]
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In 2005 Jorgensen et al. extended the use o f this catalyst for the first asymmetric 
organocatalytic epoxidation of a,(3-unsaturated aldehydes in good yield (60 -  90%) and 
excellent enantiomeric excess (mostly > 94% e.e.), using hydrogen peroxide as an 
oxidant.[I6I] This methodology has been exploited for the direct synthesis o f pheromone 
245 as shown in Scheme 93, and the group have further extended this protocol to allow 
epoxidations to be carried out in alcohol-water solutions.[,6iJ
10 mol% 242, 4 hours, DCM
Schem e 93. Asymmetric organocatalytic epoxidation for the synthesis o f  natural product 245
In 2005 MacMillan reported a new class o f iminium catalysts capable o f enantioselective 
cyclopropanations o f a,p-unsaturated aldehydes by directed electrostatic activation.[l63] It 
was thought that zwitterions such as 247 derived from indole catalyst 246 would favour the 
formation of the (Z)-iminium species to minimise Van der Waals interactions between the 
substrate olefin and the aryl hydrogen. Consequently the carboxylate of the catalyst would 
direct ylide addition to the Re face of the electrostatically activated olefin to afford 
cyclopropanes such as 248. This was found to be successful for a range of a,p-unsaturated 
aldehydes and ylides to afford cyclopropanes in reasonable yields (63 -  85%) and with 
high levels of enantioselectivity (89 -  96% e.e.) (see Scheme 94).
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Schem e 94. Cyclopropanation o f  a, P-un saturated aldehydes using a novel iminium catalyst
Recently Maruoka et al. have developed a novel axially chiral secondary amine catalyst 
251 which was successful in affecting a direct asymmetric hydroxyamination of aldehydes 
250 with nitrosobenzene 249.[164] This affords N-hydroxy-p-amino chiral aldehydes 252 
which were reduced in situ with sodium borohydride to afford N-hydroxy-P-amino 
alcohols 253 in good isolated yield (70 -  90%) and excellent enantioselectivity (> 
96% e.e.) (see Scheme 95). The reactions are carried out under very mild conditions in one 
hour and showed no evidence of the competing aminoxylation product. The synthetic 
utility o f this reaction was extended by the use of /?-methoxynitrosobenzene 254 in place of 
nitrosobenzene to yield chiral aldehyde 255 which can then be converted to either P-amino 
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Schem e 96. One-pot synthesis o f P-amino alcohol 256 and 1,2-diamine 157 catalysed by amine 251
In 2006 Enders et al. reported an elegant synthesis of tetra-substituted cyclohexene 
carbaldehydes using a three component domino reaction catalysed by pro line derivative 
260.[165] This strategy involves a Michael/Michael/aldol condensation sequence to afford 
four new stereocentres with high diastereoselectivity and complete enantioselectivity (see 
Scheme 97). The reaction involves activation o f linear aldehyde 258 by catalyst 260 by 
enamine formation, which then adds selectively to nitroalkene 259 in a Michael-type 
reaction. Subsequent hydrolysis liberates the catalyst which then forms an iminium ion 
with a,P-unsaturated aldehyde 183 which undergoes conjugate addition with the newly 
formed nitroalkane 261. Intramolecular aldol condensation followed by hydrolysis releases 
the catalyst and the desired tetra-substituted cyclohexene carbaldehyde 262 with high 
levels o f stereocontrol and moderate yield. This protocol was successfully employed for a 
range of substituents on the starting components and access to the opposite enantiomer of 
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Schem e 97. Three component domino reaction for the synthesis o f  tetra-substituted cyclohexene 
carbaldehyde 262 catalysed by (S)-proline derivative 260
1.3.12 Conclusions
It can be seen that there are a variety of methods for the synthesis o f chiral aldehydes. 
However, the structure of the desired aldehyde determines the choice of methodology used, 
with no “one fits all” approach. The remainder of this thesis will describe my 
investigations into using chiral auxiliaries and temporary stereocentres for the asymmetric 
synthesis of chiral aldehydes.
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Chapter 2: A new strategy for the synthesis o f chiral
aldehydes
This chapter describes attempts to develop a novel aldol/ directed hydrogenation/ retro- 
aldol protocol for the asymmetric synthesis of chiral a-methyl aldehydes.
2.1 In trodu ction
A new three step procedure for the synthesis of a-substituted chiral aldehydes was 
proposed which relies on the relay of stereocontrol via the reversible formation o f a 
temporary stereocentre (see Scheme 98).
A °O N
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Schem e 98. A new strategy for the asymmetric synthesis o f chiral aldehydes
In the first step the /V-acylated oxazolidinone would act as a chiral auxiliary to control the 
stereoselectivity o f its aldol reaction with an a,p-unsaturated aldehyde to produce a syn- 
aldol product. This syw-aldol contains a (3-hydroxyl stereocentre that would then be used to 
direct the hydrogenation reaction o f the alkene moiety generating a new stereocentre (NS). 
In the final step, the chiral a-substituted aldehyde would be cleaved via a retro-aldol
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reaction, thus destroying the ‘temporary’ hydroxyl stereocentre and liberating the N- 
acylated oxazolidinone auxiliary for recycling. The overall outcome o f this three step 
protocol would be the asymmetric hydrogenation of an a,J3-unsaturated aldehyde to afford 
a chiral a-methyl aldehyde using the temporary (3-hydroxyl stereocentre of an aldol 
intermediate to relay stereochemistry from the chiral auxiliary fragment to the remote 
alkene functionality.
2.1.1 Previous efforts to develop the three-step strategy
Research carried out by another member of the SDB group during the course of my PhD. 
had shown this ‘temporary stereocentre’ strategy to be a viable approach for the 












Scheme 99. Synthesis o f  chiral cyclopropane carboxaldehydes using a novel three-step strategy
In step one, a stereoselective boron enolate mediated aldol reaction was used to synthesise 
unsaturated syw-aldol product 263 which contained a |3-hydroxyl stereocentre in greater 
than 95% diastereomeric excess (see Scheme 100).
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76 - 87% yield 
> 95% d.e.
Schem e 100. Synthesis o f  unsaturated aldol product 263
The new p-hydroxyl stereocentre was then used to control a P-hydroxyl-directed 
diastereoselective cyclopropanation reaction using diethyl zinc and iodomethane to 
generate cyclopropane aldol 264 in greater than 95% diastereoselectivity (see Scheme 
101).
Schem e 101. Highly diastereoselective P-hydroxyl-directed cyclopropanation reaction
Finally carrying out an anionic retro-aldol reaction on cyclopropane aldol 264 resulted in 
cleavage to afford enantiopure cyclopropane carboxaldehyde 265 and the N-propionyl- 
oxazolidin-2-one in good yield and excellent diastereoselectivity (see Scheme 102).
263 264
89 - 99% yield 
> 95% d.e.




51 - 75% yield 
> 95% d.e.
Scheme 102. Retro-aldol reaction to yield chiral cyclopropane carboxaldehydes 265
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This work demonstrated that this novel strategy for relaying chirality could be successfully 
applied to the synthesis of chiral cyclopropane carboxaldehydes using a directed 
cyclopropanation reaction, and as a consequence it was decided to investigate whether this 
protocol could be extended to other substrate-directed reactions for the asymmetric 
synthesis of other classes of chiral aldehyde.
2.2 H yd roxyl-d irected  hydrogenation
Directed hydrogenation reactions of allylic alcohols are an important class o f substrate- 
directed reaction. Both homogeneous and heterogeneous catalysts have shown to be 
effective in this transformation, however homogeneous methods are generally considered 
to exhibit higher levels of selectivity under milder conditions.1167] The reaction requires a 
hydroxy 1-group in close proximity to the alkene which can bind to the metal centre and 
thereby control delivery of hydrogen from the metal complex to the double bond.[l68] In the 
homogeneous reaction stereocontrol occurs because the metal centre is simultaneously 
coordinated to the directing group, the alkene and hydrogen in the transition state of the 
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Schem e 103. Catalytic cycle proposed for homogeneous hydroxyl-directed hydrogenation reactions
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In cyclic systems the hydrogen is delivered to the same face as the hydroxyl-group and in 
acyclic systems the stereochemistry is governed by allylic strain. For a 1,1-substituted 
alkene minimisation of allylic A(1,2)-strain dominates and therefore generally favours 
formation of the anti isomer of product as shown in Scheme 104.[l69]
unfavoured favoured
OH 9 H




Scheme 104. Minimisation o f  allylic strain in the transition state o f  directed hydrogenation o f a 1,1- 
substituted alkene
In the case of a 1,2-substituted alkene the opposite syn- isomer is formed, which is also 




Scheme 105. Minimisation o f  allylic strain in the transition state o f  directed hydrogenation o f a 1,2- 
substituted alkene
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It was proposed that the alcohol functionality of P-hydroxy-Ar-acyl-oxazolidin-2-ones 266 
might prove effective in controlling homogeneous directed-hydrogenation reactions o f 
their alkene functionality, which after retro-aldol cleavage of the resultant hydrogenated 















Scheme 106. Proposed synthesis o f chiral a-methyl aldehydes via a novel three-step strategy
2.3 Directed hydrogenation reactions of related aldol substrates
A review of the literature revealed that there was some precedent that directed 
hydrogenation of this class of aldol substrate might proceed with good diastereocontrol.
In 1984 Evans et al. reported investigations into directed hydrogenations of related aldol 
structures 268 and 269.[l70] They used two different metal catalysts, Crabtree’s iridium 
catalyst Ir(COD)(py)(PCy3)PF6 which had previously been shown to be effective in 
hydroxyl-directed hydrogenation of cyclic and homoallylic alcohols,[l71,172] and the
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rhodium catalyst [Rh(NBD)(DIPHOS-4)]BF4 which had also been shown to be effective 
for hydrogenation of acyclic allylic alcohols (see Figure 3).[173]
(c-C6H h )3P q
Crabtree's catalyst Brown’s catalyst
Figure 3. Structures o f  catalysts used for the directed hydrogenation o f  aldols 268 and 269
According to the allylic strain models previously described, it would be expected that 
allylic alcohols 268 and 269 would afford two diastereomeric products 270 and 271 as 
shown in Scheme 107.
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Scheme 107. Expected products from stereoselective directed hydrogenation reaction o f  syw-aldols 268 and 
269
Surprisingly, at atmospheric pressure both catalysts showed little diastereoselection (see 
Table 2.1), with large amounts o f unwanted |3-keto imide product 272 being formed from 
isomerisation o f the alkene functionality, followed by enol tautomerisation (see Scheme 
108). At more elevated pressures (640 psi) the rhodium catalyst showed improved 
diastereoselectivity (see Table 2.1), however reactions using the iridium catalyst were still 
poor. It was thought that at low pressures the rate of hydrogenation and alkene
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isomerisation were comparable leading to poor diastereoselectivity due to competing 
hydrogenation reactions of both 268 and 269. In the case o f the rhodium catalyst it was 
suggested that the rate determining step was dependent on hydrogen pressure; at low 
pressures oxidative addition of hydrogen to the catalyst-substrate complex was rate 
determining, whilst at higher pressures the complexation step of substrate and catalyst 
becomes rate determining.
Substrate
Ratio 270:271 at 15 psi H2 Ratio 270:271 at 640 psi H2 
RhIr Rh
268, R = Me 51:49 25:75 93:7
269, R = Me 56:44 13:87 9:91
268, R = Ph 54:46 71:29 93:7
269, R = Ph 60:40 21:79 6:94
268, R = 'Pr 47:53 52:48 94:6
269, R = 'Pr 54:46 12:88 8:92
T able 2.1 Directed-hydrogenation reaction o f yy/7-aldols 268 and 269 with iridium and rhodium catalysts11701
O O QH O o  OH
hydrogenation J A
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Schem e 108. Isomerisation/enolisation mechanism for the formation o f ketone 272
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These initial hydrogenation reactions were carried out using 17.5 mol% catalyst loading, 
however, in a later study it was found that the diastereoselectivity of the iridium catalysed 
reaction could be increased by reducing the catalyst loading.[ 1741 For example, 
hydrogenation of 273 with 20 mol% of catalyst gave a 14% diastereomeric excess o f in 
favour of aldol 274, whereas reducing the catalyst loading to 2.5 mol% increased the 
diastereomeric excess to 70% (see Scheme 109).
o  o  OH
/ s ,
0  N
p M  1
O 0  OH 
20  mol% lr(COD)(py)(PCy3)PF6 i l
O N'
15 psi H2, DCM
273 274
14% d.e.
O O OH 
2.5 mol% lr(COD)(py)(PCy3)PF6 11
O N'
15 psi H2, DCM
p r f K
70% d.e.
Scheme 109. Effect o f  catalyst loading on the diastereoselectivity o f  iridium catalysed hydrogenation 
reactions o f  273
In this case the diastereoselectivity was found to be independent of the hydrogen pressure 
but was found to be highly substrate dependent. The authors suggested that this meant that 
isomerisation between the starting materials 268 and 269, which would reduce the 
selectivity of the directed hydrogenation reaction, was not the cause of the low levels o f 
diastereoselectivity observed with this catalyst. Iridium complexes are known to aggregate 
in solution and consequently it was proposed that at high catalyst loading there might be 
more than one catalytic species operating.
These results by demonstrated a clear literature precedent that directed hydrogenation 
reactions might prove applicable to our ‘temporary stereocentre’ strategy for the 
asymmetric synthesis of chiral aldehydes, and therefore my first goal was to develop an 
effective and diastereoselective directed hydrogenation protocol for this class of syw-aldol 
substrate.
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2.4 Synthesis o f  E v a n s’ oxazo lid in -2 -one
At the start o f my PhD. elimination problems associated with the retro-aldol reaction o f 13- 
hydroxy A-acyl-oxazolidin-2-ones had not been established (vide supra) and as a 
consequence I initially targeted .syw-aldol products derived from conventional Evans’ 
oxazolidin-2-ones.
According to Evans’ original procedure, (S)-4-benzyl-oxazolidinone 276 was synthesised 
in good yield by borane reduction o f L-phenylalanine followed by cyclisation of the 
resulting amino alcohol 275 with diethyl carbonate under basic conditions.[175] 
Deprotonation with n-butyl lithium and addition of an acid chloride afforded A-acylated 
oxazolidin-2-ones 277 -  279 in good yield. The products could be crystallised as described 
in the literature, however it was found that better isolated yields were obtained using 
column chromatography for purification (see Scheme 110).
o
^ 2  BF3.OEt2 BH3.SM e2 K2C 0 3, (EtO)2CO
. L nH  --------------------------------- ► ----------------- ► 0




IR C = 0  stretch 1760 cm'1, 
N-H stretch 3460 cm'1O
277 R = Me, 94% yield
278 R = 'Pr, 85% yield
279 R = Ph, 87% yield
IR two C = 0  stretches 1786, 1701 cm'1
Scheme 110. Synthesis o f  7V-acylated Evans’ oxazolidin-2-ones 277 -  279
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2.5 Development of the syw-aldol reaction
My next goal was to develop diastereoselective methodology for the asymmetric synthesis 
ofsyw-aldols with high diastereomeric excess.
2.5.1 Overview of the asymmetric aldol reaction
The addition o f an enolizable carbonyl compound to an aldehyde or ketone is known as the 
aldol reaction and is a classical reaction in organic synthesis. It allows for the formation o f  
a new carbon-carbon bond with the simultaneous generation o f  two new stereocentres. The 
aldol fragment is a common motif in many natural products and therefore it has become a 
very widely used transformation.[176]
In the 1950’s Zimmerman and Traxler accounted for diastereoselection in the aldol 
reaction by suggesting that the reaction proceeds via a chair-like transition state involving 
coordination o f  the metal ion to both the enolate and carbonyl substrates, as shown in 
Scheme l l l . [177]
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anti product (threo)syn product (erythro)
Me
E-enolate
Scheme 111. Zimmerman-Traxler model accounting for diastereoselectivity o f  aldol reactions
The favoured conformation minimises steric interactions between the Ri- alkyl group of 
the enolate and the R2-substituent of the carbonyl substrate. This is supported by evidence 
that for lithium enolates, diastereoselection increases as the steric bulk o f the Ri group 
increases ('Bu > 'Pr > Et > OMe > H).[178] In the case o f the (Z)-enolate, placing the large 
R2 group in the equatorial position rather than the axial position minimises 1,3-diaxial 
interactions within the six-membered transition state and therefore favours formation of the
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syw-aldol via the lower energy transition state. With the (£)-enolate the opposite selectivity 
occurs with the low energy transition state generally favouring formation o f the anti-aldol, 
by minimisation of 1,3-diaxial interactions between Ri and R2
In order for the aldol transformation to be viable for the formation of chiral products it is 
necessary to be able to control the absolute stereochemistry of the aldol product as well as 
the diastereoselection. There are three common strategies for achieving this; Mukaiyama- 
type catalytic aldol reaction using masked silyl-enolates, direct catalytic aldol additions 
using transition metal catalysts or organocatalysts, and chiral auxiliary-based aldol 
reactions.[179] Although the use o f chiral auxiliaries introduces additional steps into a 
synthesis involving attachment and removal o f the auxiliary, they often overcome many o f 
the difficulties of using catalysts by enabling diastereomeric aldol products to be purified 
to homogeneity. Furthermore, many chiral auxiliaries are cheap and easy to make and can 
be readily recycled with their reactions generally proceeding under relatively mild 
conditions without the need for large excesses of reagents. Carrying out stereoselective 
aldol reactions using Evans’ oxazolidinone auxiliary was key to our chiral relay strategy, 
and therefore the scope and limitations of this area are now discussed briefly.
2.5.2 Evans’ auxiliary mediated aldol reactions
The A-acylated Evans’ oxazolidin-2-one has been widely used as an effective auxiliary for 
the asymmetric aldol reaction, and is known to react with a range o f aldehydes in good 









Scheme 112. Syw-aldol reactions ofboron-enolates o f  A-acyl-oxazolidin-2-ones
There are four possible diastereoisomers that may be formed in the aldol reaction of N- 
acyl-oxazolidin-2-ones, as shown in Scheme 113.
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non Evans syn-aldol 
0 O OH
anti- aldols
Scheme 113. Possible diastereoisomers formed during the asymmetric aldol reaction
The classic (Z)-boron enolate derived aldol reaction favours the Evans syw-aldol through 
formation of a Zimmerman-Traxler type chair transition state, as show in Scheme 114.[180] 
In order to observe high selectivity an a-substituent (Y) must be present, with the aldehyde 
substrate being directed away from the alkyl group of the chiral auxiliary fragment to 
favour an Evans syH-aldol product. However, competing formation o f the non-Evans syn- 
aldol can occur if the Y substituent o f the enolate is hydrogen, leading to poor 
diastereocontrol.
L2
R 0 / E k O






Scheme 114. Formation o f  Evans’ syn-aldol via chair-like transition state
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The use of sterically demanding metal centres greatly improves stereocontrol in the aldol 
reaction. For dialkylboron enolates the stereochemistry o f the sjw-aldol product is 
controlled by the stereochemistry o f the (Z)-enolate formed, whereas for 
dicyclopentadienylchlorozirconium enolates, syn-aldol products have been observed 
arising from either (E)- or (Z)-enolate geometry.[181] Recent reports using chlorotitanium 
enolates have also been shown to give very good yields and selectivity for the Evans syn- 
product, as shown in Scheme 115.[,82]
o o  9 ft 0H
.A.A. Te.(105eq)___.  A A A R
diisopropylethylamine (1 .1. eq .) 
1 -methyl-2-pyrrolidinone (1 eq.)
Ph Ph
75-99 % yield 
>93 % de
Scheme 115. Evans’ asymmetric sjw-aldol reaction using chlorotitanium enolates
Chelation control has also been reported for other metals including, lithium, zinc and tin 
although levels of diastereoselectivity are generally inferior to boron enolatest1831 
However, boron enolates in the presence of excess Lewis acids such as diethylaluminium 
chloride, have been reported to give access to anti-aldol products, however attempts to 
reproduce this chemistry in the SDB group have so far proven unsuccessful.[180l84]
More recently, Evans has reported the use of magnesium chloride, in the presence of 
triethylamine and chlorotrimethylsilane, to catalyse ow//-aldol reactions with a range o f 
aromatic and unsaturated aldehydes in good yields and moderate-to-high 
diastereoselectivity (see Scheme 116)J185]
A  °oA n
Ph
RCHO
1 ) MgCI2, Et3N, 
TMSCI, EtOAc
2) TFA, MeOH
9  Q OH
O N
Ph
71- 92% yield 
70- 94% d.e.
Scheme 116. Magnesium chloride catalysed a«//-aldol reactions
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This method was shown to be applicable to a range o f  aldehydes, although the addition o f  
NaSbF6 (30 mol %), or an increase in catalyst loading (up to 20 mol %), was necessary for 
cw/Z-aldol reactions o f less reactive aldehydes.
Several studies have shown that these types o f  aldol reactions can be capricious, with 
levels o f stereocontrol being dependent on the choice o f  solvent and base used for 
deprotonation. For example, it has been shown for titanium enolates that using diethyl 
ether as a solvent results in a 5-fold increase in diastereoselectivity compared to THF,[186] 
with suggestions that this was due to the ability o f  THF to bind to the titanium counterion, 
thus disrupting the Zimmerman-Traxler transition state. Alternatively, it has been shown 
that using triethylamine as a base to generate boron enolates gives superior 
diastereoselection to isopropylethylamine,[187] which may be due to the resulting 
ammonium salt being involved in the transition state.
The power o f the Evans aldol reaction for stereoselective synthesis is readily demonstrated 
by considering the number o f times it has been used in natural product synthesis. For 
example, Evans et al. reported the synthesis o f  the polyether antibiotic lonomycin A using 
a range o f auxiliary based aldol and acylation reactions to control the absolute 
stereochemistry o f  all the major fragments used to assemble the natural product (see 
Scheme 117).[188]
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A  °c A n
Ph
O 0  OH 
Bu2BOTf aldol O ^ ^ N ' OBn
H ' - / ° Bn Ph'
CHO
C 13-C24 fragment
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Ph




°N A °X  ph
©  1 /— \
PPh3 QMg \Q
C25 -C 30 fragment
OMe OMe
OMe
O  2 4
lonomycin A
Scheme 117. Use o f a range o f aldol reactions to control the configuration o f the major fragments used in the 
asymmetric synthesis o f  lonomycin A
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2.5.3 Optimisation of the aldol reaction
As described in the previous section, a number of protocols had been reported in the 
literature for the asymmetric aldol reactions of A-acylated oxazolidinones.[175,182'187,l89] 
Previous work within the group had shown that the use of 9-BBNOTf with 
diisopropylethylamine was an effective method for the synthesis of the syw-aldol product 
o f racemic A-acylated oxazolidinones (see Scheme 118).[190]
9-BBNOTf, DIPEA, F^CHO
R = Me, 'Pr, Ph, PhCH2- Ri = Ph, Et, Me(CH2)6-, cyclohex,
(E)-Ph(CH=CH)-, p-MeOPh
Schem e 118. Synthesis o f .sjw-aldol products using racemic TV-acylated oxazolidinones
These conditions were therefore used to optimise the syn-aldol reactions of A-acyl 
oxazolidin-2-ones 277 and 279 (see Scheme 119). Therefore, 1.1 equivalents of 
9-BBNOTf was added to the corresponding A-acyl-oxazolidin-2-ones at 0 °C in 
dichloromethane, with 1.3 equivalents o f diisopropylethylamine added after 30 minutes. 
After a further 30 minutes the reaction was cooled to -78 °C before addition of the 
appropriate aldehyde, which gave the corresponding sytt-aldols 280 -  281 in excellent 
yield after purification by chromatography.
II n  9-BBNOTf (1.2 e q ) ,
X  A / R DIPEA (1.3 eq.)O N _____________
0  O OH
A M ,
277 R = Me 
279R = Ph
(1.1 eq .) 
DCM, 0 °C to -78  °C
280 R = Me, R, = Et; 91% yield
281 R = P h, Ri = C = C C 5H11; 80% yield
Schem e 119. Model sy/7-aldol reactions
'H NMR spectroscopic analysis showed selective formation o f only one diastereomer 
which was assigned as the syn-aldol by comparison with literature data,[175] and
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consideration o f the coupling constant between their a- and (3-protons that was between 5 
-  7 Hz, with anti-aldols known to exhibit where coupling constants greater than 8.0 Hz.[185]
2.5.4 Synthesis of unsaturated aldols
Recapping, our directed hydrogenation strategy required syw-aldol substrates which 
contained a y-alkene functionality, such as 282, whose hydrogenated products would then 











Scheme 120. Synthesis o f chiral aldehydes containing an a-methyl stereocentre
The a-methylene aldehyde 283 required to prepare syn-aldol 282 was therefore synthesised 
according to the procedure previously described by Marvel et a/..[19,] An aldehyde 
containing a C6 alkane chain was chosen for ease of handling because it had a high enough 
boiling point to enable common solvents to be removed in vacuo, but was volatile enough 
to allow purification by distillation as required. Therefore, octanal, dimethylamine 
hydrogen chloride and formaldehyde (37% solution in water) were mixed together and left 
to reflux overnight to yield aldehyde 283 in good yield and purity, with no evidence of any 
aldehyde products arising from isomerisation of the alkene functionality (see Scheme 121). 
This a-methylene aldehyde 283 was then reacted without further purification with the 
boron enolate of N-acylated auxiliary 277 to yield syw-aldol product 282 according to our 
optimised procedure in good yield and diastereoselectivity (see Scheme 122).
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O O dimethylamine.HCI ft
X  + X  --------------------- ^  X  C6h13
H H H C7H15 70 °C, 24  hrs
283
90% yield
Scheme 121. Synthesis o f  a,P-unsaturated aldehyde 283
O o









Scheme 122. Synthesis o f  y-unsaturated syw-aldol 282
With y-unsaturated syn-aldol 282 in hand, it was then employed as a substrate to screen a 
series of directed hydrogenation reactions using different transition metal catalysts.
2.6 D irected  h yd rogen ation  reactions
2.6.1 An unexpected reaction
Prior to carrying out screening of catalysts in our substrate-directable reactions, aldol 282 
was first subjected to a hydrogenation reaction with Pd/C with the intention of preparing an 
authentic 50:50 mixture o f diastereomers (4ft)-284a and (4S)-284b which could then be 
used to confirm the diastereomeric excess of our directed hydrogenation reactions (see 
Scheme 123). Unexpectedly, instead o f forming the reduced products (4/?)-284a and 
(4S)-284b, this reaction lead to a quantitative yield of the isomerised starting material 285 
in 3 hours, which showed a characteristic alkene triplet resonance at 5 5.50 ppm in its *H 
NMR spectrum (see Scheme 124).
92
Chapter 2 Results and Discussion
282 4(R)-284a 4(S)-284b
50:50 mixture of diastereomers 
Schem e 123. Expected non-diastereoselective hydrogenation reaction o f aldol 282 using Pd/C as a catalyst
OH OH
3 mol% Pd/C




Scheme 124. Observed alkene isomerisation reaction o f  aldol 282 using Pd/C as a catalyst
Investigations into the mechanism of this remarkable isomerisation reaction are discussed 
later in this thesis. However, I was delighted by the outcome of this isomerisation reaction 
since it provided an easy route to the synthesis of unsaturated aldol 285 as an alternative 
substrate for our hydrogenation reactions, which meant we did not have to prepare it 
separately via sjw-aldol reaction of it’s parent aldehyde.
2.6.2 Initial catalyst screening reactions
As described earlier, previous work by Evans et al. using analogous substrates had shown 
that y-unsaturated aldols such as 268 could be hydrogenated with Brown’s or Crabtree’s 
catalyst in moderate to good diastereoselectivity depending on the conditions used.[l70,I74] 
Therefore our syw-aldol product 282 was subjected to a screen o f hydrogenation reactions 
using Evans’ original hydrogenation conditions as a starting point for our investigations. 
Crabtree’s iridium catalyst Ir(COD)(py)(PCy3)PF6 and the rhodium catalyst 
[Rh(NBD)(DIPHOS-5)]PF6 developed by Brown were screened as catalysts for 
hydrogenation o f unsaturated aldols 282 and 285. Evans et al. had previously used the 
DIPHOS-4 variant of this rhodium catalyst, however we chose the commercially available 
DIPHOS-5 variant which had also been shown to be effective for the homogeneous
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hydrogenation o f allylic alcoholsJ169,173] Trial reactions were carried out using Evans’ 
original conditions on syw-aldol 282 at both 2.5 mol% and 17.5 mol% catalyst loading and 
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1 bar 4.5 bar
0 pp
(c-CeHnJaP PFe
c / 3 >
Crabtree’s
2.5 70% SM 282 SM 282
17.5 90% ketone 286
50:50




2.5 65% ketone 286 50% SM 282
17.5
100% product 284 
(mixture of diastereomers)
100% product 284 
(mixture of diastereomers)
Table 2.2 Summary o f  results o f initial hydrogenation screen on y-unsaturated aldol 282
Although Evans had reported good results using Crabtree’s iridium catalyst at low catalyst 
loading, in our hands these hydrogenation reactions proved unsatisfactory. At higher 
catalyst loadings the starting aldol isomerised to give ketone product 286 at low pressure
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(see Scheme 125), whereas higher pressure gave a mixture of starting material 282 and 
ketone 286. The mixture of diastereomeric ketones (4ft)-286a and (4S)-286b was evident 
from the presence of a multiplet (two sets of overlapping quartets for the two 
diastereomers) at 4.84 ppm in the !H NMR spectrum for their a-protons which is 
characteristic o f this type o f p-keto-A-acyl-oxazolidin-2-one.tl88] They also exhibited a new 
,3C resonance at 211.2 ppm and 210.9 ppm which are characteristic o f a ketone 
functionality. Their structure was further confirmed by the presence of three carbonyl 
signals in the IR spectrum (1782, 1716, 1697 cm'1) and by high resolution mass 
spectroscopy (ES) which showed a molecular ion [M+H]+ of 374.2329 (calculated 
374.2326). Unfortunately it was not possible to separate these two diastereomers of ketone 
286 by column chromatography.
Schem e 125. Mechanism o f formation o f diastereomeric ketones (4/?)-286a and (4S)-286b
At low hydrogen pressure and low catalyst loading Brown’s rhodium catalyst also resulted 
in formation o f the ketone products 286. However, increasing the hydrogen pressure to 4.5 
bar reduced the formation o f ketone products but still resulted in very little conversion to 
the desired product 284. This supports the observation by Evans et al. that increasing the 
pressure o f hydrogen suppresses the isomerisation pathway to the ketone product 286. 
Higher catalyst loading o f Brown’s rhodium catalyst allowed complete conversion to the 
reduced products, however, crude !H NMR analysis showed the formation o f four different 
products (signals at 3.42, 3.56, 3.68, 3.79 ppm corresponding to C//OH of each 
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have been formed from isomerisation o f aldol 282 to afford enol 287 that equilibrated to 
afford ketone 286. Subsequent reduction would then afford the mixture o f four 
diastereomers observed in the crude reaction mixture as shown in Scheme 126.
Scheme 126. Mechanism for formation o f four possible diastereomers from hydrogenation o f aldol 282
In previously published reports Evans had noticed that at lower pressures the 
hydrogenation reaction of these type of aldols could be very slow, particularly with lower 
catalyst loadings.[l74] Because of this precedent, hydrogenation was carried out over 48 
hours, at 4.5 bar hydrogen pressure using both catalysts at 2.5 mol% and 17.5 mol%. 
Reactions with Crabtree’s iridium catalyst did not show any difference in product ratios to 
the results obtained after 24 hours. However, in the reaction with Brown’s rhodium 
catalyst at 2.5 mol% loading, H1 NMR spectroscopic analysis o f the crude reaction mixture 
showed 70% conversion to reduced products at 80% diastereomeric excess (see Scheme 
127). The major diastereomer was assigned as (4/?)-284a as shown in Scheme 127, in 
concordance with Evans’ previous results on related aldol substrates, and from 
consideration o f the allylic strain arguments (see Scheme 104). Further investigations to
o o oh
P  o  OH
A A A , .
286 o O OH
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confirm the configurational assignment of the major aldol diastereomer produced in these 
reactions are discussed later in this thesis.
2 .5  mol% [Rh(NBD)(DIPHOS-5)]PF6
4 .5  bar H2, DCM, 48 hrs
(4R)-284a
70% conversion, 80% d.e.
Scheme 127. Hydrogenation o f syn-aldol 282 with 2.5 mol% rhodium catalyst over 48 hours
The 80% d.e. obtained for the formation of (4i?)-284a was a promising result as it gave 
diastereoselectivities o f a similar magnitude to the best previously achieved by Evans using 
comparable substrates at 4.5 bar. However, Evans’ previous report required the use o f very 
high pressures of hydrogen (44 bar) to achieve their results (82 -  88% d.e.), whilst they 
describe that the use of the same catalyst at atmospheric pressure resulted in much poorer 
diastereoselectivities (4 -  76% c/.e.).[l70] It is important to note that the diastereomers 
formed in these hydrogenation reactions were easily separable by column chromatography, 
allowing access to diastereomerically pure products.
The isomerised aldol product 285 was also subjected to some exploratory reactions using 
the two hydrogenation catalysts (see Table 2.3). As indicated by Evans’ previous studies 
and from conformational analysis arguments, (see Scheme 105) it was predicted that this 
starting material would favour the formation of the opposite diastereomer 4(S')-284b to that 
produced for hydrogenation of methylene aldol 282.
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Table 2.3 Hydrogenation reactions using isomerised syn-aldol 285
The results with Crabtree’s iridium catalyst were once again disappointing, with little 
conversion to the desired reduced aldol product 284, and a significant amount o f the 
unwanted ketone products 286 being produced. With Brown’s rhodium catalyst the results 
were improved, with low catalyst loading affording a mixture of starting material and 
hydrogenated aldol product 284 in 40% diastereomeric excess, whilst increasing the 
catalyst loading gave 100% conversion to cleanly afford the reduced products 284 in a 
reasonable 64% diastereomeric excess. This suggested that aldol 285, in which the alkene 
was tri-substituted, was more stable than the methylene aldol 282 and therefore does not 
readily isomerise to give the ketone product, with consequent scrambling of stereocontrol.
These results showed that our unsaturated aldols 282 and 285 could undergo directed 
hydrogenation reactions in a similar manner to those described by Evans. Although
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reactions with Crabtree’s catalyst were disappointing in our hands, we had achieved 
comparable results to those reported by Evans using Browns catalyst [Rh(NBD)(DIPHOS- 
5 ) ] P F 6 ,  under significantly milder conditions.
2.6.3 Hydrogenation reactions with W ilkinson’s catalyst
In 1991 Simon et al. reported the use o f Wilkinson’s rhodium catalyst Rh(PPh3)3Cl for the 
hydrogenation of allylic alcohol 288 to give chiral alcohols (7?,/?)-289a and (R,S)-289b in 
70% diastereomeric excess (see Scheme 128).[l92]
2.5 mol% Rh(PPh3)3CI
288 (R,Ry289a (R,S)-289b
(R, f?)-289a :(R, S)-289b 
8 5 : 1 5
Scheme 128. Use o f  Wilkinson's catalyst for the diastereoselective hydrogenation o f  allylic alcohol 288
Consequently, it was decided to investigate whether Wilkinson’s catalyst could also be 
used for the diastereoselective hydrogenation of our unsaturated aldol products 282 and 
285. Therefore aldol 282 was subjected to hydrogenation reaction under the same 
conditions previously used with Crabtree’s and Brown’s catalysts. The results of these 
hydrogenation reactions are summarised in Table 2.4.
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Table 2.4 Hydrogenation screen using Wilkinson's catalyst
At low catalyst loading the hydrogenation reaction gave a mixture of starting material and 
reduced product with no evidence of any ketone products 286 having been produced. This 
suggested that the isomerisation pathway observed with Crabtree’s and Brown’s was not 
occurring with this catalyst. At 5 bar pressure there was 95% conversion to the reduced 
product which showed 60% diastereomeric excess by analysis o f the crude H1 NMR 
spectrum. Higher catalyst loading allowed for complete conversion to the desired products 
with 60% diastereomeric excess at 4.5 bar hydrogen pressure. These results showed an 
improvement on our initial results using this aldol substrate with Crabtree’s and Brown’s 
catalysts. These reactions were also repeated over a period of 48 hours, but showed no 
difference in the observed results, thus indicating that the hydrogenation reaction with 
Wilkinson’s catalyst was occurring over a much faster timescale.
With these promising results in hand a screen o f some common solvents was carried out 
using 17.5 mol% Wilkinson’s catalyst at 4.5 bar hydrogen pressure for 24 hours. All 
reactions proceeded to 100% conversion, with the diastereomeric excesses of each reaction 
being calculated by integration of resolved peaks for each diastereomer in the H1 NMR 
spectra ((4i?)-284a C//OH at 3.56 ppm, (4S)-284b C//OH at 3.68 ppm) (see Table 2.5).
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Table 2.5 Effect o f  solvents on hydrogenation o f jyw-aldol 282 using Wilkinson's catalyst
These results show that the choice o f solvent had a significant effect on the 
diastereoselectivity o f the hydrogenation reaction using Wilkinson’s rhodium catalyst. The 
original solvent, dichloromethane showed one of the highest diastereoselectivities, with 
only toluene being higher (64%), whilst more polar solvents resulted in a dramatic 
reduction in the diastereoselectivity of this reaction.
Hydrogenation reactions o f alternative aldol 285 then attempted with Wilkinson’s catalyst 
at 4.5 bar hydrogen pressure and at both catalyst loadings (see Scheme 129).
OHOH
2.5 mol% Rh(PPh3)3CI












Schem e 129. Hydrogenation o f  isomerised aldol 285 using Wilkinson's catalyst
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Interestingly with Wilkinson’s rhodium catalyst, the conversion of aldol 285 to its reduced 
products was more sluggish, resulting in some recovery of starting material, however there 
was no evidence of any isomerised products indicating that aldol 285 was stable under 
these hydrogenation conditions. However, whilst the observed diastereoselectivity was 
high it was found to also result in formation of the same (4R)-284a diastereomer as 
produced previously for hydrogenation o f methylene aldol 282. This result was unexpected 
since allylic strain models would predict that the (45)-284b diastereomer should have been 
favoured as had been observed previously for hydrogenation of aldol 285 with Brown’s 
catalyst. In order to explain this observation it was proposed that sterics rather than a 
hydroxyl-directing effects might be important in controlling the facial selectivity of 
hydrogenation reactions with Wilkinson’s catalyst, and further investigations into this 
hypothesis are discussed later in this thesis.
To conclude, the hydrogenation reactions o f alternative aldol 285 were highly promising 
since they allowed the possibility o f a divergent strategy where both aldol diastereomers 
(4R)-284a and (45)-284b could be accessed using readily available aldol substrates and 
different catalysts under the same conditions (see Scheme 130).
17.5 mol% Wilkinson's cat 
5 bar H2, DCM, 24 hr
O 9  OH







17.5 mol% Brown's cat. 





Scheme 130. Catalyst controlled divergent strategy for the synthesis o f both diastereomers o f  284
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2.6.4 Assignment of stereochemistry
The stereochemistry of the major diastereomer arising from hydrogenation of methylene 
aldol 282 was assigned as the (4R)-product 284a by comparison with Evans’ precedent and 
from allylic strain models (see Scheme 104). Comparison o f the *H NMR spectra o f the 
two diastereomers of product 284 also supported this assignment with (4/?)-284a 
exhibiting a larger coupling constant of J(3,4) = 8.7 Hz characteristic of an anti- 
configuration of protons, compared to a smaller coupling constant (J(3,4) = 3.8 Hz) for the 
sy«-configuration of protons of (4S)-284b (see Figure 4). However, assigning 
stereochemistry from coupling constants in acyclic systems can be misleading, and 
therefore it was decided to confirm this configurational assignment by a correlation 
method.
J = 8.7 Hz J =  3.8 Hz
(4R)-284a (4S)-284b
Figure 4. Comparison o f J(3(4) coupling constants o f  4(/?)-284a and 4(S)-284b
Lipton et al. had recently reported the synthesis and characterisation of two diastereomers 
of 3-hydroxy-2,4,6-trimethylheptanoic acid (25,3i?,4R)-290a and (2S,3R,4S)-290b.[193] 
Synthesis of one o f these acids could potentially be achieved from aldol 291 that could be 
obtained using our hydrogenation reaction methodology, according to the retrosynthesis 
shown in Scheme 131. This would then enable us to unequivocally assign the 
stereochemistry of the major diastereomer of the hydrogenation reaction of aldol 291 
arising from the hydrogenation reaction using Wilkinson’s catalyst.
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O  O H
{S,R,R)-290a











Scheme 131. Proposed retrosynthetic analysis for the synthesis o f  acid 290a
Therefore, the required unsaturated methylene aldehyde 293 was synthesised in good yield 
by PCC oxidation o f commercially available alcohol 294, followed by a dehydrative 
Mannich type reaction with dimethylamine hydrochloride and formaldehyde as described 









Scheme 132. Synthesis o f  a-methylene aldehyde 293
This aldehyde 293 was then reacted with 7V-propionyl oxazolidinone 277 according to our 
established aldol procedure to yield the sy/7-aldol product 292 in good 79% yield and 






DCM, 0 °C to - 78 °C
Ph
292
79%  yield 
> 95% d.e.
Scheme 133. Synthesis o f  syw-aldol 292
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This y-unsaturated aldol 292 was then subjected to a hydrogenation reaction using 17.5 
mol% Wilkinson’s catalyst at 5 bar hydrogen pressure (see Scheme 134). After 24 hours 
the ‘H NMR spectrum of the crude product showed an approximately 80% conversion o f 
aldol 292 to hydrogenated product 291, in a disappointing 33% diastereomeric excess. 
However, examination of the 'H NMR spectrum showed the major diastereomer produced 
in this reaction was structurally related to the major diastereomer produced previously for 
hydrogenation of aldol 282.
291a J(3f4) = 7.9 Hz
291b J(3.4) = 4.1 Hz
80% conversion 
33% d.e.
Scheme 134. Hydrogenation o f unsaturated aldol 292 using Wilkinson's catalyst
Attempts to separate these diastereomers via column chromatography proved difficult as 
both diastereomers and the starting aldol 292, eluted very close together. However, 
painstaking chromatography enabled a small amount o f the major diastereomer 291a to be 
isolated which was then treated with lithium hydroperoxide to yield the desired acid 290a 
as a single product in almost quantitative yield, without racemisation o f any stereocentres 
(see Scheme 135).t,94]
o  OH 
LiOH, H20 2 [I f
~~7
0 C, THF:H20  (3:1) |  |
(2S,3R,4fl)-290a 
> 95% yield
Scheme 135. Hydrolysis o f  aldol 291a with LiOOH to afford acid 290a
OH
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By comparison with the spectroscopic data reported by Lipton et a l  it was confirmed that 
our acid was indeed (2S,3R,4R)-29Qa with the *H NMR spectrum showing a doublet o f  
doublets resonance at 8  3.65 ppm corresponding to the C3 proton (J = 7.9, 3.4 Hz) identical 
to the data previously reported by Lipton et a l.  The product also showed a doublet o f  
quartets at 5 2.72 ppm corresponding to the C2 proton as reported by Lipton et a l ,  
however our observed coupling was J = 7.2, 3.4 Hz, rather than the J = 3.5, 3.5 Hz reported 
in the literature. By contrast, the (2<S,3R,4,S)-diastereomer 290b was reported to exhibit an 
apparent triplet for the C3 proton resonance (J = 5.5 Hz) at 8  3.68 ppm and a doublet o f  
quartets for the C2 proton at 8  2.72 ppm with a much larger coupling constant (J = 6.0, 6.0 
Hz). Also, Lipton et a l  had reported the optical rotation o f  the (25',3R,4/?)-isomer 290a as 
+ 24.4 ° (c 1.0, CHC13) and the (25',3/?,45)-isomer 290b as - 27.5 0 (c 1.0, CHC13). The 
optical rotation o f our isolated acid was measured as + 8 .6  0 (c 0.5, CHCI3), which whilst 
being smaller in magnitude matched the sign o f the specific rotation reported previously, 
supporting its assignment as the (25',3/?,4i?)-diastereomer 290a.
This correlation therefore provided good evidence that the major diastereomer produced in 
the hydrogenation o f  unsaturated aldol 282 using Wilkinson’s catalyst was in fact the 4(7?)- 
isomer, and as such it follows that the major diastereomer produced in the hydrogenation 
o f isomerised aldol 285 using Brown’s rhodium catalyst can be assigned as the opposite 
4(5)-isomer.
2.7 Conclusions
This chapter has demonstrated my success in developing conditions for the synthesis o f  
■syw-aldols in good yield and with excellent diastereoselectivity, with good 
diastereoselectivities being obtained for their hydrogenation using Wilkinson’s and 
Brown’s catalysts. In order for our novel aldol/ directed hydrogenation/ retro-aldol strategy 
to be realised it was now necessary to develop conditions to successfully carry out retro- 
aldol reactions on our hydrogenated substrates.
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Chapter 3: The retro-aldol reaction, elimination reactions
and application to natural product synthesis
With promising results in hand for both the sytt-aldol reaction and the directed 
hydrogenation reaction it was necessary to develop conditions that would enable our aldol 
substrates to undergo efficient retro-aldol cleavage to afford the desired chiral a-methyl 
aldehydes (see Scheme 136).
Schem e 136. Desired retro-aldol reaction
3.1 A novel p-elimination reaction
Previous work within our group had shown that racemic sy«-aldol products such as 294 did 
not undergo anionic retro-aldol reactions when treated with a base such as KHMDS, 
instead undergoing a novel elimination reaction to yield a,P-unsaturated amide 295 as
retro-aldol reaction
shown in Scheme 137.[l90,195]
KHMDS, -7 8  °C
294 d o e s  not o ccu r
KHMDS, - 78 °C
295
Schem e 137. Formation o f novel a, p-un saturated amide 295
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These a,(3-unsaturated amides 295 were shown to arise via the cyclisation-elimination 
mechanism shown in Scheme 138. The hydroxyl group of aldol 294 undergoes 
deprotonation on addition of KHMDS to afford an alkoxide that attacks the endocyclic 
carbonyl to give an unstable cyclic oxazinane-iV-dione 296. Subsequent anion equilibration 
of 296 affords enolate 297 which then undergoes ElcB elimination of carbon dioxide to 
yield the observed (is)-a,P-unsaturated amide 295.
Scheme 138. Mechanism o f base induced cyclisation-elimination reaction
When 10 mol% of diethyl zinc was employed as a base to deprotonate aldol 298 it was 
found that the corresponding oxazinane-jV-dione 299 intermediate could be isolated in 
good yield. When this oxazinane-2,4-dione was further treated with KHMDS it underwent 
elimination to yield the (F)-unsaturated amide 300 in greater than 90% diastereomeric 
excess (see Scheme 139). This result was in accordance with the mechanism proposed in 
Scheme 138, with the enolate of l,3-oxazinane-2,4-dione 299 playing a key role in 













8 8 % yield
KHMDS  







Schem e 139. Cyclisation and elimination reactions ofsy /7-aldol 298
3.2 Attempted retro-aldol reaction on chiral syn-aldol 284
Bearing in mind the precedent that alkoxides o f related syw-aldol substrates had undergone 
elimination reactions, it was proposed that introducing a benzyl substituent into the 4- 
position of the oxazolidinone ring might shield the endo cyclic carbonyl o f syn-aldol 284 
from intramolecular attack of its (3-hydroxyl anion, thus allowing the desired retro-aldol 
pathway to proceed. Concurrent work carried out within the group on the retro-aldol 
reaction of cyclopropane aldols found that LHMDS was a superior base at preventing the 
formation of unwanted elimination products.[,66J Therefore, s>7?-aldol (4/?)-284a was 
treated with 1.1 equivalents of LHMDS in toluene at a range of temperatures in an attempt 
to establish conditions where the retro-aldol reaction would occur preferentially.
At -78 °C no reaction occurred, enabling quantitative recovery o f starting aldol (7?)-284a. 
However at - 40 °C and 0 °C, the lithium alkoxide of 284a did not undergo the desired 
retro-aldol reaction but instead underwent the unwanted elimination reaction to afford a,p- 
unsaturated amide 302 in quantitative yield as a single (£)-diastereomer (see Scheme 140).
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Scheme 140. Formation o f  (£)-unsaturated amide 302
The structure of 302 was assigned as the (£)-isomer from our previous literature precedent 
and by analysis of its NOESY ’H NMR spectra, which showed correlation between the two 
methyl groups, with no cross-peaks between the alkene proton and the methyl group as 
would be expected for its (Z)-isomer (see Figure 5).
Figure 5. Observed NOESY ’H NMR correlation o f the (£)-isom er 302 and expected correlation for 
(Z)-isomer that was not observed
Since this was the first example o f a chiral aldol product such as 303 undergoing 
elimination in a similar way to that observed previously for achiral p-hydroxy-A'- 
acyloxazolidin-2-ones it was decided to investigate the scope and limitation of this 
cyclisation-elimination pathway for the synthesis of a range o f chiral oxazinane-2,4-diones 
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Scheme 141. Proposed synthesis o f chiral oxazinane-2,4-diones and chiral a,(3-unsaturated amides from 
chiral aldol products such as 303
3.3 Synthesis of chiral 7V-2-hydroxyethyl-l,3-oxazinane-2,4-diones
B e n z o - l ,3 - o x a z in a n e - 2 ,4 - d io n e s  have often been screened for activity as potential drug 
targets,tl96'200] and as a result there are a range of synthetic methods available for their 
preparation. t201'204] However, synthetic routes towards chiral l,3-oxazinane-2,4-diones 
were much less well explored and therefore our investigations into their synthesis would 
provide a valuable contribution to this area.
Therefore, a range of vV-acyloxazolidin-2-one 5y«-aldols were prepared in good isolated 
yield in greater than 90% d.e. using our previously established boron enolate syw-aldol 
procedure (see Table 3.1).
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o  °  o  °  QH
O 9 9-BBNOTf, DIPEA O
k + A i
DCM, 0 °C to - 78 °C 
Ph' Ph'
syw-aldol R R1 Yield (%)
306 Me Cyclohexyl 90
280 Me Et 91
307 'Pr Et 72
308 Me C(Et)=CH2 83
309 Me Ph 75
282 Me C(C6H,3)=CH2 85
310 Me /?-MeOC6H4 68
311 Ph C(C6H13)=CH2 70
Table 3.1 Synthesis o f  5>w-aldol products
These syw-aldols were then treated with diethyl zinc in dichloromethane at room 
temperature to afford their corresponding chiral oxazinane-2,4-diones 312 -  319 as 
described in Table 3.2 and Table 3.3. It was found that simple aliphatic sjw-aldols 306, 280 
and 307 underwent rearrangement cleanly using 10 mol% diethyl zinc over a period of two 
hours, to yield syn-1,3-oxazinane-2,4-diones 312 -  314 that could be isolated in high yield 
and with excellent diastereoselectivity (see Table 3.2).
o  o  o h  PhN .  o
o  N‘^ N / N s 'R 1 Et2Zn, DCM H 0 \ ^ \ NX 0 




R R1 Conditions Yield (%)
d.e.
(%)
312 Me Cyclohexyl 10 mol%, 2 hr 94 >95
313 Me Et 10 mol%, 2 hr 94 >95
314 'Pr Et 10 mol%, 2 hr 90 >95
Table 3.2 Synthesis o f  chiral l,3-oxazinane-2,4-diones
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The structure and configuration of oxazinane-2,4-diones 312 -  314 was confirmed by 
HMBC 'H -^C  correlation spectra which showed cross-peaks between the 13C resonance o f 
the C2 carbonyl and the 'H resonances of H6 and N-CH protons (for an example see 
Figure 6). Their structures were also supported by the small !H NMR J  coupling between 
the H5 and H6 protons (3.0 -  4.5 Hz), and a large up field shift in the H5 proton resonance 
in comparison to the corresponding resonance o f the parent sy«-aldol product.
N 2 0
= H
Figure 6 . Selected resonances from HMBC 'H-I3C correlation experiment
Rearrangement reactions involving treatment o f chiral aldol products containing (3-aryl- or 
(3-alkene substituents using catalytic amounts o f diethyl zinc proved much less successful 
(see Table 3.3).
o  o  o h
O N
Ph\ o
R1 Et2Zn, DCM H O v^ ^ n ^ O




R R1 Conditions Yield (%)
d.e.
(%)
315 Me C(Et)=CH2 10 mol%, 2 hr 17a >85
315 Me C(Et)=CH2 100 mol%, 2 hr 60 > 90
316 Me Ph 10 mol%, 2 hr 35 > 90
317 Me C(C6H13)=CH2 10 mol%, 2 hr 20a -
317 Me C(C6H,3)=CH2 10 mol%, 16 hr 20a -
317 Me C(C6H13)=CH2 100 mol%, 16 hr 20a -
318 Me /?-MeOC6H4 10 mol%, 2 hr 15a -
318 Me p-MeOC6H4 100 mol%, 16 hr 15a -
319 Ph C(C6H13)=CH2 10 mol%, 2 hr - -
a yield shown is N1VIR conversion
Table 3.3 Reaction o f |3-aryl and |3-alkene aldols with diethyl zinc
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In the case of aldol 308 employing a stoichiometric amount of diethyl zinc improved the 
overall yield of 315 from 17% to 60% yield. Unfortunately the same effect was not 
observed for aldols 282 or 310 where 'H NMR analysis o f the crude reaction product 
revealed the presence o f a number of diastereomeric aldol products which made it difficult 
to analyse the outcome of the rearrangement reaction. This led us to conclude that the 
rearrangement reactions of these types of chiral aldol substrate were reversible, with an 
equilibrium distribution of aldol/ l,3-oxazinane-2,4-diones occurring via reversible retro- 




other three aldol diastereomers
Schem e 142. Mechanism for the reversible rearrangement reaction leading to scrambling o f the a- and 
P-stereocentres o f the aldol product
This hypothesis was confirmed when aldol 309 was treated with 10 mol% diethyl zinc, 
which gave l,3-oxazinane-2,4-dione 316 in high diastereomeric excess but in a low 35% 
yield due to a competing retro-aldol reaction occurring to afford 7V-propionyl 
oxazolidinone 277 (see Scheme 143).
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Scheme 143. Competing retro-aldol o f 5y/7-aldol 309 with 10 mol% diethyl zinc
The presence o f this competing retro-aldol reaction was also confirmed for syw-aldol 311 
which underwent a clean retro-aldol reaction to yield jV-phenylacetyl oxazolidinone 279 
and aldehyde 283 when treated with diethyl zinc under standard conditions (see Scheme 
144). Therefore it appears that the added electronic stabilisation o f the a-aryl substituent o f 
the zinc enolate of 279 allows the retro-aldol pathway to dominate in the reaction o f this 
syrc-aldol 311 with diethyl zinc.
Scheme 144. Retro-aldol reaction o f syw-aldol 311 using 10 mol% diethyl zinc
3.4 Synthesis of Semiplenamide natural products
The novel base induced cyclisation-elimination methodology that had been established was 
then exploited to synthesise a range of a,|3-unsaturated amidic natural products. In 2003 
Gerwick et al. had reported the isolation o f a series o f novel semiplenamide metabolites 
from a Papua New Guinea collection of the marine cyanobacterium Lyngbya 
semiplena.[205] The structures of these natural products are shown in Scheme 145, and were 
shown to exhibit a range o f biological activity including affinity for the cannabinoid CB] 











1 _  i i  r»2Semiplenamide A; R = H, R = H, R~ = (3ii)-«-Ci7H33
3 3
1 _  r>2
Semiplenamide B; R = Ac, R1 = H, R2 = (3£)-n-Ci7H
Semiplenamide C; R = H, R = Me, R = «-Ci3H27 
Semiplenamide D; R = Ac, R1 = Me, R2 = n-Ci7H35 





Semiplenamide F; R = H, R1 = Me, R2 = n-Ci5H3i 
Semiplenamide G; R = Ac, R1 = Me, R2 = n-Ci5H3J
Scheme 145. Structures o f Semiplenamides A-G
It was proposed that our novel cyclisation-elimination methodology was ideally suited for 
the synthesis of the core fatty acid amide fragments of a number of these semiplenamides. 
Therefore, L-alanine methyl ester 320 was reduced with lithium aluminium hydride in 
diethyl ether and the resulting (S)-amino alcohol 321 cyclised with diethyl carbonate to 
give (S)-4-methyl-oxazolidinone 322 in 45% overall yield. The oxazolidinone 322 was 
then deprotonated with butyl lithium at -78 °C before addition of propionyl chloride to 
yield A-propionyl oxazolidinone 323 in 78% yield (see Scheme 146).
o o o
MeO NH2 LiAIH4 HO NH2 (EtO)2CO n-B uL i,-78°C
O NH ----------------------- ► O
THF \  KOEt \ ___ /  EtCOCI, THF
320 321 322 323
45% yield 78% yield
Scheme 146. Synthesis o f  A-propionyl oxazolidinone 323
Before carrying out the aldol reaction the aldehydes 324 -  326 required for the natural 
product synthesis were synthesised from the corresponding commercially available
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primary alcohols via oxidation with pyridinium chlorochromate in excellent 96 -  99% 
yields (see Scheme 147).
PCC, DCM
324, R = C 13H27 , 97% yield;
325, R = C 15H31l 99% yield;
326, R = C 17H35, 96% yield
O
Schem e 147. Synthesis o f required aldehydes 324 -  326
TV-propionyl oxazolidinone 323 was then subjected to our .yyw-aldol conditions, involving 
addition of 1.1 equivalents of 9-BBNOTf and diisopropylethylamine in DCM at 0 °C, 
followed by cooling to -78 °C and addition of the appropriate aldehyde 324 -  326. This 
produced the desired sjw-aldol products 327 -  329 in good yields and high 
diastereoselectivity (see Scheme 148). The syw-stereochemistry was confirmed by the 
small *H NMR J coupling constants between the a- and |3-protons of 2.0 -  3.0 Hz. The 
stereoselectivity in this aldol reaction was particularly noteworthy considering the 
configuration o f the sy/?-aldol was controlled by the relatively sterically undemanding 
(4S)-methyl substituent on the oxazolidinone ring.
O o  o  O OHA A {? 9-BBNOTf. DIPEA A X A
J  N + II  ► O I ' T V ^ R
\ ___ ^  I H R DCM, 0 ° C --78 °C \  ^  I
323 327 R = C13H27 , 81 % yield, > 95% d.e.
328 R = C15H31, 87% yield, > 95% d.e.
329 R = C ^H ^, 80% yield, > 95% d.e.
Schem e 148. Synthesis o f syn-aldol products 327 -  329
Treatment of these syn-aldol products 327 -  329 with KHMDS or LHMDS initially 
resulted in poor yields of a,|3-unsaturated amide products 330 -  332 which was thought to 
be due to a competing retro-aldol pathway occurring, as evidenced by the presence of 
significant amounts o f the respective aldehyde and N-propionyl oxazolidin-2-one 323 in 
the ‘H NMR spectrum of the crude product. However, changing the base used for 
deprotonation o f the syw-aldols to potassium Ze/7-butoxide at -78 °C afforded a clean
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p-elimination reaction to give semiplenamide C 330 and the related unsaturated products 
331 and 332 as precursors to semiplenamides D and E, in good yield after column 
chromatography (see Scheme 149).
o  o  OH 0
U II ? KOfBu, THF
o  ►  HO HN
= -78 °C to RT
327 - 329 330 Semiplenamide C, R = C 13H27 , 74% yield
331 R = C15H31, 79% yield
332 R = C17H33, 74% yield
Schem e 149. Synthesis o f  a,p-unsaturated amides 330 -  332
Treatment o f a,p-unsaturated amides 331 and 332 with pyridine in acetic anhydride and 
dichloromethane, according to the general O-acylation procedure previously described by 
Vega-Perez et al.,[206] resulted in clean formation o f semiplenamide D 333 and 
semiplenamide E 334 in excellent 92 -  94% yield, which were easily isolated by column 
chromatography (see Scheme 150).
A c 2 0
HO H N ' "R
.pyridine U J J
\ ----- /  I DCM I
331 - 332 333 Semiplenamide D; R = C ^ H ^ , 92% yield
334 Semiplenamide E; R = C i5H3-|, 94% yield
Schem e 150. Synthesis o f  semiplenamides D 333 and E 334
Treatment o f a,|3-unsaturated amides 331 and 334 with mCPBA in DCM allowed for non- 
stereoselective formation o f a 45:55 mixture of the diastereomers of epoxy alcohols 
335a:335b and epoxy acetates 336a:336b in excellent 90 -  95% yield (see Scheme 151). 
'I! NMR spectra of these compounds revealed the presence o f singlet resonances at 5 1.55 
ppm corresponding to the methyl substituent o f the epoxide ring and a triplet resonance at 
5 2.83 ppm corresponding to the C-H o f the epoxide ring. In addition l3C NMR spectra 
exhibit signals at 6 60.0 and 63.8 ppm characteristic o f the epoxide functionality, with 
paired signals in the carbon spectrum indicating the presence of two diastereomers of 
product.
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RO HN C 15H3i + RC ‘C i5H31
331, 334 45 : 55 mixture of diastereomers 
335a:335b R = H, 90% yield 
336a:336b R = Ac, 95%  yield
Scheme 151. Synthesis o f diastereomeric mixtures containing semiplenamides F 335 and G 336
Unfortunately repeated attempts to separate these epoxide diastereomers by 
chromatography proved unsuccessful. However, comparison o f the !H NMR spectrum o f 
the diastereomeric mixture of 335a:335b and 336a:336b with NMR data reported by 
Gerwick et al. for the corresponding natural products, clearly revealed that the minor 
diastereomers produced in our epoxidation reactions corresponded to the natural products 
and enabled us to confirm their configuration as shown in Figure 7.
Figure 7. Confirmed structures o f  semiplenamides F and G
3.5 Further attempts at the retro-aldol reaction
Since I had shown that treatment of chiral .syw-aldol 284 with base resulted in elimination 
in the same manner as achiral oxazolidin-2-one 294, it was necessary to modify the 
structure of our chiral auxiliary so that the retro-aldol reaction pathway would 
predominate.
o
C 1 5 H 3 1
335 Semiplenamide F; R = H
336 Semiplenamide G; R = Ac
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3.5.1 Probing the reactivity of a-phenyl and a-isopropyl aldols
It was proposed that a syw-aldol substrate containing a more sterically demanding 
substituent in its a-position might allow the retro-aldol reaction to be favoured over the 
cyclisation-elimination pathway. This was because it was thought that steric interactions 
between the a-substituent (R) and the benzyl substituent of the oxazolidin-2-one fragment 
would result in the aldol adopting chair-like conformations that would disfavour the 




disfavoured by oxazolidin-2-one disfavoured by larger R group
benzyl group projecting towards adopting pseudo-axial conformation
A/-acyl fragment
Scheme 152. Both conformers required for p-elimination disfavour elimination reaction
•Syw-aldols 337 and 311 were therefore prepared using our established boron enolate 
procedure in order to test this hypothesis. Aldol 337 was synthesised in high yield and 
excellent diastereoselectivity (see Scheme 153), however whilst a-phenyl-substituted aldol 
311 was formed in good conversion only small amounts of the desired aldol product could 
be isolated after column chromatography. This was thought to be due to the fact that the 
aldol 311 underwent a premature retro-aldol reaction on acidic silica. This was confirmed 
by adsorbing the syw-aldol 311 onto silica overnight which resulted in isolation of large 
amounts of TV-phenylacetyl oxazolidinone 279 and oxazolidinone 276 on work-up. 
However, carrying out chromatography using neutral alumina as the stationary phase, 
resulted in isolation of a higher 70% yield of the desired aldol 311.
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9-BBNOTf, ^Pr2NEt, 






337 R = 'Pr, 81% yield, >95% d.e. 
311 R = Ph, 70% yield, > 90% d.e.
Scheme 153. Synthesis o f alternative unsaturated aldols
Both aldols 337 and 311 were subjected to hydrogenation reaction using Wilkinson’s 
catalyst according to the standard procedure as shown in Scheme 154. Unfortunately, crude 
‘H NMR spectroscopic analysis of these hydrogenation reactions proved to be difficult to 
interpret as the characteristic H3/H4 protons of the mixture of diastereomers (2S,3R,4R)~ 
338a and (25',3/?,45)-338b and (2S,3R,4R)-339a and (2S,3R,4S)-339b were not resolved in 
their 'H NMR spectra, as they had been previously for corresponding diastereomers of the 




eHl3 17.5 mol% RhCI(PPh3)3




338 R = 'Pr
339 R = Ph
Scheme 154. Hydrogenation reactions using alternative a-substituted syw-aldols
Therefore, it was decided that aldols 337 and 311 would be difficult substrates for 
optimising the hydrogenation procedure, and as a consequence it was decided to explore an 
alternative approach to fixing the retro-aldol problem.
3.5.2 Investigation of a thermal retro-aldol procedure
Due to the ease with which a-phenyl aldol 311 had previously undergone retro-aldol 
reaction on exposure to silica, it was proposed that heating methyl-substituted sjw-aldol 
284 in the presence of silica might allow a thermal retro-aldol reaction to occur, thus 
eliminating the need to use basic conditions. Diastereomerically pure aldol (4/?)-284a was
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refluxed in toluene with silica for 5 hrs, with !H NMR spectroscopic analysis showing 
formation of A-propionyl oxazolidinone 277, indicating that the retro-aldol reaction had 
occurred (see Scheme 155). However, all attempts to isolate the desired a-methyl aldehyde 
340 from these thermal retro-aldol reactions at a range o f temperatures were unsuccessful, 
with no resonance corresponding to an aldehyde proton being visible in the 'H NMR 
spectra of the crude reaction products.
silica, toluene




*- n o t iso la te d
Scheme 155. Desired thermal retro-aldol reaction on silica
It was proposed that my inability to isolate volatile aldehyde 340 from these thermal retro- 
aldol reactions might be a consequence o f its loss during reaction work-up. A thermal 
retro-aldol was therefore attempted by heating neat aldol 4(R)-284 to 205 °C in a 
Kugelrohr microdistillation apparatus with the distillation bulb cooled using an acetone/dry 
ice coolant. Once again although the 'H NMR spectrum of the crude product showed a 
good yield of the TV-propionyl oxazolidinone 277, very little of the desired aldehyde 340 
was present.
3.6 Successful retro-aldol reactions
Clearly, the ability to identify conditions that would enable successful retro-aldol reaction 
was the key to the success of our novel three step strategy for the synthesis of chiral
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aldehydes. It was therefore necessary to suppress the competing cyclisation/elimination 
reaction and this was ultimately achieved using a strategy involving blocking 
intramolecular attack of the p-alkoxide at the ring carbonyl o f the oxazolidin-2-one 
fragment.
3.6.1 Use of the SuperQuat auxiliary
There was significant literature precedent describing the susceptibility o f the endocyclic 
carbonyl of simple oxazolidin-2-ones to intermolecular nucleophilic attack. For example, 
Davies et al. had reported that sterically hindered N-pivaloyl oxazolidin-2-one 341 
underwent competing endocyclic cleavage on treatment with lithium hydroxide to afford a 
mixture of a secondary amide 342 and the exocyclic cleavage products pivolic acid 343 
and oxazolidin-2-one 276 (see Scheme 156).t207]
341 342 276 343
Scheme 156. Endocyclic cleavage o f  iV-pivaloyl oxazolidin-2-one 341
In this cleavage reaction the steric demands o f the large tertiary butyl group were proposed 
to block attack of the incipient nucleophile at the exocyclic carbonyl, and therefore 
competing attack of the nucleophile at the endocyclic carbonyl o f the oxazolidin-2-one 
fragment occurs. To overcome this problem, Davies et al. developed a new class of chiral 
oxazolidin-2-one known as the SuperQuat auxiliary 344 (see Scheme 157).[208] This new 
oxazolidin-2-one contains a gem-5,5-dimethyl group which was designed to block the 
trajectory of attack of nucleophiles at the endocyclic carbonyl, resulting in clean exocyclic 
cleavage, even in the presence o f the bulky tertiary butyl group (see Scheme 157).
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Schem e 157. Exclusive exocyclic cleavage o f  A^-pivaloyl SuperQuat 345
The SuperQuat auxiliary had shown excellent levels of stereocontrol in the syw-aldol 
reaction and during the course o f my studies another member of the SDB group 
demonstrated that alkoxides of sy/7-aldols derived from SuperQuat oxazolidin-2-ones 
underwent clean anionic retro-aldol reactions to afford chiral aldehydes. For example, 
treatment of SuperQuat derived cyclopropane-aldol 264 with LHMDS in toluene at 5 °C 
resulted in a clean retro-aldol reaction to yield cyclopropane carboxaldehyde 265 and N- 




LHMDS, 5 °C 0
toluene H .(/= R
265
8 examples 
51 - 75% yield 
> 95% d.e.
1  °O N
Ph
346
Schem e 158. Successful retro-aldol reaction o f SuperQuat derived aldol 264
Therefore, it was decided to employ the SuperQuat oxazolidin-2-one as a chiral auxiliary 
fragment for our aldol/ hydrogenation/ retro-aldol protocol since the presence of the 
gem-dimethyl fragment should serve to suppress any competing elimination reaction 
pathway during the retro-aldol reaction.
3.6.2 Synthesis of the SuperQuat auxiliary
The SuperQuat oxazolidin-2-one 344 was synthesised according to the procedure 
previously developed by Davies et al. .[208] (S)-phenylalanine was converted into its methyl 
ester by treatment with thionyl chloride in methanol to afford 347 in good 90% yield. The
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crude product was treated with Boc-anhydride and sodium hydrogen carbonate to give 
Af-Boc-protected ester 348 in 83% yield without the need for further purification. 
Treatment of 348 with excess methyl magnesium iodide afforded alcohol 349, although 
yields o f this Grignard reaction were somewhat variable due to difficulties in isolating the 
N-Boc-amino alcohol during work up. Treatment of 349 with potassium tert-butoxide gave 
an alkoxide that cyclised intramolecularly onto the carbonyl o f the N-Boc fragment to 
afford 5,5-dimethyl-(,S)-4-benzyl oxazolidin-2-one 344 in a good 50% overall yield (see 
Scheme 159).
NH, NH2 NHBoc
SOCI2, MeOH ^  I _  Boc20 ,  NaH C 03 
HO Ph 2 MeO^ A ^  .Ph     „ MeO^ A ^  ^Ph
RT, 24 hr N EtOH, 0 °C  to RT, 4 8  hr Q
347 348
90% yield 83% yield
O
Mg, Mel NHBoc k o 'Bu , THF O ' ^ N H
HO-sA^Ph




Scheme 159. Synthesis o f SuperQuat auxiliary 344
3.6.3 5y«-aldol reactions o f SuperQuat auxiliaries
To confirm that the SuperQuat auxiliary 344 would perform similarly under our syn-aldol 
conditions oxazolidin-2-one 344 was acylated with propionyl chloride to afford N- 
propionyl oxazolidin-2-one 346, which was then reacted with 9-BBNOTf, diisopropyl 
ethylamine and a,P-unsaturated aldehyde 283 in dichloromethane to produce syw-aldol 
product 350 in 83% yield and > 95% diastereomeric excess as determined by analysis o f 
the *H NMR spectrum o f the crude product (see Scheme 160). The resultant aldol product 
350 was assigned as the syw-diastereomer by the small coupling constant J(2,3) = 3.4 Hz 
between its a- and p-protons as described previously.
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Schem e 160. Formation o f sjw-aldol product 350 derived from SuperQuat auxiliary 344
3.6.4 Hydrogenation reaction with SuperQuat derived aldol product
It was expected that the gem-dimethyl group of the SuperQuat auxiliary was unlikely to 
interfere with the diastereoselectivity o f the hydrogenation reaction o f unsaturated aldol 
350. In order to check this hypothesis, syw-aldol 350 was subjected to hydrogenation using
17.5 mol% of Wilkinson’s catalyst and 5 bar hydrogen gas (see Scheme 161). From 
analysis of the 'H NMR spectrum of the crude product it was apparent that aldol 350 had 
successfully undergone hydrogenation in a similar diastereoselectivity o f 56% d.e. as that 
observed previously for hydrogenation of the corresponding aldol 282 derived from the 
Evans oxazolidin-2-one (60% d.e.). The configuration of the major diastereomer was 
assigned as (25,3/?,4/?)-351a by consideration of the coupling constant o f J(3,4) = 8.7 Hz, 
which was similar to that previously observed for hydrogenation o f Evans’ aldol 282, and 
therefore the same (4/?)- stereochemistry was assigned. This aldol (47?)-351a was then 
purified to > 95% d.e. via chromatography, and used as a substrate in subsequent 
retro-aldol studies.
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Scheme 161. Comparison o f the hydrogenation reaction o f  SuperQuat derived aldol 350 with Evans derived 
aldol 282 using Wilkinson’s catalyst
3.6.5 Retro-aldol of SuperQuat derived aldols
Having established that the SuperQuat auxiliary performed well under both the aldol and 
hydrogenation conditions, it was necessary to demonstrate that aldol 351 would undergo 
the required retro-aldol reaction. Treatment of aldol 351 with either KHMDS or LHMDS 
at -78 °C and - 40 °C resulted in no reaction, with no evidence of products arising from 
either the elimination or retro-aldol reactions (see Table 3.4, entries 1 -  4). This indicated 
that the gem-dimethyl substituents had indeed proven successful in preventing the 
cyclisation-elimination reaction from occurring, since the corresponding Evans aldol 284 
had eliminated cleanly under these conditions. The SuperQuat aldol 351 was therefore 
subjected to a range of bases, temperatures and solvents in order to find conditions that 
would enable the retro-aldol reaction to proceed (see Table 3.4).
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KHMDS -78 THF no reaction
KHMDS -4 0 THF no reaction
LHMDS -78 THF no reaction
LHMDS -40 THF no reaction
LHMDS -15 THF 3 6 : 2 7 : 2 0 :  17
LHMDS 0 THF 0 : 59 : 11 : 30
LHMDS 0 Toluene 0 : 49 : 7 : 44
LHMDS RT Toluene 0 : 9 : 8 5 : 6
al. l  equivalents of base; Reactions carried out over 2 hours; cDetermined by analysis o f 
the 'H NMR spectrum of the crude product
Table 3.4 Anionic retro-aldol reaction o f  syw-aldol 351 under a range o f conditions
These results revealed that the yield o f aldehyde 340 produced in these anionic retro-aldol 
reactions was highly dependent on the choice of solvent and temperature employed. 
Treatment of ■syw-aldol 351 with LHMDS in toluene at room temperature resulted in 
formation of large amounts of the parent oxazolidin-2-one 344 rather than the desired 
aldehyde and the JV-propionyl oxazolidin-2-one 346 (see Table 3.4, entry 8). This was 
thought to arise from aldol 351 undergoing retro-aldol reaction to afford a lithium enolate 
352 that further decomposes via a retro-ketene type mechanism as shown in Scheme 162. 
Unfortunately, these conditions did not result in any o f the desired aldehyde 340 being 
isolated, however no alternative products could be isolated from an extensive investigation 
of the aqueous or organic extracts of this reaction.
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1.1 eq. LHMDS, RT
340
Schem e 162. Proposed retro-aldol/retro-ketene mechanism for the formation o f  oxazolidin-2-one 344
In contrast, cooling the reaction to 0 °C resulted in an improved 44% yield of the desired 
aldehyde 340 although there was still a small amount of the parent oxazolidin-2-one 344 
produced (see Table 3.4, entry 7). However, on decreasing the temperature to - 15 °C the 
reaction failed to proceed to completion (see Table 3.4, entry 5). Changing the solvent 
from tetrahydrofuran to toluene resulted in an improved yield o f the desired aldehyde 340 
and minimised the formation of the SuperQuat oxazolidin-2-one 344. The retro-aldol 
reaction was therefore optimised at 0 °C in toluene as this gave a good 44% yield o f  
desired a-methyl aldehyde 340, 50% yield of TV-propionyl oxazolidin-2-one 346 and < 6% 




toluene, 2  hr
O
O o
A  A1.1 eq. LHMDS, 0 °C O
 *- l—lI + H' CsH'3
Ph
346 340
6 8 % 54%
isolated yield isolated yield
Schem e 163. Optimised retro-aldol conditions o f aldol 351
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3.7 Determining the enantiomeric excess of a-methyl octanal 340
Since I had discovered conditions that enabled the retro-aldol reaction to proceed in good 
yield it was then necessary to determine whether the basic reaction conditions employed 
for cleavage had resulted in racemisation o f the a-stereocentre o f chiral aldehyde 340. 
Alexakis et al. had shown that derivatisation o f racemic chiral aldehydes with 
enantiomerically pure (S,S)-N,N’-dimethyl- 1,2-diphenyl ethylene diamine (DMPEDA) 
afforded imidazolidinine diastereomers whose 'H NMR spectra were well resolved, thus 
enabling the enantiopurity of the starting aldehydes to be determined by integration o f 
appropriate resonances.[209] Therefore, diastereomerically pure aldol (4R)-351a was 
subjected to the optimised retro-aldol procedure using LHMDS in toluene at 0 °C which 
gave a crude reaction product which was evaporated in vacuo and redissolved in ether 
before addition o f an excess o f DMPEDA to afford the derivatised product 353 without 
resolution (see Scheme 164).
o o
LHMDS o ^ n E ,  y
   I * H" \ "
luene, 2 hr " y  \  j
Ph
(4F?)-351a 346 340a
DMPEDA, Et20  





Scheme 164. Derivatisation o f chiral aldehyde 340a using DMPEDA
An authentic sample o f racemic aldehyde 340 was prepared via hydrogenation o f  
unsaturated aldehyde 283 with 10 mol% palladium on carbon, which was then derivatised 
with DMPEDA to afford a 50:50 mixture o f diastereomers 354 whose ‘H NMR was 
acquired for comparative purposes (see Scheme 165).
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Ph NPh
O ' \
II — N N—
h ^ L / C 6H 13 h ^ ><C / C 6H 13
°  10m o l% P d /C ,5 b a rH 2 * DMPEDA, Et20
C6H13 ------------------------► +  ►





H> < ^ C6Hi3
(rac)-340 (rac)-354
Schem e 165. Derivatisation o f racemic aldehyde 340 using DMPEDA
The ’H NMR spectrum of the imidazolidine derived from the racemic aldehyde showed a 
series o f doublets between 3.5 and 4.2ppm corresponding to the resonances of the PhC // 
and N2C//protons of both diastereomers as shown in Figure 8.
n vpn Kn xpn
v ~ \ a v ~ \ a'
-N N—  — N .N—HX i c 6H,3 b.HX ^ C eH,3
(rac)-354
a I a'
4.10 4.00 3.90 3 80 3.70 3 60
Figure 8. 1H NMR spectrum o f racemic aldehyde derivatised with DMPEDA
Integration of these ]H NMR resonances of the mixture o f diastereomeric imidazolidines 
derived from a-methyl aldehyde 340a produced in the retro-aldol cleavage o f
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diastereomerically pure aldol (4i?)-351a revealed that less than 5% racemisation had 
occurred (see Figure 9). This was considered to be acceptable, especially as these chiral a- 
methyl aldehydes were subsequently shown to be highly susceptible to racemisation.
353
3 "04 20 4 10 40 0 390 3 80
Figure 9. 'H NMR spectrum o f aldehyde 340a from anionic retro-aldol reaction o f  aldol (4/?)-351a 
derivatised with DMPEDA
Although the anionic retro-aldol reaction was shown not to erode the enantiomeric excess 
o f the chiral aldehyde significantly, it proved very difficult to isolate without any further 
racemisation. Purification of the crude reaction mixture by distillation or chromatography 
over silica or alumina resulted in an erosion o f the enantiomeric excess of aldehyde 340a 
to 70 -  83% e.e., as shown by the DMPEDA derivatisation protocol. The aldehyde also 
proved labile to racemisation after leaving on the bench for a few days. This issue was 
solved by derivatising the chiral aldehyde in situ to afford stable chiral products as 
described in the next chapter.
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3.8 Conclusions
Having found appropriate conditions for the retro-aldol reaction our novel aldo 1/directed 
reaction/retro-aldol methodology could be considered to be validated. Optimisation o f  the 
hydrogenation procedure was then necessary and this will be discussed in the next chapter.
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Chapter 4: Optimisation of the hydrogenation reaction
Having established successful syw-aldol and retro-aldol conditions for SuperQuat derived 
substrates it was important to see whether out hydrogenation reactions could be improved 
to give higher levels o f diastereoselectivity.
4.1 Effect of a-substituents on hydrogenation with W ilkinson’s catalyst
The observation that hydrogenation o f the isomerised Evans aldol 285 with Wilkinson’s 
catalyst gave the same major diastereomer as hydrogenation o f methylene-aldol 282, rather 
than the opposite diastereomer as predicted from allylic strain models lead us to postulate 
that for this catalyst the steric environment around the alkene might be more important in 
governing diastereoselectivity than the directing effect o f the hydroxyl group. In order to 
investigate these hydrogenation reactions further, unsaturated aldols 350 and 357 -  358 
containing three different substituents at their a-positions were synthesised according to 
our established procedures. Therefore, SuperQuat auxiliary 344 was deprotonated with 
butyl lithium in THF at -  78 °C and acylated with the appropriate acid chloride to afford 
TV-acylated auxiliaries 346 and 355 -  356, followed by syw-aldol reaction using unsaturated 
aldehyde 283, 9-BBNOTf and diisopropylethylamine to yield sy/7-aldols 350 and 357 -  
358 in reasonable yield and good diastereoselectivity (see Scheme 166).
o
O NH BuLi, THF, -78 °C















350, R = Me, 83% yield, > 95% d.e.
357, R = 'Pr, 79% yield, > 90% d.e
358, R = Ph, 70% yield, > 90% d.e
Schem e 166. Synthesis o f unsaturated aldols 350, 357, 358
These unsaturated aldols 350 and 357 -  358 were then subjected to hydrogenation 
reactions using 17.5 mol% Wilkinson’s catalyst and 5 bar hydrogen pressure as shown in
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Table 4.1. The diastereomeric excess o f these reactions was difficult to determine by *H 
NMR spectroscopy due to multiple overlapping peaks. Therefore, in order to determine the 
diastereoselectivity and configuration o f the major products, the crude reaction product 
from each hydrogenation reaction was treated with LHMDS at 0 °C, resulting in clean 
retro-aldol reactions in each case. Immediate derivatisation of aldehyde 340 produced in 
these retro-aldol cleavage reactions with DMPEDA allowed the enantiomeric excess o f the 
chiral aldehyde to be determined by analysis o f the *H NMR spectra of the resultant 
mixture of diastereomeric imidazolidines. The absolute configuration o f the aldehyde 
could also be determined by comparison with the spectra arising from derivatisation o f the 
enantiomerically enriched (7?)-aldehyde 340a produced earlier.
P  o  OH o  o  OH
■C 6 H 13 17.5 mol% Wilkinson's cat. O N







LHMDS, 0 C DMPEDA, molecular sieves
C 6 H 13
toluene ether
C 6 H 13
Ph  ^ ^Ph
^ > < 7 c6h13
(S)-340b
(S)-353b
Aldol R £^.a (%)
Stereochemistry of 
major aldehyde
350 Me 60 R
357 'Pr 52 S
358 Ph 62 S
a Determined by derivatisation with DMPEDA
Table 4.1 Hydrogenation o f  aldols 350, 357, 358 with Wilkinson's catalyst
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Remarkably, it was found that increasing the steric bulk o f the substituent at the a-position 
from a methyl group to an isopropyl group in aldol 357 not only reduced the 
diastereoselectivity o f the hydrogenation reaction, but also reversed the facial selectivity 
affording the opposite diastereomer with a (4S)-configuration. Aldol 358 containing a 
phenyl group in the a-position was also reduced with poorer diastereocontrol, once again 
resulting in inversion o f configuration in favour o f the (5)-enantiomer o f product.
In order to further investigate the effect o f the a-substituent we decided to change the 
relative stereochemistry at the a- and (3-positions o f  the aldol substrate from syn to anti. 
Therefore, JV-acylated auxiliaries 346, 355 and 356 were dissolved in ethyl acetate before 
addition o f  magnesium chloride, triethylamine, chlorotrimethylsilane and the unsaturated 
aldehyde 283 according to Evans’ recently published procedure (see Scheme 167).[185] The 
mixture was stirred at room temperature before filtering and treatment with trifluoroacetic 
acid in methanol to remove the O-trimethylsilyl group. These anti-aldol reactions tended to 
be very slow, with the JV-propionyl auxiliary 346 proceeding to 60% conversion after 24 
hours, and the 7V-isovaleryl auxiliary 355 affording 40% conversion after 72 hours. 
However the diastereoselectivity o f these reactions was high and therefore the 
diastereomerically pure material could easily be isolated after column chromatography 
albeit in low yield. Evans et al. have reported that the addition o f 30mol% o f  NaSbF6 
improves the conversion in this reaction but this was not attempted as sufficient aldol 
substrate was isolated from these reactions to carry out our desired hydrogenation 
reactions. For the A-phenylacetyl oxazolidin-2-one 356 the *H NMR spectrum o f  the crude 
product after 24 hours was very complex, and although the JH NMR spectrum revealed the 
formation o f  some o f  the desired product, it was very difficult to isolate by column 
chromatography. The stereochemistry o f  aldol products 359 and 360 was assigned 
according to literature precedent with a larger coupling constant o f J(2,3) = 10.0 Hz (360 
used as an example) observed for the vicinal protons characteristic o f an anti-aldol having 
been formed (J(2,3) = 4.8 Hz for corresponding syw-aldol).
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o o
II II o  a ) M g C I 2 , E t 3 N
O  H _  u  T M S C I ,  E t O A c\ / I + hX \ ^ C6H13
' j
b )  T F A ,  M e O H
346, 355, 356 283 359, R = Me, 55% yield, >95% d.e.
360, R = 'Pr, 35% yield, >95% d.e
Scheme 167. Synthesis o f anti-aldols 359 and 360
^ //-a ldo ls  359 and 360 were then subjected to hydrogenation reaction with 17.5 mol% of 
Wilkinson’s catalyst under 5 bar hydrogen pressure. 1.1 equivalents o f LHMDS were then 
added to the crude product in toluene at 0 °C to affect the retro-aldol reaction before 
derivatisation with DMPEDA to determine the enantiomeric excess and stereochemistry of 
the resultant aldehyde as described previously (see Scheme 168).
o  o  O H  
P h
359
5  b a r  H 2 , D C M ,  2 4  h r
O H
L H M D S
P h








t o l u e n e
(R)-340a
9% e.e a




O O O H
P h
O
L H M D S -C6H13H
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Analysis o f the 'H NMR spectrum of the crude product arising from hydrogenation of the 
a-methyl-substituted anti-a\do\ 359 showed very high levels of diastereoselectivity (96% 
d.e. by integration) for an (^-configuration at the newly formed stereocentre. However, 
increasing the steric bulk at the a-position to an isopropyl group in anti-aldol 360 led to 
complete loss o f selectivity in the hydrogenation reaction affording an essentially 1:1 
mixture of the two diastereomers.
The result for a-methyl anti-aldol 359 was very promising as it would allow for substrate 
controlled hydrogenation protocols where both enantiomers of chiral aldehyde 340 could 
be accessed with good selectivity depending on whether a syn- or anti-aldol was employed 
as a substrate (see Scheme 169). Therefore, hydrogenation o f syw-aldol 350 with 
Wilkinson’s catalyst affords the (4/?)-aldol product 351a in 60% d.e., which could be 
purified to greater than 95% d.e. via chromatography, before retro-aldol cleavage to afford 
(R)-aldehyde 340a in greater than 90% e.e. Alternatively, hydrogenation o f anti-a\do\ 359 
with Wilkinson’s catalyst affords the (4S)-aldol product 351b in 96% d.e., which after 
retro-aldol cleavage affords the opposing (5)-aldehyde 340b in greater than 90% e.e.
17.5 mol% Wilkinson's cat.













17.5 mol% Wilkinson's cat. O N'








Schem e 169. Substrate controlled hydrogenation using Wilkinson's catalyst (a determined by derivatisation 
with DMPEDA)
These results complement our earlier screening results which employed catalyst controlled 
diastereocontrol to afford either enantiomer o f the target aldehyde (see Scheme 170).
anti-aldol 359
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Therefore we demonstrated that hydrogenation of syw-aldol 361 with Wilkinson’s catalyst 
afforded the (4/?)-aldol 351a in 78% d.e., which could be purified to homogeneity and 
subjected to retro-aldol reaction to afford (^)-aldehyde 340a in greater than 90% e.e. 
Conversely, hydrogenation with Brown’s catalyst afforded the (4S)-aldol 351b in 64% d.e. 
which after purification and retro-aldol reaction afforded (5)-aldehyde 340b in greater than 
90% e.e.
X i  ?H a
‘ ^ ^ C s H u  17.5 mol% Wilkinson's cat. O '^ ^ N
5 bar H2, DCM, 24 hr ----- C
Ph Ph










‘CsH-n 17.5 mol% Brown's cat. LHMDSN






64%  d.e. > 9 0 % e.e.a
> 95% d.e. after chromatography
Scheme 170. Catalyst controlled hydrogenation o f syn-aldol 361 (a determined by derivatisation with 
DMPEDA)
4.2 H yd rogenation  o f  <m//-aldols w ith B ro w n ’s cata lyst
Hydrogenation of a-methyl anti-aldol 359 was also attempted using Brown’s catalyst 
[Rh(NBD)(DIPHOS-5)]PF6. The most successful conditions previously established using 
Brown’s catalyst employed 2.5 mol% catalyst loading, 4.5 bar hydrogen over 48 hours, 
therefore these conditions were used for the hydrogenation o f anti-aldol 359 as shown in 
Scheme 171.
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OHOH
:6Hl3 2 .5  mol% [Rh(NBD)(DIPHOS-5)]PF6
4 .5  bar H2, DCM, 4 8  hrs
Ph Ph
anf/'-aldol 359
>95% conversion, 92% d.e.
OH OH
CeHi3 2 .5  mol% [Rh(NBD)(DIPHOS-5)]PF6
4 .5  bar H2, DCM, 4 8  hrs
PhPh
syn-aldol 350
70% conversion, 80% d.e.
Scheme 171. Hydrogenation o f awft-aldol 359 and syn-aldol 350 with Brown's catalyst
Analysis of the 'H NMR spectrum o f the crude product showed that this hydrogenation 
reaction proceeded with high diastereoselectivity (92% d.e. by integration). Comparison 
with the 'H NMR spectrum obtained from hydrogenation o f anti-aldol 359 previously 
produced using Wilkinson’s catalyst (see Scheme 168) showed that the same major 
(4S)-diastereomer 362b had been produced.
4.3 H ydrogenation  o f  isom erised  an ti-aldols
For completeness it was interesting to see what effect changing the stereochemistry at the 
a-position had on hydrogenation o f the tri-substituted alkene functionality o f aldol 363. 
a-Methyl substituted anti-aldol 359 in IPA was treated with palladium on carbon under 5 
bar hydrogen for 3 hours to afford the isomerised anti-aldol 363 in almost quantitative 










Schem e 172. Synthesis o f isomerised anti-aldol 363
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Isomerised anti-aldol 363 was then subjected to hydrogenation with both Brown’s and 
Wilkinson’s catalyst at 17.5 mol% and 4.5 bar hydrogen (see Scheme 173). Comparison o f 
the !H NMR spectra obtained from these reactions with authentic standards (see Scheme 
168) showed that the major diastereomer formed in both these reactions was the (4/?)- 
diastereomer 362a. This is what would have been expected from an allylic strain model 
where changing from a 1,1 -substituted olefin to a 1,2-substituted olefin would be predicted 
to give the opposite diastereomer of product (see Chapter 1). Interestingly, Wilkinson’s 
and Brown’s catalysts both favour the same diastereomer, which was not observed for 
hydrogenation of the isomerised syn-aldol 285. This suggests therefore that for the anti- 
aldol there may be ‘matching’ between the hydroxyl directing effect and the steric effect, 




17 .5  mol% R h(P Ph3)3CI
O O OH 
O N' ^  ^  "CgHn
4 .5  bar H2. DCM. 48  hrs
Ph
(4R)-362a
>95% conversion, 50%  d.e.
17.5 mol% [R h(NBD)(DIPH O S-5)]PF6
4 .5  bar H2 . DCM. 48 hrs
(4R)-362a
>95% conversion, 85%  d.e.
Scheme 173. Hydrogenation reaction o f  isomerised anti-aldol 363
In my hands Brown’s catalyst was found to be very sensitive to exposure to the atmosphere 
and therefore great care had to be taken to ensure that hydrogenation reactions were carried 
out in a completely inert atmosphere, with several experiments failing under less rigorous 
conditions. In contrast, Wilkinson’s catalyst was much more robust and cheaper/2101 and 
therefore we consider it to currently be the catalyst o f choice for these hydrogenation 
reactions.
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4.4 R ation a lisin g  the d iastereoselectiv ity  o f  hyd rogen ation  reactions
Although hydrogenation reactions o f sy«-aldols 350 and 361 and anti-aldols 359 and 363 
had proceeded with good levels o f diastereocontrol with Brown’s and Wilkinson’s 
catalysts it was clear that the major isomer produced was not always the expected one. The 
major isomer produced in each of these reactions is summarised in Table 4.2 (Browns 
catalyst) and Table 4.3 (Wilkinson’s catalyst).
Aldol Major diastereomer d,e.
o  O QH









0  o OH 
Ph
359
0  O OH
o^ n' ^ Y ^ ^ c5h11
^  1 Ph
(4S)-362b
92%
0  O QH








O O QH 
Ph
363
0  0  OH




Table 4.2 Major diastereomer produced in hydrogenation reactions using Brown's catalyst
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Aldol Major diastereomer d.e.
0  0  OH 
Ph
350







o  o QH





0  0  OH
1Ph
361





o\ /^ / V N c5Hii
Ph
363
O 0  OH




Table 4.3 Major diastereomer produced in hydrogenation reactions using Wilkinson's catalyst
For Brown’s catalyst it appears that the configuration at the a-position is important in 
determining the diastereoselectivity o f the hydrogenation reaction. It is proposed that this 
is because the steric demand o f the methyl group is important in determining which 
conformer is favoured in the allylic strain model. For the sy«-aldols 350 and 361 this steric 
interaction matches the simple allylic strain model as described in Chapter 1 to produce the 
expected major diastereomers observed by Evans et a/..tl70] For the aw/z-isomers 359 and 
363 the opposite diastereomers are produced due to minimisation o f steric interactions as 
shown in Scheme 174 and Scheme 175.
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Scheme 174. Minimisation o f  steric interactions in hydrogenation o f anti-aldol 359 with Brown's catalyst
favoured unfavoured
OH




Scheme 175. Minimisation o f steric interactions in hydrogenation o f  isomerised anti-aldol 363 with Brown's 
catalyst
In the case o f Wilkinson’s catalyst both the 1,1-substituted sjw-aldol 350 and the 
1,2-substituted syn-aldol 361 give the same product unlike the reactions with Brown’s 
catalyst. This suggests that hydrogenation reactions with this catalyst may not be directed 
by the hydroxyl functionality in the same way as Brown’s. Indeed it is unlikely that the 
Wilkinson’s catalyst complex contains two labile ligands that would allow it to coordinate 
to both the hydroxyl group and the olefin at the same time. In this case it is postulated that
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the diastereoselectivity observed in these reactions is solely dependent on the conformation 
of the substrate molecule, with a number o f low energy conformers all contributing to the 
diastereocontrol. This hypothesis is supported by the large decrease in diastereoselectivity 
that was observed when syw-aldol 292 was used in the hydrogenation reaction with 
Wilkinson’s catalyst (see Scheme 176). It can be seen that a small change in the alkyl 
chain (3- to the alkene functionality had a large effect on the diastereoselectivity even 
though the local environment around the allylic alcohol fragment had not changed.
1 7 .5  mol% R h(P Ph3)3CI 
5 bar H2, DCM, 24  hrs
(4f?)-291a
80% conversion, 33% d.e.
(4F?)-351a 
1 0 0 % conversion, 60% d.e.
17 .5  mol% R h(PPh3)3CI
4 .5  bar H2, DCM, 24 hrs
Schem e 176. Comparison o f  diastereoselectivity o f  hydrogenation o f syn-aldols 292 and 350 using 
Wilkinson's catalyst
Some molecular modelling calculations were carried out on our aldol substrates ( C 3 H 7  
chain used in place o f  C6H 13 for ease of calculation) in order to determine the likely lowest 
energy conformation using Spartan 04. Structures were optimised in vacuo before 
application o f the PM3HD (hexadecane) solvation system. It was thought that the presence 
o f a hydrogen bond between the hydroxyl group and the exocyclic carbonyl would be 
important in determining the lowest energy conformation o f the substrate aldol. 
Interestingly it was found that the predicted lowest energy conformations for the a-methyl 
syH-aldol 350 showed the presence of this hydrogen bond (see Figure 10). However, 
altering the configuration at the a-position to a-methyl anti-aldol 359 or increasing the 
steric bulk at the a-position to a-isopropyl-substituted syn-aldol 357, resulted in the 
predicted low energy conformer no longer containing a hydrogen bond (see Figure 11 and 
Figure 12). Examination o f these structures highlights how critical the steric environment
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of the substrate, and the presence or absence of a hydrogen bond is in governing the 
orientation of the alkene fragment. It is likely that there are multiple low energy states that 
all contribute to the diastereoselectivity of these hydrogenation reactions and therefore 
levels o f diastereocontrol are difficult to predict or rationalise. The importance of the 
hydrogen bond is also supported by the result o f the solvent screen carried out on 
hydrogenation o f syw-aldol 282 since the use of Wilkinson’s catalyst in polar protic 
solvents such as ethanol drastically reduced the diastereoselectivity o f the reaction, 
probably by disrupting the hydrogen bonding within the molecule (see Table 2.5).
Figure 10. Low energy model for a-methyl syw-aldol 350
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Figure 11. Low energy model for a-methyl anti-aldol 359
Figure 12. Low energy model for a-isopropyl syn-aldol 357
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The results o f the molecular modelling suggest that small changes in sterics or 
stereochemistry o f the substrate molecule can have a large effect on its conformation and 
therefore the transition states and outcomes of the hydrogenation reaction with Wilkinson’s 
catalyst are likely to be substrate specific and difficult to predict.
4.5 Optimised retro-aldol reactions
It can be seen that our hydrogenation strategy had proven successful in affording protocols 
for the synthesis of both enantiomers of chiral aldehyde using our originally envisaged 
aldo 1/hydrogenation/re/ro-aldo 1 protocol, with the most successful hydrogenation reactions 
using anti-aldol substrates 363 and 359 described in Scheme 177 and Scheme 178. 
Therefore, £w//'-aldols 363 and 359 could be hydrogenated with either Browns catalyst or 
Wilkinson’s catalyst to afford either aldol diastereomer (4R)-362a and (45)-362b in high 
d.e. Subsequent treatment of each reduced aldol product (4/?)-362a and (45)-362b with 
LHMDS at 0 °C initiated the retro-aldol reaction enabling access to both enantiomers of 






1  °O N
Ph
346
1a) MgCI2, Et3N, TMSCI, 
CHOC(C6H13)=CH2, EtOAc; 
b) TFA, MeOH 0
2. Pd/C, 5 bar H2, IPA
363
17 .5  mol%  
[Rh(NBD)(DIPHOS-5)]PF6







>95% conversion, 85% d.e.
> 95% d.e. after chromatography
Schem e 177. Optimal synthesis o f  (7?)-enantiomer o f aldehyde 340 using our aldol/hydrogenation/retro-aldol 
strategy (a determined by derivatisation with DMPEDA)
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o  o  o  o  OH












17.5  mol% 
R h(P P h3)CI
4 .5  bar H2, DCM, 24  hrs
C.H,
(4S)-362b 
100% conversion, 96% d.e.
Scheme 178. Optimal synthesis o f  (S)-enantiomer o f  aldehyde 340 using our aldol/hydrogenation/retro-aldol 
strategy (a determined by derivatisation with DMPEDA)
4.6 In situ derivatisation of a-substituted aldehyde 340
Although chiral aldehyde 340 was shown not to racemise significantly during the retro- 
aldol cleavage reaction it proved difficult to isolate the aldehyde in an enantiomerically 
pure form unless great care was taken. To overcome this problem it was decided that it 
would be useful to devise protocols that would enable the chiral aldehyde to be derivatised 
in situ to form a range o f synthetically useful chiral synthons that would be less susceptible 
to epimerisation at the chiral centre (see Scheme 179).
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from retro-aldol cleavge of (4/?)-351
Scheme 179. Possible derivatisation o f  chiral aldehyde 340 to synthesise other chiral synthons
As described previously, derivatisation of chiral aldehyde 340 with DMPEDA forms a 
stable chiral imidazolidine.[209] In a similar way, diastereomerically pure aldol (4/?)-351a 
was treated with LHMDS in toluene at 0 °C which underwent retro-aldol cleavage to 
afford chiral aldehyde (/?)-340a. The solvent was evaporated in vacuo and the crude 
product redissolved in DCM and immediately treated with propane-1,3-dithiol and boron 
trifluoride diethyl etherate (see Scheme 180) according to the procedure previously 
reported by Jones et a l.P u ] Purification by column chromatography allowed isolation o f 
the desired dithiane product (R)-364 in good yield, whose specific rotation was found to be 
+ 8.0 0 (c = 3, ether), which compared well with the previously reported literature value for 
this enantiomerically pure dithiane of + 8.3 ° (c = 3, ether) . [2121 This indicates that the 
a-stereocentre is not racemised in the retro-aldol/derivatisation protocol whilst providing 
further evidence that the absolute configuration of the a-methyl centre of the aldehyde was
indeed (R) ([a]p - 9.6 ° for (S)-enantiomer, c = 3, ethanol).[212]
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Scheme 180. Synthesis o f  (7?)-dithiane 364
In the same way, the crude chiral aldehyde (/?)-340a from the retro-aldol reaction o f 
(4/?)-351a was reacted with the stabilised ylid 365 to produce the chiral (/?)-a,(3- 
unsaturated ester 366 in excellent yield after column chromatography (see Scheme 181). 
Although (/?)-a,|3-unsaturated ester 366 is not reported in the literature, this type of Wittig 
reaction has been carried out previously on a number o f structurally related chiral alkyl 
aldehydes, and in all cases the reaction was found to proceed with no loss of 
enantiopurity.[2l3'2l5] Also, the specific rotation o f (is)-(/?)-4-methyl-dec-2-enoic acid 
methyl ester 366 was found to be -  27.5 ° (c 0.40, CHCI3), which compared well to the 
previously reported literature value for the structurally similar enantiomerically pure 
(£)-(R)-4-methyl-oct-2-enoic acid ethyl ester o f -  30.8 0 (c 1.0, CHCl3).[216]
(R)-340a 365
Scheme 181. Synthesis o f  a,P-unsaturated ester (/?)-366
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Enders and SchiiBeler previously reported reduction of aldehyde (S)-340b using a borane 
dimethyl sulfide complex in their RAMP/SAMP hydrazone mediated synthesis o f the 
female pheromone components o f the spring hemlock looper and the pitch pine looper.[217] 
Gas chromatography over a chiral stationary phase indicated that under these conditions 
there was no detectable racemisation o f the chiral centre. In the same way, chiral aldehyde 
(7?)-340a from the crude retro-aldol reaction of (4^?)-351a was treated with an excess of 
borane dimethyl sulfide to yield chiral alcohol 367 in good yield (see Scheme 182). The 
specific rotation of alcohol (R)-361 was found to be + 10.0 ° (c 1.0, CHCI3) which 
corresponded very well with the literature value for the enantiomerically pure compound 
+ 10.3 0 (c 1 .0 , CH2C12),[218] indicating that the a-methyl stereocentre had not racemised.
C6H13
5 eq. BH3.SMe2 
Et20 ,  RT
HO
C 6 H 13
(f?)-340a 367
75%  y ield
Scheme 182. Synthesis o f  chiral alcohol (R)-361
It can therefore be seen that it is possible to derivatise the chiral aldehyde formed from our 
novel aldol/ hydrogenation/retro-aldol strategy into a number of enantiomerically enriched, 
stable chiral synthons which would prove to be synthetically useful.
4.7 Conclusions
It has been demonstrated that our aldol/hydrogenation/retro-aldol protocol could be used 
for the stereodivergent synthesis o f both enantiomers o f chiral a-methyl aldehyde 340 
which could subsequently be easily derivatised in situ to afford synthetically useful chiral 
synthons in an enantiomerically pure form.
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Chapter 5: Investigations into palladium on carbon
isom erisation reaction
5.1 Introduction
As described in Chapter 2 during the initial screen o f hydrogenation reactions, attempted 
hydrogenation of unsaturated aldol 282 with 3 mol% palladium on carbon under 1 bar 
hydrogen pressure resulted in the unexpected formation of isomerised aldol product 285 in 
















Schem e 183. Observed isomerisation o f aldol 282 using palladium on carbon as a catalyst
It is suspected that this type of isomerisation pathway may also be present in some o f the 
other hydrogenation reactions described in this thesis (see Chapter 2), however these 
isomerisation products are not observed as the hydrogenation reaction proceeds to afford 
the fully reduced product 284. Isomerisations o f allylic alcohols to enolates have been 
reported previously using rhodium catalysts/219’220] whilst Hodgson et al. have reported the 
isomerisation o f vinyldisilane 368 to allyldisilane 369 using palladium on carbon (see 
Scheme 184).[221] However, I could find no literature precedent for isomerisations o f allylic 
methylenic alcohols with palladium and it was therefore decided to carry out further
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investigations to see if more information could be elucidated about the mechanism o f this 
reaction.
H3C(H2C)6 \ ^ ^ ^ S i M e 3 20% Pd(OH)2/C, 1atm. H2 H3C(H2C)6 ^ ^ ^ ^ S i M e 3 H a C ^ C f e ^ ^ - ^ ^ S i M e a
SiM e3 e ther, 25 °C SiMe3 SiM e3
368 369 370
ratio 6 : 87 : 7 (368 : 369 : 370)
Schem e 184. Palladium catalysed isomerisation o f vinyldisilane 368 to afford allyldisilane 369
5.2 Effect of hydrogen pressure on isomerisation
Since the tri-substituted alkene functionality of unsaturated aldol 285 was not 
hydrogenated during the reaction it was decided to determine whether hydrogen gas was 
taking part in the reaction. Aldol 282 was treated with 3 mol% palladium on carbon in IPA 
at atmospheric pressure in the absence of hydrogen gas to see if the isomerisation reaction 
would still occur (see Scheme 185). After 3 hours, 'H NMR spectroscopic analysis showed 
only starting material present in the reaction mixture. The reaction was left for a further 24 
hours, however once again only starting material could be observed in the !H NMR 
spectrum, indicating that the presence o f hydrogen gas was playing a key role in the 







Schem e 185. Palladium on carbon reaction o f 282 in the absence o f  hydrogen gas
Surprisingly, it was found that increasing the hydrogen pressure to 5 bar still resulted in the 
isomerisation reaction occurring very cleanly, with less than 1 % yield o f the expected 
reduced aldol 284 present in the *H NMR spectrum of the crude product (see Scheme 186). 
This was a remarkable observation since it was thought that higher hydrogen pressure
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would result in the hydrogenation reaction dominating over the isomerisation reaction, 
however this does not appear to be the case.
A °3 mol% Pd/C O N 
5 bar H2, IPA
CcH'5n 11
> 99% yield
Scheme 186. Palladium on carbon isomerisation o f aldol 282 at increased hydrogen pressure
5.3 E ffect o f  pallad ium  source on the reaction
Recently there have been several reports of soluble palladium nanoparticles acting as 
homogeneous catalysts in a variety of reactions, which had proposed that palladium could 
‘leach’ into solution to form soluble palladium species which are responsible for catalytic 
reaction.[222]'t223'224] For example, soluble palladium species arising from insoluble 
palladium on carbon had been reported to catalyse intra- and inter-molecular ligand-free 






Scheme 187. Ligand free intramolecular arylation using soluble palladium species arising from Pd(OH)2/C
Consequently it was considered that the isomerisation reaction of sy«-aldol 282 might have 
arisen from the catalytic activity o f a soluble palladium species.
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In order to investigate this hypothesis, the isomerisation reaction was repeated using 3 
mol% of palladium (II) acetate as a soluble palladium source, under otherwise identical 
conditions (see Scheme 188). At both 1 bar and 5 bar hydrogen pressure the reaction with 
palladium (II) acetate occurred cleanly to give isomerised product 285, with only trace 
amounts of reduced aldol 284 being observed in the 'H NMR spectrum of the crude 
product. This indicated that soluble palladium could indeed be involved in the 
isomerisation reaction of unsaturated aldol 282, and therefore that the choice o f solvent 
used in this reaction may also be important.
3 md% Pd(ll) acetate
1 or 5 bar H2. IPA
Scheme 188. Isomerisation o f aldol 282 with palladium acetate
5.4 Effect of solvent on the reaction
In order to see what effect the choice o f solvent had on the isomerisation reaction, 
unsaturated aldol product 282 was treated with 3 mol% palladium on carbon at 1 bar 
pressure using a range of different solvents. After 3 hours the 'H NMR spectrum of the 
crude product was analysed and the results are summarised in Table 5.1.
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Solvent Ratio 282 : 285 : 284
isopropyl alcohol 0 : 9 9  : 1
ethanol 0 : 97 : 3
ether 1 : 97 : 2
dichloromethane 0 : 98 : 2
toluene 1 : 95 : 4
hexane 61 : 38: 1
Table 5.1 Effect o f  solvent on palladium on carbon isomerisation o f  aldol 282
Serendipitously, the isomerisation proceeded best in IPA which was the original solvent 
employed in the reaction. However, it appeared that the reaction was also successful 
(> 95% isomerised product) in other polar solvents, with only small amounts of starting 
material 282 or reduced aldol 284 being present. Interestingly the reaction also appeared to 
be successful using toluene, a non-polar solvent, and even with hexane, although in this 
case a large amount of starting material remained. These results suggested that the solvent 
was probably not intrinsically involved in the mechanism o f this rearrangement as it had 
occurred successfully in polar-protic, polar-aprotic and non-polar solvents. It is unclear 
whether these results support the idea that a soluble palladium species is acting as a 
catalyst in these reactions, since the literature reports suggest that palladium leaching 
occurs only in polar solvents such as DME, and is greatly reduced in non-polar solvents 
such as toluene.[225]
5.5 Deuterium labelling experiments
In order to further probe the mechanistic aspects of the isomerisation reaction, a series of 
deuterium labelling experiments were carried out with the aim o f determining where the 
deuterium would be incorporated into the isomerised aldol product 285.
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Unsaturated aldol 282 was initially subjected to isomerisation with 3 mol% palladium on 
carbon under a balloon of deuterium gas. After 3 hours, the crude *H NMR spectrum 
showed very little conversion (< 1 0 %) to the isomerised product, which was ascribed to a 
large kinetic isotope effect for deuterium being incorporated into the compound. This was 
confirmed since after 16 hours only 50% conversion of aldol 282 to the isomerised aldol 
was observed. This compares to the analogous reaction using hydrogen gas which 
proceeded to 100% conversion after 3 hours. Analysis of the ’H NMR spectrum showed 
that the resonance corresponding to the alkene proton of the isomerised aldol 374 ( 8  5.50 
ppm) was very small, whilst integration of the resonance corresponding to its new methyl 
signal ( 8  1.57 ppm) was also reduced to two protons. This would indicate that deuterium 
had been incorporated into both these positions and therefore were not being observed in 
the *H NMR spectrum (see Scheme 189). 2H NMR spectroscopy confirmed that deuterium 
had been added into these two sites of the isomerised aldol 374 with deuterium resonances 










Scheme 189. Isomerisation carried out under deuterium gas showing incorporation o f deuterium into 
isomerised product 374
l 1 ' ' ' l 1 ' ' ' l 1 ' ' ' I ' ' ' ' l ’ ' ' ' l ' ' ' ' l | | .
i.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
Figure 13. Deuterium NMR spectrum o f isomerised aldol 374
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The reaction was then carried out using deuterated ds-IPA under 1 bar hydrogen to see if 
deuterium would be incorporated into the product from the solvent (see Scheme 190). 
After 3 hours the !H NMR spectrum of the crude product showed approximately 50% 
conversion o f starting material 282 and after 16 hours there was 75% conversion to the 
isomerised product 285. 2H NMR analysis o f this isomerised aldol 285 showed no 
significant incorporation of deuterium into the compound, reinforcing the conclusion from 









Scheme 190. Isomerisation reaction carried out in deuterated solvent
From these results a tentative mechanism was proposed to explain this isomerisation 
reaction involving addition of a palladium-deuteride catalytic species across the alkene 
functionality of aldol 282 to afford palladium-deuteride species 375. This species could 
then reversibly eliminate Pd-H to afford a new tri-substituted alkene species 376. 
Reversible addition of the Pd-D species to alkene 376 would then afford palladium- 
deuteride species 377 which could further eliminate Pd-H to afford the more stable 1,2- 
substituted alkene 374 containing two deuterium atoms (see Scheme 191).
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Scheme 191. Proposed mechanism for the palladium-deuteride isomerisation
5.6 Other substrates
In order to determine whether this palladium promoted isomerisation reaction had the 
potential to be a useful, generally applicable protocol it was decided to investigate whether 
it could be applied to other substrates. The tetra-substituted olefin functionality of aldol 
378 was therefore chosen as a challenging substrate for this methodology because of its 
increased steric hindrance.
Consequently, a-methylene aldehyde 379 was first synthesised in good yield from 
commercially available isovaleraldehyde and formaldehyde, according to the standard 
procedure described by Marvel et al. (see Scheme 192).[,91]
O O | dimethylamine.HCI
H ^ H  70 °C, 24 hrs
379
90% yield
Scheme 192. Synthesis o f  a-methylene aldehyde 379
160
Chapter 5 Results and Discussion
Aldehyde 379 was then employed in a syn-aldol reaction with A-propionyl-oxazolidin-2- 
one 277 according to our established procedure to afford unsaturated aldol 378 in 80% 







DCM, 0 to - 78  °C
Ph
378
Schem e 193. Synthesis o f unsaturated aldol 378
80% yield
Syw-aldol 378 was then treated with 3 mol% palladium on carbon with 1 bar hydrogen gas 
under the same conditions described previously. After 3 hours analysis of the 'H NMR 
spectrum o f the crude product showed very little conversion to the isomerised aldol 380, 
which was proposed to be due to increased steric hindrance at the (3-position of the alkene 
fragment. Increasing the hydrogen pressure to 5 bar resulted in approximately 50% 
conversion to the desired isomerisation product after 3 hours, however the crude ‘H NMR 
spectrum showed evidence o f more than one product, possibly due to formation o f the 
reduced product 381 (see Scheme 194).
3 mol% Pd/C
5 bar H2, IPA, 3 hrs
378 380 381
~ 50% conversion
Scheme 194. Palladium on carbon isomerisation o f aldol 378
Repeating this reaction using 3 mol% palladium (II) acetate resulted in a much cleaner 
reaction affording a mixture of starting aldol 378 and isomerised aldol 380 in the 'H NMR 
spectrum. However, on leaving the reaction for 24 hours the ]H NMR spectrum o f the 
crude product showed a mixture of isomerised aldol 380 and reduced product 381 in a
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45:55 ratio (see Scheme 195). Fortunately these products could be easily separated by 





3 mol% Pd(ll) acetate







45% conversion 55% conversion
Scheme 195. Palladium (II) acetate isomerisation o f aldol 378
These results suggest that with this substrate there may be an equilibrium between the 
starting aldol 378 and the isomerised aldol 380 and over time hydrogenation of either 
substrate may occur. This supports our proposed mechanism that palladium hydride 
species can add reversibly to the alkene in equilibrium, favouring the most stable isomer.
Therefore, these results show that this isomerisation methodology may be applied to more 
hindered substrates and further investigation into using this protocol to rearrange different 
types o f a-methylene alcohols is currently being carried out by other members o f the SDB 
group.
5.7 Future work
It is likely that these isomerised aldol products may undergo retro-aldol reaction which 
would provide a useful method for the synthesis o f highly substituted a,(3-unsaturated 
aldehydes 384 that are difficult to prepare using existing methodology (see Scheme 196).
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Schem e 196. Possible synthesis o f highly substituted aldehydes
More importantly, the SDB group is currently investigating the scope and limitation of this 
methodology for the isomerisation o f simple methylene alcohols such as 386 into their 
more substituted analogue 387 (see Scheme 197).
reduce
Schem e 197. Possible synthesis o f 1,2-substituted allylic alcohols
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Chapter 6: Experim ental
6.1 General conditions
Anhydrous solvents were obtained by passing through anhydrous alumina columns using 
an Innovative Technology Inc. PS-400-7 solvent purification system. All commercial 
reagents were used without purification unless stated otherwise. Hydrogenation catalysts 
were obtained from Strem Chemicals and were stored and handled under nitrogen, except 
palladium on carbon which was obtained from Johnson Matthey (10% Pd/charcoal Type 
87L). All glassware was dried in an oven and allowed to cool under nitrogen prior to use 
and all reactions were carried out under nitrogen unless otherwise stated. Hydrogenation 
reactions were carried out on either the Argonaut Technologies (now Biotage AB) 
Endeavour® catalyst screening system or in a Parr 4714 screwcap pressure vessel. Flash 
chromatography was performed under medium pressure using matrix 60 silica or Merck 
Kiesgul 60 unless otherwise stated. Reactions were monitored by TLC on Whatman 
aluminium baked UV254 silica gel plates and visualised under UV . Optical rotations were 
measured with an AA-10 automatic polarimeter from Optical Rotations Ltd. Proton and 
carbon magnetic resonance spectra (]H and 13C NMR) were recorded ort a Bruker 300MHz 
spectrometer, using the residual CHCI3 solvent as an internal standard. The assignment o f  
13C was assisted by DEPT experiments. All chemical shifts (6 ) are reported in ppm and J 
values are recorded in Hz. IR spectra were recorded on a Perkin-Elmer 1605 spectrometer 
as thin films using NaCl windows or as pressed KBr discs and wavenumbers are reported 
in cm'1. Mass spectrometry measurements were performed at the EPSRC National 
Spectrometry Service Centre, University o f Wales, Swansea. All compounds were 
modelled in Spartan 04, ab initio calculations were conducted post-conformational search 
using Hartree-Fock 3-21G(*) level o f theory. Compounds were optimised in vacuo before 
application o f solvation method PM3HD (assuming hexadecane systems).
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6.2 Synthetic procedures and analytical data
6.2.1 Procedures for the synthesis of (S)-4-Benzyl-oxazolidin-2-one (E vans’ 
auxiliary) 276
(S)-2-Amino-3-phenyl-propan-l-ol, 275
(L)-Phenylalanine (10 g, 0.0605 moles) in dry THF (60mL) was placed in a dry 3 neck 
flask fitted with double walled condenser, nitrogen bubbler and thermometer under 
nitrogen. BF3.0 Et2 ( 1  eq.) was added dropwise over 2 0  min and the reaction left stirring at 
room temperature for a further 15 min. The mixture was then heated to reflux in an oil bath 
and left stirring for 2 hr (solution turns colourless). BH3.SMe2 (1.25 eq.) was added 
carefully over 2 hr whilst vigorously refluxing and the reaction left to reflux overnight. The 
reaction was allowed to cool to room temperature and the excess BH3 quenched by careful 
addition of 1:1 THFiwater (8 mL) followed by 5M NaOH (45mL). The mixture was heated 
to reflux and left stirring overnight before removing from the oil bath and cooling to room 
temperature. The white precipitate was filtered off under vacuum and washed with THF. 
The collected filtrate was evaporated in vacuo to remove most o f the THF. The organics 
were extracted into DCM, washed with brine and dried (MgS0 4 ) before evaporating in 
vacuo. The crude product was recrystallised in hot ethyl acetate to yield (5)-2-ainino-3- 
phenyl-propan-l-ol 275 (8.40 g, 92%) as a white crystalline solid, with spectroscopic data 
essentially identical to the literature compound.[l75]
mp 89 °C [lit. 89.5 -  91.5 °C]; [aft5 - 23.4 0 (c 1.03, ethanol) [lit. -  24.7 0 (c 1.03, 
ethanol)]; *H NMR (CDC13, 300 MHz): 5 1.63 (3H, broad peak, NH2, OH), 2.46 (1H, dd, 
C/^HePh, J = 13.6, 8.7 Hz), 2.71 (1H, dd, CHA//z?Ph, J = 13.6, 5.3 Hz), 3.04 (1H, m, 
C//NH2), 3.35 (1H, dd, C//^HbOH, J = 10.3, 7.2 Hz), 3.58 (1H, dd, CHAHB, J = 10.3, 3.8 
Hz), 7.19 (5H, m, Ph); ,3C NMR (CDC13, 75 MHz): 5 41.8 (CH2Ph), 54.7 (CHNH2), 6 6 . 8  
(CH2OH), 126.8 (phenyl CH), 128.9 (phenyl CH), 129.6 (phenyl CH), 140.00 (phenyl C); 






2-Amino-3-phenyl-propan-l-ol 275 (3 g, 0.020 moles) was placed in a 2 neck flask fitted 
with distillation apparatus (distillation head clad with cotton wool and foil). Potassium 
carbonate (0 . 1  eq.) and diethyl carbonate (2.06 eq.) are added and the mixture lowered into 
an oil bath pre heated to 135°C. The distillation receiver was cooled in an ice bath and 
approximately 2.6 mL of ethanol was collected over 4 hours. The yellow mixture was 
allowed to cool to room temperature and diluted with DCM, washed with water, dried 
(MgS0 4 ), filtered and evaporated in vacuo. The crude material was recrystallised in hot 2:1 
ethyl acetateicyclohexane to yield (5)-4-benzyI-oxazolidin-2-one 276 (2.01 g, 57%) as an 
off white solid with spectroscopic data essentially identical to literature compound.[l75] 
mp 82 °C [lit. 87 °C]; [a]2* + 4.8 ° (c 1.10, ethanol) [lit. + 4.9 ° (c 1.10, ethanol)]; !H 
NMR (CDC13, 300 MHz): 5 2.80 (2H, m, CH2Ph), 4.11 (2H, m, C //20), 4.40 (1H, app t, 
C//NH, J = 8 . 6  Hz), 5.08 (1H, broad s, NH), 7.09-7.39 (5H, broad m, Ph); ,3C NMR 
(CDCI3, 75 MHz): 5 42.00 (CH2Ph), 54.3 (CHNH), 70.1 (CH20), 127.7 (phenyl CH),
129.4 (phenyl CH), 129.5 (phenyl CH), 136.4 (phenyl Q ,  159.4 (C O ); IR (KBr disc) vmax 
(cm'1): 3460 (N-H), 1760 (C=0)
6.2.2 Typical procedure for the 7V-acylation o f (£)-4-Benzyl-oxazolidin-2-one 
(Evans’ auxiliary) 276
(S)-4-Benzyl-oxazolidin-2-one 276 (1 eq.) in dry THF was cooled to -  78 °C before 
addition of butyl lithium (1.01 eq., 2.5 M solution in hexanes) slowly over a 10 minute 
period followed by the acid chloride (1.1 eq.). The mixture was left stirring at - 78 °C for 
45 minutes before warming to room temperature whilst stirring for 1 hour and excess acid 
chloride quenched by addition o f aqueous ammonium chloride. Most of the THF and 
hexane was removed by evaporation in vacuo and the organics extracted with DCM. The 
combined organic extracts were washed with 1 M NaOH and brine, dried (MgSO-O,
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filtered and evaporated in vacuo. The resulting oil was left in the fridge overnight to form a 
crystalline solid. The crude material was recrystallised in hot cyclohexane.
(£)-4-Benzyl-3-propionyl-oxazolidin-2-one, 277
According to general procedure 6.2.2, employing 4-benzyl-oxazo lid in-2-one 276 (0.60 g, 
3.39 mmol) in THF (10 mL), butyl lithium (1.37 mL, 2.5 M, 3.42 mmol), propionyl 
chloride (0.33 mL, 3.73 mmol), the crude product was prepared as a colourless oil. 
Recrystallisation in hot cyclohexane afforded (5)-4-benzyl-3-propionyl-oxazolidin-2-one 
277 (0.74 g, 94%) as an almost colourless crystalline solid, with spectroscopic data 
essentially identical to literature compound.[226]
mp 43 °C [lit. 41.2 °C]; [a]2* + 93.2 ° (c 1.01, ethanol) [lit. + 92.3 ° (c 1.00, ethanol)]; 'H 
NMR (CDC13, 300 MHz): 5 1.14 (3H, t, CH3, J = 7.3 Hz), 2.72 (1H, dd, C/^HePh, J =
13.4 Hz, 9.8 Hz), 2.88 (2H, m, C//2CH3), 3.23 (1H, dd, CHA/ / fiPh, J = 13.4 Hz, 3.4 Hz), 
4.11 (2H, m, CH20), 4.61 (1H, m, CHN), 7.21 (5H, broad m, Ph); 13C NMR (CDC13, 75 
MHz): 5 8 . 8  (CH3), 29.1 (CH2CH3), 38.2 (CH2Ph), 55.4 (CHN), 66.5 (CH20), 127.7 
(phenyl CH), 129.3 (phenyl CH), 129.8 (phenyl CH), 135.6 (phenyl C), 154.00 (OC=0), 




According to general procedure 6.2.2, employing 4-benzyl-oxazolidin-2-one 276 (1.00 g,
5.64 mmol) in THF (15 mL), butyl lithium (2.28 mL, 2.5 M, 5.70 mmol), isovaleryl 
chloride (0.76 mL, 6.20 mmol), the crude product was prepared as a pale yellow oil. 
Purification via column chromatography afforded 4-benzyl-3-(3-methyI-butyryl)- 
oxazolidin-2-one 278 (1.25 g, 85%) as a white solid, with spectroscopic data essentially 
identical to literature compound.[227]
mp 50 -  51 °C [lit. 50 -  51 °C]; [a ] 25 + 61.5 ° (c 1.04, CHC13) [lit. + 55.8 ° (c 1.01, 
CHC13)]; ‘H NMR (CDCI3, 300 MHz): 5 0.94 (3H, d, CH3, J = 6 . 8  Hz), 0.95 (3H, d, CH3, J 
= 6 . 8  Hz), 2.15 (1H, apparent septet, CH(CH3)2, J = 6 .8 ), 2.68 (1H, dd, C//„HBPh, J = 13.2,
9.3 Hz), 2.70 (1H, dd, C /^H BCH(CH3)2, J = 16.2, 7.2 Hz), 2.82 (1H, dd, 
CHA//*CH(CH3)2, J = 16.2, 6 . 8  Hz), 3.24 (1H, dd, CHA/ / sPh, J = 13.2, 3.4 Hz), 4.10 (2H, 
m, CH20), 4.61 (1H, m, CHN), 7.12 - 7.30 (5H, m, Ph); 13C NMR (CDCI3, 75 MHz): 6  
22.8 (CH3), 23.00 (CH3), 25.4 (CH(CH3)2), 38.4 (CH2Ph), 44.4 (C=OCH2), 55.6 (CHN),
66.5 (CH20), 127.7 (phenyl CH), 129.3 (phenyl CH), 129.8 (phenyl CH), 135.8 (phenyl 





According to general procedure 6.2.2, employing 4-benzyl-oxazolidin-2-one 276 (1.00 g,
5.64 mmol) in THF (15 mL), butyl lithium (2.28 mL, 2.5 M, 5.70 mmol), phenyl acetyl 
chloride (0.82 mL, 6.20 mmol), the crude product was prepared as a yellow oil. 
Purification by column chromatography afforded (5)-4-benzyl-3-phenylacetyl- 
oxazolidin-2-one 279 (1.45 g, 87%) as a white solid, with spectroscopic data essentially 
identical to literature compound.t227]
mp 69 °C [lit. 71.5 °C]; [a]2* + 75.7 ° (c 1 .0 1 , CHC13) [lit. + 72.4 ° (c 1.01, CHC13)]; ]H 
NMR (CDC13, 300 MHz): 5 2.69 (1H, dd, CHAHBPh, J = 13.4 Hz, 9.4 Hz), 3.20 (1H, dd, 
CHAF/flPh, J = 13.4 Hz, 3.3 Hz), 4.11 (2H, m, CH2O), 4.20 (1H, d, C(0)C//^HBPh, J =
15.4 Hz), 4.27 (1H, d, QCOC/^HePh, J = 15.4 Hz), 4.60 (1H, m, CHN), 7.06 (2H, dd, Ph, 
J = 7.5 Hz, 1.9 Hz), 7.17-7.30 (8 H, broad m, Ph); ,3C NMR (CDC13, 75 MHz): 6  37.6 
(CHCH2Ph), 41.4 (C=OCH2Ph), 55.2 (CHN), 66.0 (CH20), 127.1 (phenyl CH), 128.4 
(phenyl CH), 128.8 (phenyl CH), 129.3 (phenyl CH), 129.7 (phenyl CH), 133.4 (phenyl 
C), 135.0 (phenyl C), 153.3 (OC=0), 171.1 (NC=0); 1R (KBr disc) vmax (cm'1): 1776 
(C=0), 1698 (C=0)
6.2.3 Typical procedure for the Evans auxiliary mediated syw-aldol reaction
A solution o f A-acylated oxazolidinone (1 eq.) in DCM was cooled to 0 °C in an ice bath 
and 9-BBNOTf (1.1 eq., 0.5 M solution in hexanes) added dropwise. The mixture was left 
stirring for 30 min at 0 °C before addition of diisopropylethylamine (1.3 eq.) and stirring 
for a further 40 min. The reaction was then cooled to -  78 °C in an acetone-dry ice bath 
before addition o f the aldehyde (1.1 eq.) and stirring for 1 hr at -  78 °C followed by 1 hr at 
0 °C. The mixture was allowed to warm to room temperature, pH 7 phosphate buffer added 
and stirred for 5 min before addition o f 2:1 hydrogen peroxide:methanol (v/v) and stirring
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for 16 hrs. The bulk of the solvent was removed in vacuo and the resulting slurry 
partitioned between water and diethyl ether. The combined organic extracts were washed 
with 5 % Na2CC>3 and brine, dried (MgSCU), filtered and evaporated in vacuo.
(S)-4-Benzyl-3-((2£,3/?)-3-hydroxy-2-methyl-pentanoyl)-oxazolidin-2-one, 280
According to general procedure 6.2.3, employing (5)-4-benzyl-3-propionyl-oxazolidin-2- 
one 111 (0.35 g, 1.50 mmol) in DCM (15 mL), 9-BBNOTf (3.60 mL, 1.80 mmol), 
diisopropylethylamine (0.34 mL, 1.95 mmol), propionaldehyde (0.12 mL, 1.65 mmol), the 
crude product was prepared as a pale yellow oil. Purification by column chromatography 
afforded (S')-4-benzyl-3-((2S',3/?)-3-hydroxy-2-methyl-pentanoyl)-oxazolidin-2-one 280 
(0.4 g, 91%) as an off white solid, with spectroscopic data essentially identical to the 
literature compound.[228]
mp 78 °C [lit. 77 -  79 °C]; [a]2*- 94.0 0 (c 1.06, ethanol) [+ 38.5 ° (c 1.07, CHC13)]; 'H 
NMR (CDC13, 300 MHz): 5 0.91 (3H, t, CH2CH3, J = 7.4 Hz), 1.20 (3H, d, CHCH3, J = 7.2 
Hz), 1.36 -  1.57 (2H, m, CH2CH3), 2.74 (1H, dd, C /^H BPh, J = 13.6, 9.6 Hz), 2.87 (1H, 
broad singlet, OH), 3.19 (1H, dd, CHA//*Ph, J = 13.6, 3.4 Hz), 3.73 (1H, qd, CHCH3, J = 
7.2, 2.6 Hz), 3.80 (1H, m, C//OH), 4.14 (2H, m, CH2O), 4.64 (1H, m, C//N), 7.11-7.31 
(5H, broad m, Ph); ,3C NMR (CDC13, 75 MHz): 5 10.7 (CH3), 10.8 (CH3), 38.2 (CH2Ph),
42.1 (CHCH3), 55.5 (CHN), 6 6 . 6  (CH20 ), 73.4 (CHOH), 128.0 (phenyl CH), 129.4 
(phenyl CH), 129.8 (phenyl CH), 135.1 (phenyl Q ,  153.5 (OC=0), 177.8 (NC=0); IR 
(KBr disc) vmax (cm'1): 3510 (O-H), 1777 (C=0), 1689 (C=0); HRMS: m/z (ES) [M+H]+ 





According to general procedure 6.2.3, employing (4S)-4-benzyl-3-phenylacetyl-oxazolidin- 
2-one 279 (0.30 g, 1.02 mmol) in DCM (15 mL), 9-BBNOTf (2.44 mL, 0.5 M, 1.22 
mmol), diisopropylethylamine (0.23 mL, 1.33 mmol) and oct-2-ynal (0.14 g, 1.12 mmol), 
the crude product was prepared as a yellow oil. Purification by column chromatography 
afforded (»S)-4-benzyl-3-((25',35)-3-hydroxy-2-phenyl-dec-4-ynoyl)-oxazolidin-2-one 
281 (0.34 g, 80%) as a pale yellow oil.
[a]2* - 36.5 ° (c 1.0, CHC13); !H NMR (CDC13, 300 MHz): 5 0.82 (3H, t, CH3 , J = 7.2 Hz), 
1.24 (4H, m, C2H4), 1.41 (2H, m, CH2 ), 2.12 (2H, dt, C=CCH2, J = 7.2 Hz, 1.9 Hz), 2.27 
(1H, d, OH, J = 4.5 Hz), 2.55 (1H, dd, C/C,HBPh, J = 13.6 Hz, 9.0 Hz), 3.07 (1H, dd, 
CHA//*Ph, J = 13.6 Hz, 3.4 Hz), 4.04 (1H, dd, C/C,HbO, J = 9.0 Hz, 3.0 Hz), 4.13 (1H, app 
t, CHaHbO, J = 9.0 Hz), 4.70 (1H, m, CHN), 4.96 (1H, m, C//OH), 5.18 (1H, d, C//Ph, J =
7.2 Hz), 6.93 (2H, m, Ph), 7.19 (4H, broad m, Ph), 7.31 (4H, broad m, Ph); ,3C NMR 
(CDCI3, 75 MHz): 5 14.4 (CH3), 19.1 (CH2), 22.6 (CH2), 28.7 (CH2), 31.4 (CH2), 37.7 
(CH2Ph), 55.2 (CHN), 56.2 (CHPh), 64.1 (CHOH), 66.3 (CH20), 79.2 (C=C), 87.7 (O C ),
127.7 (phenyl CH), 128.6 (phenyl CH), 129.1 (phenyl CH), 129.3 (phenyl CH), 130.3 
(phenyl CH), 131.0 (phenyl CH), 133.9 (phenyl Q ,  135.1 (phenyl C), 153.0 (OC=0),
178.3 (NC=0); IR (thin film) v™* (cm 1): 3520 (O-H), 1765 (C=0), 1700 (C=0); HRMS: 






According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (1.5 g, 6.4 mmol) in DCM (65 mL), 9-BBNOTf (14.15 mL, 0.5 M, 7.04 mmol), 
diisopropylethylamine (1.46 mL, 8.32 mmol), 2-methylene-octanal 283 (0.99 g, 7.04 
mmol), the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25',35)-3-hydroxy-2-methyl-4-methylene- 
decanoyl)-oxazolidin-2-one 282 (2.39 g, 85%) as a colourless oil.
[afo + 38.0 ° (c 1.0, CHC13); 'H NMR (CDC13, 300 MHz): 5 0.86 - 0.89 (3H, broad m, 
CH2CH3), 1.18 (8H, m, C4H8), 1.25 - 1.32 (3H, broad m, CHCH3), 1.99 (2H, m, 
C //2C=CH2), 2.73 (1H, dd, C//^HBPh, J = 13.5 Hz, 8.9 Hz), 2.97 (1H, broad s, OH), 3.21 
(1H, dd, CHA/ / sPh, J = 13.5 Hz, 3.5 Hz), 3.96 (1H, m, C//CH3), 4.21 (2H, m, CH2O), 4.44 
(1H, m, C//OH), 4.63 (1H, m, CHN), 4.93 (1H, m, C=CHAHB), 5.12 (1H, m, C=CHA/ / fl), 
7.10-7.31 (5H, broad m, Ph); ,3C NMR (CDC13, 75 MHz): 6 10.1 (CH3), 14.0 (CH3), 22.6 
(CH2), 27.9 (CH2), 29.1 (CH2), 31.7 (CH2), 32.7 (CH2), 37.7 (CH2Ph), 40.3 (CHCH3),
55.2 (CHN), 66.2 (CH20), 73.1 (CHOH), 110.4 (C=CH2), 127.4 (phenyl CH), 128.9 
(phenyl CH), 129.4 (phenyl CH), 135.0 (phenyl Q , 148.2 (C=CH2), 152.9 (OC=0), 177.2 
(NC=0); IR (thin film) vmax (cm'1): 3521 (O-H), 3029 (C=C), 1780 (C=0), 1700 (C=0); 






According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (0.50 g, 2.14 mmol) in DCM (25 mL), 9-BBNOTf (4.72 mL, 0.5 M, 2.35 mmol), 
diisopropylethylamine (0.49 mL, 2.78 mmol), 4-methyl-2-methylene-pentanal 293 (0.26 g, 
2.35 mmol), the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5r)-4-benzyl-3-((25,3<S)-3-hydroxy-2,6-dimethyl-4-methylene- 
heptanoyl)-oxazolidin-2-one 292 (0.58 g, 79%) as a pale yellow oil.
[a]2* + 26.7 ° (c 1.31, CHC13); !H NMR (CDC13, 300 MHz): 5 0.88 (3H, d, CH(C//3)2, J = 
6.4Hz), 0.91 (3H, d, CH(C//3)2, J = 6.4 Hz), 1.19 (3H, d, CHC//3, J = 6.8 Hz), 1.80 (1H, m, 
C//(CH3)2), 1.88 (2H, d, C //2CH(CH3)2, J = 6.0 Hz), 2.80 (1H, dd, C/^HePh, J = 13.6, 9.4 
Hz), 2.99 (1H, d, OH, J = 3.0 Hz), 3.26 (1H, dd, CHA//z?Ph, J = 13.6, 3.4 Hz), 3.94 (1H, qd, 
CHCH3, J = 7.2, 3.0 Hz), 4.22 (2H, m, CH2O), 4.42 (1H, apparent s, C//OH), 4.71 (1H, m, 
CHN), 4.98 (1H, t, C=CHaUb, J = 1.3 Hz), 5.24 (1H, t, C=CHAHB, J = 1.7 Hz), 7.19 -  7.37 
(5H, m, Ph); 13C NMR (CDC13, 75 MHz): 6 10.0 (CH3), 22.1 (CH(CH3)2), 22.8 
(CH(CH3)2), 26.4 (CH(CH3)2), 37.7 (CH2Ph), 40.0 (CHCH3), 42.6 (CH2), 55.2 (CHN),
66.2 (CH20), 72.7 (CHOH), 111.9 (C=CH2), 127.4 (phenyl CH), 129.0 (phenyl CH), 129.4 
(phenyl CH), 135.0 (phenyl Q , 146.5 (C=CH2), 152.9 (OC=0), 177.3 (NC=0); IR (thin 
film) vmax (cm’1): 3538 (O-H), 1795 (C=0), 1685 (C=0); HRMS: m/z (ES) [M+H]+ 
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According to general procedure 6.2.3, employing (5)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (0.50 g, 2.14 mmol) in DCM (10 mL), 9-BBNOTf (4.71 mL, 0.5 M, 2.35 mmol), 
diisopropylethylamine (0.48 mL, 2.78 mmol), cyclohexanecarbaldehyde (0.29 mL, 2.35 
mmol), the crude product was prepared as a yellow oil. Purification by column 
chromatography afforded (S')-4-benzyl-3-((2S',3^)-3-cydohexyl-3-hydroxy-2-methyl- 
propionyl)-oxazo!idin-2-one 306 (0.74 g, 90%) as a pale yellow oil.
[a f l  + 26.4 ° (c 1.21, CHC13); 'H NMR (CDC13, 300 MHz): 5 0.97 (2H, broad m, 
cyclohexyl CH2), 1.18 (2H, broad m, cyclohexyl CH2), 1.23 (3H, d, CH3, J = 7.2 Hz), 1.40 
(2H, broad m, CH2), 1.66 (2H, broad m, cyclohexyl CH2), 1.75 (2H, broad m, cyclohexyl 
CH2), 2.10 (1H, broad m, cyclohexyl CH), 2.78 (1H, dd, CHAHBPh, J = 13.6, 9.4 Hz), 3.26 
(1H, dd, CHA//fiPh, J = 13.6, 3.4 Hz), 3.60 (1H, dd, C//OH, J = 8.7, 2.3 Hz) 3.95 (1H, qd, 
C//CH3, J = 7.2, 2.3 Hz), 4.20 (2H, m, CH2 0 ), 4.70 (1H, m, CHN), 7.18 -  7.37 (5H, broad 
m, Ph); 13C NMR (CDC13, 75 MHz): 6  9.6 (CH3), 25.9 (CH2), 28.6 (CH2), 29.6 (CH2),
37.6 (CH2Ph), 39.1 (CH), 40.0 (CHCH3), 55.1 (CHN), 66.1 (CH20), 75.4 (CHOH), 127.3 
(phenyl CH), 128.9 (phenyl CH), 129.3 (phenyl CH), 135.0 (phenyl Q , 153.2 (OC=0),
177.8 (NC=0); IR (thin film) vm  (cm 1): 3481 (O-H), 1751 (C=0), 1688 (C=0); HRMS: 




According to general procedure 6.2.3, employing (S)-4-benzyl-3-(3-methyl-butyryl)- 
oxazolidin-2-one 278 (1.00 g, 3.83 mmol) in DCM (50 mL), 9-BBNOTf (8.43 mL, 0.5 M, 
4.21 mmol), diisopropylethylamine (0.87 mL, 4.98 mmol), propionaldehyde (0.24 g, 4.21 
mmol), the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25',3/?)-3-hydroxy-2-isopropyl-pentanoyl)- 
oxazolidin-2-one 307 (0.88 g, 72%) as a cloudy oil.
[a]2* + 25.0 ° (c 1.00, CHCfi); 'H NMR (CDC13, 300 MHz): 5 1.00 (9H, m, CH3 and 
CH(C//j)2), 1.47 ( 1 H, m, C///4HBCH3), 1.61 (1H, m, CHA/ / fiCH3), 2.25 ( 1 H, m, 
CH(CH3)2), 2.63 (1H, dd, C/^HePh, J = 13.2, 10.5 Hz), 3.42 (1H, dd, CHA/ / BPh, J = 13.2
3.4 Hz), 3.93 (1H, m, CHOH), 4.07 (1H, dd, CH-1Pr, J = 8.7, 6.0 Hz), 4.14 (2H, m, CH2O), 
4.75 (1H, m, CHN), 7.22 -  7.37 (5H, m, Ph); I3C NMR (CDC13, 75 MHz): 5 11.1 (CH3),
20.7 (CH3), 21.4 (CH3), 25.8 (CH2), 28.6 (CH), 38.6 (CH2Ph), 54.5 (CH), 56.0 (CH), 66.3 
(CH20), 73.7 (CHOH), 127.7 (phenyl CH), 129.3 (phenyl CH), 129.7 (phenyl CH), 135.8 







According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (0.50 g, 2.14 mmol) in DCM (10 mL), 9-BBNOTf (4.71 mL, 0.5 M, 2.35 mmol), 
diisopropylethylamine (0.48 mL, 2.78 mmol) and 2-ethyl-propenal (0.20 g, 2.35 mmol), 
the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25,35)-3-hydroxy-2-methyl-4-methylene- 
hexanoyl)-oxazolidin-2-one 308 (0.56 g, 83%) as a colourless viscous oil.
[a]* + 35.0 ° (c 1.00, CHC13); 'H NMR (CDC13, 300 MHz): 5 1.12 (3H, t, CH3, J = 7.5 
Hz), 1.23 (3H, d, CHCHj, J = 7.2 Hz), 2.07 (2H, m, CH2CH3), 2.84 (1H, dd, CHAHBPh, J = 
13.6, 9.4 Hz), 3.00 (1H, broad s, OH), 3.31 (1H, dd, CHAHB?h, J = 13.6, 3.4 Hz), 4.00 
(1H, qd, CHCH3, J = 7.2, 3.0 Hz), 4.26 (2H, m, CH20),  4.50 (1H, apparent s, C//OH), 4.76 
(1H, m, CHN), 5.04 (1H, apparent t, C=CHAHB, J = 1.5 Hz), 5.23 (1H, apparent t, 
C=CHaHb, J = 1.1 Hz), 7.23 -  7.42 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 10.1 
(CH3), 12.1 (CH3), 25.3 (CH2), 37.7 (CH2Ph), 40.3 (CHCH3), 55.2 (CHN), 66.2 (CH20),
73.2 (CHOH), 109.5 (C=CH2), 127.4 (phenyl CH), 128.9 (phenyl CH), 129.4 (phenyl CH),
135.0 (phenyl C), 149.6 (C=CH2), 152.9 (O C O ), 177.1 (NC=0); IR (thin film) v™* 







According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 111 (0.15 g, 0.44 mmol) in DCM (4 mL), 9-BBNOTf (1.06 mL, 0.5 M, 0.53 mmol), 
diisopropylethylamine (0.10 mL, 0.58 mmol), benzaldehyde (0.049 mL, 0.49 mmol), the 
crude product was prepared as a dark yellow oil. Purification by column chromatography 
afforded (S')-4-benzyl-3-((2S',3S)-3-hydroxy-2-methyl-3-phenyl-propionyl)-oxazolidin- 
2-one 309 (0.11 g, 75%) as a colourless oil, with spectroscopic data essentially identical to 
the literature compound.[229]
[a]„ + 54.0 ° (c 1.32, CHC13) [lit. + 75.7 (c 1.00, CH2C12)]; *H NMR (CDC13, 300 MHz): 
8  1.14 (3H, d, CH3, J = 7.0 Hz), 2.68 (1H, dd, C//„HBPh, J = 13.5, 9.5 Hz), 3.10 (1H, broad 
s, OH), 3.15 (1H, dd, CHA//*Ph, J = 13.5, 3.5 Hz), 4.01 (3H, m, CHCH3 and CH2O), 4.49 
(1H, m, CHN), 5.00 (1H, d, C//OH, J = 4.0 Hz), 7.22 (10H, broad m, Ph); 13C NMR 
(CDC13, 75 MHz): 5 11.4 (CH3), 38.10 (CH2Ph), 45.0 (CHCH3), 55.6 (CHN), 6 6 . 6  
(CH20), 74.2 (CHOH), 126.5 (phenyl CH), 127.8 (phenyl CH), 127.9 (phenyl CH), 128.6 
(phenyl CH), 129.4 (phenyl CH), 129.8 (phenyl CH), 135.4 (phenyl C), 141.7 (phenyl Q ,
153.3 (O C O ), 177.1 (N C O ); IR (thin film) vmax (cm’1): 3507 (broad O-H), 1770 (C O ), 





According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (0.10 g, 0.43 mmol) in DCM (5 mL), 9-BBNOTf (1.03 mL, 0.5 M, 0.52 mmol), 
diisopropylethylamine (0.10 mL, 0.56 mmol), 4-methoxy-benzaldehyde (0.06 mL, 0.47 
mmol), the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-[(25,,3,S)-3-hydroxy-3-(4-methoxy-phenyl)-2- 
methyl-propionyl]-oxazolidin-2-one 310 (0.11 g, 6 8 %) as a colourless oil.
[afo + 41.2 ° (c 1.00, CHC13); *H NMR (CDC13, 300 MHz): 5 1.23 (3H, d, CHCH3, J =
6 . 8  Hz), 2.76 (1H, dd, C/^HePh, J = 13.5, 9.4 Hz), 3.23 (1H, dd, CHA//*Ph, J = 13.5, 3.4 
Hz), 3.79 (3H, s, OCH3), 4.09 (3H, overlapping m, CH2O, CHCH3), 4.58 (1H, m, CHN),
5.02 (1H, d, C//OH, J = 4.5 Hz), 6.87 (2H, m, Ph), 7.19 -  7.37 (7H, m, Ph); 13C NMR 
(CDCI3, 75 MHz): 5 9.8 (CH3), 38.2 (CH2Ph), 44.8 (CHCH3), 55.7 (CHN), 56.1 (OCH3),
6 6 . 8  (CH20), 75.0 (CHOH), 114.2 (phenyl CH), 126.6 (phenyl CH), 127.7 (phenyl CH),
128.6 (phenyl CH), 129.8 (phenyl CH), 135.2 (phenyl C), 153.5 (Q , 159.3 (C), 177.2 
(NC=0); IR (thin film) (cm 1): 3522 (O-H), 1780 (C=0), 1691 (C=0); HRMS: m/z 




According to general procedure 6.2.3, employing (5)-4-benzyl-3-phenylacetyl-oxazolidin- 
2-one 279 (1.37 g, 4.64 mmol) in DCM (50 mL), 9-BBNOTf (10.21 mL, 0.5 M, 5.10 
mmol), diisopropylethylamine (1.05 mL, 6.03 mmol), 2-methylene-octanal 283 (0.72 g, 
5.10 mmol), the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (S)-4-benzyl-3-((2,S,35)-3-hydroxy-4-methylene-2-phenyl- 
decanoyl)-oxazolidin-2-one 311 (1.41 g, 70%) as a pale yellow oil.
[a]2* - 8.0 ° (c 1.00, CHC13); ‘H NMR (CDC13, 300 MHz): 8  0.95 - 1.83 (13H, broad m, 
C6///j) , 2.37 - 2.45 (1H, broad m, OH), 2.77 (1H, dd, C//^HBPh, J = 13.2, 9.4 Hz), 3.27 
(1H, dd, CHA/ / flPh, J = 13.2, 3.4 Hz), 4.19 (2H, m, CH2O), 4.23 (1H, d, CHFh, J = 10.2 
Hz), 4.32 (1H, d, C//OH, J = 10.2 Hz), 4.69 (1H, m, CHN), 5.99 (1H, d, C=C/C,HB, J = 0.8 
Hz), 6.25 (1H, d, C=CHaHb, J = 0.8 Hz), 7.14 (2H, m, Ph), 7.25 -  7.38 (8 H, broad m, Ph); 
,3C NMR (CDCI3, 75 MHz): 8  14.1 (CH3), 22.6 (CH2), 27.8 (CH2), 29.1 (CH2), 31.7 
(CH2), 32.4 (CH2), 37.1 (CH2Ph), 53.0 (CHPh), 54.7 (CHN), 65.7 (CH20), 75.5 (CHOH),
112.0 (C=CH2), 127.2 (phenyl CH), 128.0 (phenyl CH), 128.6 (phenyl CH), 128.8 (phenyl 
CH), 129.3 (phenyl CH), 130.0 (phenyl CH), 134.0 (phenyl C), 134.6 (phenyl Q ,  148.6 
(C=CH2), 152.6 (OC=0), 172.7 (NC=0); IR (thin film) vmax (cm 1): 3516 (O-H), 1771 







According to general procedure 6.2.3, employing (,S)-4-benzyl-3-(3-methyl-butyryl)- 
oxazolidin-2-one 278 (1.19 g, 4.56 mmol) in DCM (50 mL), 9-BBNOTf (10.03 mL, 5.02 
mmol), diisopropylethylamine (1.03 mL, 5.93 mmol) and 2-methylene-octanal 283 (0.70 g,
5.02 mmol), the crude product was prepared. Purification by column chromatography 
afforded (5)-4-benzyI-3-((25',35)-3-hydroxy-2-isopropyl-4-methylene-decanoyl)- 
oxazolidin-2-one 337 (1.48 g, 81%) as a pale yellow oil.
[of* + 28.0 ° (c 1.0, CHC13); *H NMR (CDC13, 300 MHz): 5 0.80 (3H, t, CH2CH3, J = 6 . 6  
Hz), 1.03 (6 H, d, CH(CH3)2, J = 6 . 8  Hz), 1.14 -  1.42 (8 H, m, C4//«), 2.00 (2H, m, 
CH2C=CH2), 2.20 (1H, d, OH, J = 4.5 Hz), 2.30 (1H, m, C//(CH3)2), 2.53 (1H, dd, 
CHaHBPh, J = 13.2, 10.5 Hz), 3.32 (1H, dd, CHA//*Ph, J = 13.2, 3.4 Hz), 4.02 (2H, m, 
CH20 ), 4.25 (1H, dd, CH-'Pr, J = 7.9, 5.2 Hz), 4.36 (1H, dd, CHOH, J = 7.9, 4.5 Hz), 4.57 
(1H, m, CHN), 4.81 (1H, d, C=CHAHB, J = 1.5 Hz), 5.04 (1H, apparent s, C=CHAHB), 7.13 
-  7.29 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 14.1 (CH3), 19.9 (CH3), 20.4 (CH3),
22.6 (CH2), 27.8 (CH2), 29.1 (CH2), 29.4 (CH), 31.7 (CH2), 32.3 (CH2), 37.9 (CH2Ph),
50.2 (CH-'Pr), 55.5 (CHN), 66.3 (CH20), 74.3 (CHOH), 111.1 (C=CH2), 127.3 (phenyl 
CH), 129.0 (phenyl CH), 129.3 (phenyl CH), 135.3 (phenyl Q , 150.2 (C=CH2), 153.3 
(OC=0), 172.7 (NC=0); IR (thin film) vmax (cm'1): 1782 (C=0), 1700 (C=0); HRMS: m/z 






According to general procedure 6.2.3, employing (S)-4-benzyl-3-propionyl-oxazolidin-2- 
one 277 (2.00 g, 8.57 mmol) in DCM (100 mL), 9-BBNOTf (18.86 mL, 0.5 M, 9.43 
mmol), diisopropylethylamine (1.94 mL, 11.14 mmol), 3-methyl-2-methylene- 
butyraldehyde 379 (0.93 g, 9.43 mmol), the crude product was prepared as a viscous oil. 
Purification by column chromatography afforded (5)-4-benzyl-3-((25',3lS)-3-hydroxy-2,5- 
dimethyl-4-methylene-hexanoyl)-oxazolidin-2-one 378 (2.27 g, 80%) as a white solid, 
mp 99 -  102 °C; [arg + 37.1 ° (c 1.16, CHC13); 'H NMR (CDC13, 300 MHz): 5 1.06 (3H, 
d, CH(CH3)2, J = 6.8 Hz), 1.09 (3H, d, CH(C//3)2, J = 6.8 Hz), 1.20 (3H, d, CHCH3, J = 6.8 
Hz), 2.19 (1H, apparent septet, CH(CH3)2, J = 6.8 Hz), 2.80 (1H, dd, C//^HBPh, J = 13.2,
9.6 Hz), 2.92 (1H, d, OH, J = 3.0 Hz), 3.27 (1H, dd, CHA/ / flPh, J = 13.2, 3.4 Hz), 3.94 (1H, 
qd, CHCH3, J = 7.2, 3.0 Hz), 4.23 (2H, m, CH2O), 4.51 (1H, broad m, C//OH), 4.72 (1H, 
m, CHN), 5.06 (1H, m, C=C//y4HB), 5.21 (1H, apparent t, C=CHAHB, J = 1.1 Hz), 7.19 - 
7.38 (5H, m, Ph); ,3C NMR (CDC13, 75 MHz): 5 10.2 (CH3), 21.9 (CH3), 23.4 (CH3), 30.4 
(CH(CH3)2), 37.7 (CH2Ph), 40.4 (CHCH3), 55.2 (CHN), 66.2 (CH20), 72.3 (CHOH),
108.4 (C=CH2), 127.5 (phenyl CH), 129.0 (phenyl CH), 135.0 (phenyl CH), 145.7 
(OC=0), 154.7 (C=CH2), 177.4 (N C O ); IR (KBr disc) vmax (cm 1): 3520 (O-H), 1788 
(C=0), 1691 (C O ); HRMS m/z (ES) [M+H]+ requires 332.1856, found 332.1858
6.2.4 Typical procedure for the synthesis o f a-m ethylene aldehydes
A mixture of aldehyde (1 eq.), formaldehyde (approximately 60% by volume, 37% in H20 )  
and dimethylamine hydrochloride (1.2 eq.) was stirred at 70 °C for 24 hours. The reaction 
was cooled to room temperature and extracted with petrol. The combined organic extracts
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were washed with NaHCC>3 and brine, dried (MgS0 4 ), filtered and concentrated under 
reduced pressure (care taken as product is volatile).
2-Methylene-octanal, 283
o
According to general procedure 6.2.4, employing octanal (12.18 mL, 0.078 mol), 
formaldehyde (7.50 mL, 37 % in H2O) and dimethylamine hydrochloride (7.63 g, 0.094 
mol), 2-methylene-octanal 283 (9.40 g, 8 6 %) was prepared as a colourless oil without the 
need for further purification and with spectroscopic data essentially identical to the 
literature compound.[230]
JH NMR (CDCI3, 300 MHz): 5 0.81 (3H, m, CH3), 1.18 -  1.27 (8 H, broad m, CaH8), 2.16 
(2H, t, CH2C=CH2, J = 7.7 Hz), 5.92 (1H, s, C=CHAUB), 6.18 (1H, s, C=CHAHB), 9.46 
(1H, s, (O)CH); 13C NMR (CDC13, 75 MHz): 8  14.5 (CH3), 23.00 (CH2), 26.7 (CH2), 27.1 
(CH2), 30.4 (CH2), 30.5 (CH2), 134.2 (C=CH2), 150.9 (C=CH2), 195.1 (C=0); IR (thin 
film) Vmax (cm'1): 1725 (C=0)
4-Methyl-2-methylene-pentanal, 293
o
Pyridinium chlorochromate (10.55 g, 48.94 mmol) was added to 4-methyl-pentan-l-ol 
(2.57 g, 24.47 mmol) in DCM (300 mL) and stirred for 24 hours. The reaction mixture was 
filtered through fluorosil and celite and evaporated in vacuo to yield 4-methyl-pentanal 
(2.42 g, 99%) as a colourless liquid which could be used crude in the next reaction.
'H NMR (CDCI3, 300 MHz): 8  0.86 (6 H, d, (CH3)2, J = 6.7 Hz), 1.43 -  1.61 (3H, m, 
CH2CH), 2.37 (2H, ro, CH2), 9.72 (1H, t, C/70, J = 1.9 Hz)
According to general procedure 6.2.4, employing 4-methyl-pentanal (2.42 g, 24.16 mmol), 
formaldehyde (2.31 mL, 37 % in H20 )  and dimethylamine hydrochloride (3.36 g, 28.99
182
Chapter 6 Experimental
mmol), 4-methyl-2-methylene-pentanal 293 (2.44 g, 90%) was prepared as a colourless 
liquid without the need for further purification.
!H NMR (CDC13, 300 MHz): 5 0.87 (6 H, d, (CH3)2, J = 6 .8  Hz), 1.77 (1H, septet, 
CH(CH3)2, J = 6 .8  Hz), 2.12 (2H, dd, CH2, J = 7.2, 1.1 Hz), 6.02 (1H, d, C=CHAHB, J = 1.1 
Hz), 6.22 (1H, dd, C=CHAH*, J = 1.9, 1.1 Hz), 9.52 (1H, s, C/70); 13C NMR (CDCI3, 75 
MHz): 6  22.1 (CH3), 26.7 (CH), 36.9 (CH2), 135.1 (C=CH2), 156.3 (C=CH2), 194.6 
(HC=0); IR (thin film) vmax (cm'1): 1736 (C=0)
3-Methyl-2-methylene-butyraldehyde, 379
According to general procedure 6.2.4, employing isovaleraldehyde (20 mL, 0.19 mol), 
formaldehyde (18 mL, 37 % in H20 )  and dimethylamine hydrochloride (18.24 g, 0.23 
mol), 3-methyl-2-methylene-butyraldehyde 379 (16.8 g, 90%) was prepared as a 
colourless oil without the need for further purification and with spectroscopic data 
essentially identical to the literature compound.t231]
lH NMR (CDCI3, 300 MHz): 6  1.02 (6 H, d, CH(C//j)2, J = 6 .8  Hz), 2.75 (1H, doublet o f  
septets, C//(CH3)2, J = 6 .8 , 1.1 Hz), 5.89 (1H, s, C=CHAHB), 6.19 (1H, d, C=CHAHB, J =
1.1 Hz), 9.48 (1H, s, COH)\ i3C NMR (CDC13, 75 MHz): 5 20.0 (CH3), 25.1 (CH), 132.0 
(C=CH2), 155.1 (C=CH2), 193.6 (C=0); IR (thin film) vmax (cm'1): 1697 (C=0)
6.2.5 Typical procedure for the asymmetric hydrogenation reaction
A: Using the Endeavour catalyst screening system, unsaturated aldol (1 eq.) was dissolved 
in DCM in a dry reaction tube and placed in the hydrogenator at 25 °C. The sealed vessel 
was purged three times with nitrogen before injection o f  the hydrogenation catalyst in 
DCM and pressurising with hydrogen to the required pressure. After 24 hours the crude 
mixture is removed from the hydrogenator and filtered through a plug o f  silica, washed 
with methyl tert-butyl ether and evaporated in vacuo.
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B: Using the Parr pressure vessel, unsaturated aldol (1 eq.) was dissolved in DCM and 
added to the vessel under a nitrogen atmosphere at room temperature. The hydrogenation 
catalyst in DCM was added under nitrogen before sealing of the vessel and pressurising 
with hydrogen to the desired pressure. After 24 hours the crude mixture is filtered through 




According to general procedure 6.2.5 A or B, employing (5)-4-benzyl-3-((25,35)-3- 
hydroxy-2-methyl-4-methylene-decanoyl)-oxazolidin-2-one 282 (50mg, 0.13 mmol) in 
DCM (0.5 mL), the crude product is prepared as a pale brown oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25,3/?,4/?)-3-hydroxy-2,4-dimethyl- 
decanoyl)-oxazolidin-2-one (4/?)-284a as a colourless oil.
[a]2* + 15.0 ° (c 0.6, CHC13); *H NMR (CDC13, 300 MHz): 5 0.82 (6 H, m, CH2CHC/ / 5 
and CH2CH3), 1.18 (3H, d, CHCH3, J = 6 . 8  Hz), 1 .16 -1 .27  (8 H, m, (C//2)4), 1.50 (1H, m, 
CH2C//CH3), 1.68 (2H, m, CH2), 2.75 (1H, dd, CHAHBPh, J = 9.4, 4.1 Hz), 2.87 (1H, d, 
OH, J = 3.4 Hz), 3.20 (1H, dd, CHA/ / fiPh, J = 13.6, 3.4 Hz), 3.56 (1H, apparent dt, CHOH, 
J = 8.7, 2.9 Hz), 3.91 (1H, qd, CHCH3 , J = 6 .8 , 2.3 Hz), 4.15 (2H, m, CH20 ,  J = Hz), 4.64 
(1H, m, CHN), 7.15 (2H, m, Ph), 7.19 -  7.32 (3H, m, Ph); ,3C NMR (CDC13, 75 MHz): 5
9.7 (CH3), 14.1 (CH3), 15.3 (CH3), 22.6 (CH2), 26.7 (CH2), 29.6 (CH2), 31.9 (CH2), 32.6 
(CH2), 35.7 (CH2CH), 37.7 (CH2Ph), 39.4 (CHCH3), 55.1 (CHN), 66.1 (CH20 ), 75.3 
(CHOH), 127.4 (phenyl CH), 128.9 (phenyl CH), 129.4 (phenyl CH), 135.00 (phenyl Q ,
152.8 (OC=0), 178.00 (NC=0); IR (thin film) v™* (cm 1): 3448 (O-H), 1783 (C=0), 1697 





According to general procedure 6.2.5 A or B, employing (5)-4-benzyl-3-((25,35)-3- 
hydroxy-2-methyl-4-methylene-decanoyl)-oxazolidin-2-one 282 (50 mg, 0.13 mmol) in 
DCM (0.5 mL), the crude product is prepared as a pale brown oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25,3/?,45)-3-hydroxy-2,4-dimethyl- 
decanoyl)-oxazolidin-2-one (45)-284b as a colourless oil.
[erg - 22.5 ° (c 0.4, CHC13); 'H NMR (CDC13, 300 MHz): 5 0.88 (3H, m, CH2CH3), 0.97 
(3H, d, CH2CHC//3, J = 6.4 Hz), 1.26 (3H, d, CHCH3, J = 6 . 8  Hz), 1.22 -  1.40 (9H, m, 
CH(CH2)4), 1.57 (2H, m, CH2), 2.60 (1H, d, OH, J = 3.8 Hz), 2.79 ( 1 H, dd, C/^HePh, J =
9.4, 13.2 Hz), 3.26 (1H, dd, CHA/ / 5 Ph, J = 13.2, 3.2 Hz), 3.68 (1H, apparent pentet, 
C//OH, J = 3.8 Hz), 3.99 (1H, qd, CHCH3, J = 6 .8 , 3.8 Hz), 4.20 (2H, m, 0H 2O), 4.69 (1H, 
m, CHN), 7.21 (2H, m, Ph), 7.25 -  7.37 (3H, m, Ph); ,3C NMR (CDC13, 75 MHz): 6  11.2 
(CH3), 14.1 (CH3), 15.1 (CH3), 22.6 (CH2), 26.8 (CH2), 29.5 (CH2), 31.8 (CH2), 32.9 
(CH2), 35.6 (CH2CHCH3), 37.8 (CH2Ph), 39.9 (CHCH3), 55.1 (CHN), 66.1 (CH20), 75.3 
(CHOH), 127.4 (phenyl CH), 129.0 (phenyl CH), 129.4 (phenyl CH), 135.0 (phenyl C),







According to general procedure 6.2.5 B, employing (S)-4-benzyl-3-((2S,3S)-3-hydroxy-
2.6-dimethyl-4-methylene-heptanoyl)-oxazolidin-2-one 292 (200 mg, 0.58 mmol) in DCM 
(2 mL), Wilkinson’s catalyst (93.7 mg, 0.10 mmol) in DCM (2 mL) and 5 bar hydrogen 
pressure, the crude product was prepared in 33% d.e. after 24 hours as a light brown oil. 
Purification by column chromatography afforded (5)-4-benzyl-3-((25,3/?,4f?)-3-hydroxy-
2.4.6-trimethyl-heptanoyl)-oxazolidin-2-one 291a as a pale yellow oil.
[afo + 17.4 ° (c 1.0, CHCI3); *H NMR (CDC13, 300 MHz): 5 0.84 (3H, d, CH(C//i)2, J =
4.7 Hz), 0.86 (3H, d, CH(C//j)2, J = 4.7 Hz), 0.92 (3H, d, CHCH3, J = 6.4 Hz), 1.25 (3H, d, 
C=OCHC//i, J = 7.2 Hz), 1.49 -  1.73 (4H, overlapping multiplets, C//CH3, C //2-'Pr, 
C//(CH3)2), 2.79 (1H, dd, CHAHBPh, J = 13.2, 9.4 Hz), 3.26 (1H, dd, CHA//*Ph, J = 13.2,
3.4 Hz), 3.58 (1H, apparent dt, C//OH, J = 7.9, 3.4 Hz), 3.98 (1H, qd, C=OC//CH3, J =
7.2, 2.6 Hz), 4.21 (2H, m, CH2O), 4.69 (1H, m, C/fN), 7.19 -  7.38 (5H, m, Ph); 13C NMR 
(CDCI3, 75 MHz): 5 1 0 .2  (CH3), 15.5 (CH3), 21.3 (CH3), 24.3 (CH3), 25.3 (CH(CH3)2),
33.5 (CHCH3), 37.7 (CH2-'Pr), 39.6 (C=OCHCH3), 42.0 (CH2Ph), 55.2 (CHN), 66.1 
(CH20 ), 76.1 (CHOH), 127.4 (phenyl CH), 129.0 (phenyl CH), 129.4 (phenyl CH), 135.0 
(phenyl C), 152.8 (OC=0), 177.8 (NC=0); IR (thin film) vmax (cm 1): 3540 (O-H), 1792 
(C=0), 1689 (C=0); HRMS: m/z (ES) [M+H]+ requires 348.2169, found 348.2173
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(<S)-l-((5)-4-Benzyl-2-oxo-oxazoIidin-3-yl)-2,4-dimethyl-decane-l,3-dione, 286 and ent- 
286
According to general procedure 6.2.5 A or B, employing (,S)-4-benzyl-3-((25,35)-3- 
hydroxy-2-methyl-4-methylene-decanoyl)-oxazolidin-2-one 282 (50 mg, 0.13 mmol) in 
DCM (0.5 mL), the crude product is prepared as a pale brown oil. Purification by column 
chromatography afforded (5)-l-((5)-4-benzyl-2-oxo-oxazolidin-3-yI)-2,4-dimethyl- 
decane-l,3-dione 286 and ent-286 as a 84:16 mixture of diastereomers.
'H NMR (CDC13, 300 MHz): 5 0.82 (6 H, m, 286 CH2CH3 and ent-286 CH2CH3), 1.05 
(3H, d, 286 CH3, J = 6 . 8  Hz), 1.08 (3H, d, ent-286 CH3, J = 7.2 Hz), 1.11 (3H, d, 286 CH3, 
J = 7.2 Hz), 1.16 (3H, d, ent-286 CH3, J = 7.2 Hz), 1.18 -  1.28 (16H, broad m, 286 C M  
and ent-286 C M ),  1.38 (1H, apparent d, £?«/-286 C=OCHC//„HB, J = 2.3 Hz), 1.40 (1H, 
apparent d, 286, C=OCHC//^Hb, J = 2.6 Hz), 1.41 ( 1H, apparent d, ent-286 
C=OCHCHa//s, J = 2.3 Hz), 1.42 (1H, apparent d, 286 C=OCHCHA//*, J = 2.3 Hz), 2.70 
(4H, overlapping m, 286 C//„HBPh and C=OC//CH2 and ent-286 C /^H BPh and 
C=OC//CH2), 3.25 (1H, dd, 286 CHA// fiPh, J = 13.2, 3.0 Hz), 3.43 (1H, dd, ent-286 
CHA/ / fiPh, J = 13.2, 3.0 Hz), 4.15 (4H, overlapping m, 286 CH2O and ent-286 CH2O), 
4.69 (2H, overlapping m, 286 CHN and ent-286 CHN), 4.84 (2H, overlapping m, 286 
CHCH3 and ent-286 C//CH3), 7.13 -  7.32 (10H, m, 286 Ph and ent-286 Ph); 13C NMR 
(CDCI3, 75 MHz): 5 13.0 (CH3), 14.1 (CH3), 16.1 (CH3), 22.6 (CH2), 27.0 (CH2), 29.2
286 and e n t -286
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(CH2), 31.7 (CH2), 32.6 (CH2), 37.9 (CH2Ph), 44.3 (C=OCHCH2), 51.7 (CH), 55.3 (CH),
66.3 (CH20 ), 127.3 (phenyl CH), 128.9 (phenyl CH), 129.4 (phenyl CH), 135.5 (phenyl 
C), 153.5 (0C =0), 170.7 (NC=0), 211.2 (CHC=0) all peaks exhibit a smaller 
corresponding peak for ent-286; IR (thin film) vmax (cm'1): 1782 (C=0), 1716 (C=0), 1697 
(C=0); HRMS: m/z (ES) [M+H]+ requires 374.2326, found 374.2329





(12 mg, 0.04 mmol) in 3:1 THF:H20  (0.8 mL) at 0 °C was treated with H20 2 (0.02 mL, 
35% solution, 0.24 mmol) followed by LiOH (1.7 mg, 0.08 mmol). The reaction was 
stirred at 0 °C for 3 hours and the excess peracid was quenched with a 10% excess o f  
Na2SC>3 (28.7 mg) dissolved in water. The mixture was buffered to pH 9 - 1 0  with 
NaHCC>3 and the solvent removed in vacuo. Extraction with DCM removes oxazolidin-2- 
one 276, and the aqueous layer was acidified to pH 1 - 2  with 1M HC1 before extraction 
with ethyl acetate. The combined organic extracts were dried (MgSCU), filtered and 
evaporated in vacuo to afford (25',3/?,4i?)-3-hydroxy-2,4,6-trimethyl-heptanoic acid 
290a (7 mg, 97%) as a colourless oil with spectroscopic data essentially identical to the 
literature compound.[ 193]
[or]“  + 8 .6  ° (c 0.47, CHC13) [lit. + 24.4 0 (c 1.00, CHC13)]; JH NMR (CDC13, 300 MHz): 8  
0.83 (3H, d, CH(CH3)2, J = 6 .8  Hz), 0.84 (3H, d, CHCH3, J = 6.4 Hz), 0.91 (3H, d, 
CH(CH3)2, J = 6 .8  Hz), 1.04 (2H, m, CH2), 1 .2 1  (3H, d, OOCHC/ft, J = 7.2 Hz), 1.49 
(1H, m, C//(CH3)2), 1.64 (1H, m, C//CH3), 2.72 ( 1H, qd, C=OC//CH3, J = 7.2, 3.4 Hz), 
3.65 (1H, dd, CM)H, J = 7.9, 3.4 Hz); 13C NMR (CDC13, 75 MHz): 8  9.9 (CH3), 14.1 
(CH3), 21.0 (CH(CH3)2), 2 1 .2  (CH(CH3)2), 25.2 (CH(CH3)2), 30.9 (CHCH3), 41.6 (CH2),
50.8 (C=OCHCH3), 76.2 (CHOH), 180.9 (C=0); IR (thin film) vmax (cm'1): 1710 (C=0)
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6.2.7 Procedure for the synthesis of (£)-(/?)-2,4-dim ethyl-dec-2-enoic acid ((5)-
l-benzyl-2-hydroxy-ethyl)-am ide, 302
o
LHMDS (0.076 mL, 1 M solution, 0.076 mmol) was added to (5)-4-benzyl-3-((25',3/?,4/?)-
3-hydroxy-2,4-dimethyl-decanoyl)-oxazolidin-2-one (4/?)-284a (26 mg, 0.069 mmol) in 
toluene (1.5 mL) at 0 °C. After stirring for 2 hours at 0 °C the reaction was quenched with 
a few drops of pH 7 buffer, dried (MgSC>4), filtered and evaporated in vacuo to yield the 
crude product as a yellow oil. Purification by column chromatography afforded (£)-(/?)-
2,4-dimethyl-dec-2-enoic acid ((S)-l-benzyl-2-hydroxy-ethyl)-amide 302 (23 mg, 99%) 
as a colourless oil.
[a]2* -  36.6 ° (c 0.57, CHC13); ’H NMR (CDC13, 300 MHz): 6  0.87 (3H, t, CH2CH3, J =
6 . 8  Hz), 0.93 (3H, d, CHCH3, J = 6.4 Hz), 1.17 -  1.32 (10H, m, (CH2)j), 1.76 (3H, d, 
CH=CCH3, J = 1.5 Hz), 2.39 (1H, m, C//CH3), 2.91 (2H, apparent qd, CHAHBPh, J = 13.6,
7.1 Hz), 3.28 (1H, broad s, OH), 3.64 (1H, dd, C/^HbOH, J = 10.9, 5.7 Hz), 3.75 (1H, dd, 
CHa/ / 5OH, J = 10.9, 3.4 Hz), 4.17 (1H, m, C//NH), 5.88 (1H, broad d, NH, J = 6 .8  Hz), 
5.97 (1H, dd, CH=C, J = 9.8, 1.1 Hz), 7.19 -  7.35 (5H, m, Ph); ,3C NMR (CDC13, 75 
MHz): 5 12.7 (CH3), 14.1 (CH3), 17.4 (CH2), 20.2 (CH3), 22.6 (CH2), 27.4 (CH2), 29.4 
(CH2), 31.8 (CH2), 32.9 (CHCH3), 36.9 (CH2Ph), 53.6 (CHNH), 65.1 (CH2OH), 126.8 
(phenyl CH), 128.7 (phenyl CH), 129.2 (phenyl CH), 135.3 (Q , 137.6 (Q , 143.2 (CH=C),
170.5 (C=0); IR (thin film) vmax (cm’1): 3348 (O-H), 1659 (C=0); HRMS: m/z (ES) 
[M+H]+ requires 332.2584, found 332.2586
6.2.8 Typical procedure for the diethyl zinc rearrangem ent reaction
A solution of diethyl zinc (1.0 M, 0.1 eq.) in toluene was added dropwise to a stirred 
solution o f the syn-aldol (1 eq.) in DCM at room temperature. After 2 hours the reaction 
was quenched with saturated N H 4 C I  and the organics extracted with DCM. The combined
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organic extracts were washed with brine, dried (MgS0 4 ) and concentrated in vacuo to 
afford the crude product.
(55,6/?)-3-((iS)-l-Benzyl-2-hydroxy-ethyl)-6-cyclohexyl-5-methyl-[l,3]oxazinane-2,4- 
dione, 312
According to general procedure 6.2.8, employing (S)-4-benzyl-3-((25',3/?)-3-cyclohexyl-3- 
hydroxy-2-methyl-propionyl)-oxazolidin-2-one 306 (0.10 g, 0.29 mmol) and diethyl zinc 
(0.029 mL, 1 M solution, 0.029 mmol), the crude product was prepared as a colourless oil. 
Purification by column chromatography afforded (55,6/?)-3-((»S)-l-benzyl-2-hydroxy- 
ethyI)-6-cyclohexyl-5-methyl-|l,3]oxazinane-2,4-dione 3 1 2  (0.09 g, 94%) as a colourless 
oil.
[a]2* - 17.0 0 (c 1.00, CH2 CI2 ); ’H NMR (300MHz, CDC13): 5 0.59 -  0.81 (2H, m, 
cyclohexyl), 0.82 (3H, d, C //3CH, J = 7.2 Hz), 1.06 -  1.20 (3H, m, cyclohexyl), 1.29 -  1.38 
(1H, m, cyclohexyl), 1.41 -  1.49 (1H, m, cyclohexyl), 1.55 -  1.69 (3H, m, cyclohexyl), 2.04 
(1H, apparent d, cyclohexyl, J = 13.2 Hz), 2.47 (1H, qd, C//CH3, J = 7.5, 2.6 Hz), 2.99 (1H, 
dd, PhC//ACHB, J = 13.9, 6.4 Hz), 3.12 (1H, dd, PhCHAC //B, J = 13.9, 10.6 Hz), 3.23 (1H, 
obscured m, CH-cyclohexyl) 3.81 (1H, dd, C //AHBOH, J = 11.7, 3.8 Hz), 3.99 (1H, dd, 
CHaHbOH, J = 11.7, 7.5 Hz), 5.01 (1H, apparent ddt, C//N, J = 13.9, 6 .8 , 3.4 Hz), 7.08 -  
7.23 (5H, m, Ph); 13C NMR (75MHz, CDC13): 5 9.4 (CH3), 25.4 (CH2), 26.3 (CH2), 27.5 
(CH2), 29.6 (CH2), 33.9 (CH2Ph), 37.2 (CH) 38.1 (CH), 56.5 (CHN), 63.8 (CH2OH), 81.1 
(CHO), 127.1 (phenyl CH), 128.9 (phenyl CH), 129.5 (phenyl CH), 137.9 (phenyl C),
152.4 (C=0), 174.2 (C=0); IR (thin film) vmax (cm'1): 3396 (broad, OH), 1747 (C O ), 









According to general procedure 6.2.8, employing (5)-4-benzyl-3-((25',3/?)-3-hydroxy-2- 
methyl-pentanoyl)-oxazolidin-2-one 280 (0.10 g, 0.34 mmol) and diethyl zinc (0.034 mL, 
1 M solution, 0.034 mmol) the crude product was prepared as a colourless oil. Purification 
by column chromatography afforded (55',6/?)-3-((iS)-l-benzyl-2-hydroxy-ethyl)-6-ethyl- 
5-methyI-[l,3]oxazinane-2,4-dione 313 (0.093 g, 94%) as a colourless oil.
[a]2* - 6.4 0 (c 0.47, CH2C12); *H NMR (300MHz, CDC13): 5 0.82 (3H, t, CH2C//3, J = 7.5 
Hz), 0.99 (3H, d, C //3CH, J = 7.2 Hz), 1.33 (2H, m, C //2CH3), 2.50 (1H, qd, C//CH3, J =
7.5, 3.4 Hz), 2.99 (1H, dd, PhC//ACHB, J = 13.9, 6.4 Hz), 3.16 (1H dd, PhCHAC //B, J = 
13.9, 10.5 Hz), 3.68 (1H, obscured m, C//-CH2CH3), 3.82 (1H, dd, C //AHBOH, J = 11.7,
3.8 Hz), 4.01 (1H, dd, CHA/ / BOH, J = 11.7, 7.7 Hz), 5.04 (1H, app ddt, CHN, J = 13.9, 6 .8 ,
3.4 Hz), 7.10 -  7.15 (5H, m, Ph). 13C NMR (75MHz, CDC13): 5 9.2 (CH3), 9.5 (CH3), 22.6 
(CH2CH3), 33.7 (CH2Ph), 39.2 (CHCH3), 56.5 (CHN), 63.3 (CH2OH), 78.4 (CHO), 126.6 
(phenyl CH), 128.5 (phenyl CH), 129.1 (phenyl CH), 137.4 (phenyl Q , 151.8 (C O ),
173.1 (C O ); IR (thin film) v,™ (cm 1): 3462 (broad, OH), 1755 (C O ), 1700 (C O ); 





According to general procedure 6.2.8, employing (S)-4-benzyl-3-((2S,3/J)-3-hydroxy-2- 
isopropyl-pentanoyl)-oxazolidin-2-one 307 (0.1 g, 0.31 mmol) and diethyl zinc (0.031 mL, 
1 M solution, 0.031 mmol), the crude product was prepared a pale yellow oil. Purification 
by column chromatography afforded (55,6/?)-3-((5)-l-benzyl-2-hydroxy-ethyl)-6-ethyl- 
5-isopropyl-[l,3]oxazinane-2,4-dione 314 (0.089 g, 90%) as a colourless oil.
H 2d5 - 6 . 8  ° (c 0.59, CH2C12); 'H NMR (300MHz, CDC13): 5 0.84 (3H, t, CH2CH3, J = 7.5 
Hz), 0.85 (3H, d, CH(CH3)2, J = 7.0 Hz), 0.92 (3H, d, CH(CH3)2, J = 7.0 Hz), 1 .31-1 .46  
(1H, dqd, CHaHbCH3, J = 14.0, 7.5, 5.0 Hz), 1.45 -  1.61 (1H, m, CHAHBCH3), 1.94 -  2.05 
(1H, m, C//(CH3)2), 2.18 (1H, apparent t, CH -Pr, J = 4.5 Hz), 2.53 (1H, broad s, OH), 2.99 
(1H, dd, C/^HePh, J = 14.0, 7.0 Hz), 3.13 (1H, dd, CHAC //5 Ph, J = 14.0, 10.5 Hz), 3.64 
(1H, obscured m, CHO), 3.82 (1H, dd, C/^HbOH, J = 12.0, 4.0 Hz), 4.02 (1H, dd, 
CHaC/ZsOH, J = 12.0, 7.0 Hz), 5.04 -  5.14 (1H, apparent dtd, CHN, J = 10.5, 7.0, 4.0 Hz),
7.08 -  7.22 (5H, m, Ph); 13C NMR (75MHz, CDCI3): 5 10.4 (CH3), 20.2 (CH3), 22.6 
(CH3), 23.4 (CH2CH3), 25.5 (CH(CH3)2), 34.3 (CH2Ph), 50.2 (CH-'Pr), 56.5 (CHN), 63.7 
(CH2OH), 79.4 (CHO), 127.0 (phenyl CH), 128.9 (phenyl CH), 129.5 (phenyl CH), 135.0 
(phenyl Q , 152.5 (OC=0), 171.4 (NC=0); IR (thin film) vmax (cm 1): 3423 (broad OH), 





According to general procedure 6.2.8, employing (JS')-4-benzyl-3-((2S',3iS)-3-hydroxy-2- 
methyl-4-methylene-hexanoyl)-oxazolidin-2-one 308 (0.1 g, 0.32 mmol) and diethyl zinc 
(0.32 mL, 1 M solution, 0.32 mmol), the crude product was prepared as a colourless oil. 
Purification by column chromatography afforded (5iS',65)-3-((5)-l-benzyI-2-hydroxy- 
ethyl)-5-methyl-6-(l-inethylene-propyl)-[l,3]oxazinane-2,4-dione 315 (0.061 g, 60%) 
as a colourless oil.
[afo - 49.0 ° (c 0.59, CHC13); JH NMR (300MHz, CDC13): 6  0.99 (6 H, overlapping m, 
CH2CH3 and CHC//3), 1.83 (2H, overlapping m, CH2CH3), 2.60 (1H, qd, CHCH3, J = 7.5,
3.0 Hz), 3.07 (1H, dd, C/^HePh, J = 13.9, 6.4 Hz), 3.22 (1H, dd, CHAHBPh, J = 13.9, 10.5 
Hz), 3.90 (1H, dd, C//^HBOH, J = 11.9, 4.0 Hz), 4.10 (1H, dd, CHA//z?OH, J = 11.9, 7.4 
Hz), 4.21 (1H, apparent s, CHO), 5.08 (1H, s, C=C//^HB), 5.13 (1H, m, CHN), 5.22 (1H, s, 
C=CHaHb), 7.16 -  7.31 (5H, m, Ph); ,3C NMR (75MHz, CDC13): 5 9.7 (CH3), 12.0 (CH3),
25.4 (CH2CH3), 33.9 (CH2Ph), 38.8 (CHCH3), 56.7 (CHN), 63.8 (CH2OH), 77.6 (CHO),
112.1 (C=CH2), 127.1 (phenyl CH), 128.9 (phenyl CH), 129.8 (phenyl CH), 137.8 (C),
142.4 (C), 151.8 (OC=0), 173.7 (NC=0); IR (thin film) v,™ (cm*1): 3441 (O-H), 1751 





According to general procedure 6.2.8, employing (5)-4-benzyl-3-((2iS,35)-3-hydroxy-2- 
methyl-3-phenyl-propionyl)-oxazolidin-2-one 309 (0.1 g, 0.29 mmol) and diethyl zinc 
(0.029 mL, 1 M solution, 0.029 mmol), the crude product was prepared as a yellow oil. 
Purification by column chromatography afforded (55,65')-3-((5)-l-benzyl-2-hydroxy- 
ethyl)-5-methyl-6-phenyl-[l,3]oxazinane-2,4-dione 316 (0.035 g, 35%) as a yellow oil.
[a]2* - 59.0 ° (c 0.48, CHC13); 'H NMR (300MHz, CDC13): 5 0.91 (3H, d, CHS, J = 7.5 
Hz), 1.66 (1H, broad s, OH), 2.72 (1H, qd, C//CH3, J = 7.5, 3.0 Hz), 3.10 (1H, dd, 
C/^HePh, J = 13.9, 6.4 Hz), 3.26 (1H, dd, CHA/ / sPh, J = 13.9, 10.9 Hz), 3.94 (1H, dd, 
C/^HbOH, J = 11.7, 4.1 Hz), 4.15 (1H, dd, CHA/ / fiOH, J = 11.7, 7.9 Hz), 4.97 (1H, 
apparent s, CHO), 5.19 (1H, m, CHN), 7.19 -  7.40 (10H, m, Ph); ,3C NMR (75MHz, 
CDC13): 5 9.9 (CH3), 34.0 (CH2Ph), 42.0 (CHCH3), 63.8 (CH2OH), 77.8 (CHO), 125.8 
(phenyl CH), 127.2 (phenyl CH), 128.9 (phenyl CH), 129.1 (phenyl CH), 129.4 (phenyl 
CH), 129.5 (phenyl CH), 134.4 (phenyl C), 137.8 (phenyl Q , 153.2 (OC=0), 173.6 
(NC=0); IR (thin film) vmax (cm 1): 3449 (O-H), 1755 (C=0), 1697 (C=0); HRMS m/z 
(ES) [M+H]+ requires 340.1543, found 340.1545
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6.2.9 Procedure for the synthesis of (S)-4-methyl-oxazolidin-2-one, 322
o
Diethyl carbonate (19.0 mL, 157.80 mmol) was added to (S)-alaninol (5.75 g, 76.6 mmol), 
immediately followed by the addition of potassium carbonate (1.06 g, 7.66 mmol) in one 
portion to a three-necked flask fitted with standard distillation equipment. The reaction was 
stirred for 10 minutes then heated to 135 °C for 6  hours, or until ethanol ceased to distil 
from the reaction. The reaction was quenched with saturated aqueous ammonium chloride 
solution and the organics extracted with ether. The combined organic extracts were washed 
with brine, dried (MgS0 4 ) and the solvent evaporated in vacuo to afford the crude product. 
Recrystallisation in diethyl ether/hexane afforded (5)-4-methyl-oxazolidin-2-one 322 
(6.58 g, 85%) as a white solid, with spectroscopic data essentially identical to the literature 
compound.[232]
mp 42 -  44 °C [lit. 45.9 °C]; [ a g  + 11.0 ° (c 1.32, CHCI3) [lit. 8.1 (c 2.00, CHCI3)]; !H 
NMR (300MHz, CDC13): 5 1.24 (3H, d, J = 6.0 Hz, C //3CH), 3.89 (1H, dd, OCHA/ /B, J =
8.5, 6.5 Hz), 3.96 (1H, m, OC//AHB), 4.47 (1H, m, CHCH3), 6.53 (1H, broad s, NH); ,3C 
NMR (75MHz, CDC13): 5 21.5 (CH3), 49.2 (CHCH3), 72.6 (CH2), 161.1 (C=0); IR (KBr 
disc) vmax (cm 1): 3256 (broad N-H), 1745 (C=0)
6.2.10 Procedure for the synthesis of (<S)-4-methyl-3-propionyloxazolidin-2-one, 
323
fl-BuLi (4.40 mL, 2.5 M solution in hexanes, 10.98 mmol) was added to a solution of (S)- 
4-methyloxazolidin-2-one 322 (1.10 g, 10.88 mmol) in THF (40 mL) at -78 °C and stirred 
for 30 minutes. Propionyl chloride (1.04 mL, 11.97 mmol) was then added dropwise over 5
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minutes and stirred for a further two hours whilst warming to 0 °C. The reaction was 
quenched with aqueous saturated ammonium chloride solution and allowed to warm to 
room temperature, diluted with ether (20 mL), washed with aqueous saturated sodium 
hydrogen carbonate solution, sufficient to dissolve the white precipitate. The organics were 
extracted with ethyl acetate, dried (MgS0 4 ) and the solvent removed in vacuo to give the 
crude product. Purification by column chromatography afforded (*S)-4-methyl-3- 
propionyloxazolidin-2 -one 323 (1.33 g, 78%) as a yellow oil.
[o ff  + 81.0 ° (c 1.21, CH2C12); JH NMR (300MHz, CDCI3): 5 1.15 (3H, t, C //3CH2, J =
7.0 Hz), 1.41 (3H, d, C //3CH, J = 6.0 Hz), 2.95 -  2.86 (2H, apparent td, C i/2CH3, J = 7.0,
2.5 Hz), 3.97 (1H, dd, OCHAtfB, J = 8.5, 3.0 Hz), 4.41 (1H, apparent t, OC7/AHB, J = 8.5 
Hz), 4.55 (1H, m, CHN); 13C NMR (75MHz, CDC13): 5 8.7 (CH3), 19.7 (CH3), 29.6 
(CH2CH3), 50.8 (CHCH3), 69.5 (CH20), 154.0 (OC=0), 174.4 (NC=0); IR (thin film) vmax 
(cm'1): 1775 (C=0), 1702 (C=0); HRMS: m/z (ES) [M+H]+ requires 158.0812, found 
158.0812
6.2.11 Typical procedure for the pyridinium chlorochromate oxidation of  
alcohols to aldehydes
Pyridinium chlorochromate (2 eq.) was added to the primary alcohol (1 eq.) in DCM and 
stirred for 3 hours. The reaction mixture was filtered through fluorosil and celite and 
evaporated in vacuo to yield the product which could be used crude in subsequent 
reactions.
Tetradecanal, 324
According to general procedure 6.2.11, employing 1-tetradecanol (0.5 g, 2.33 mmol) in 
DCM (60 mL) and pyridinium chlorochromate (1.00 g, 4.66 mmol), tetradecanal 324 




*H NMR (300MHz, CDC13): 5 0.88 (3H, t, J = 8.5 Hz, CH3\  1.35 (20H, m, C10H20), 1.55 
(2H, m, CH2), 2.41 (2H, td, J = 7.0, 2.0 Hz, CHOC//2), 9.76 (1H, t, J = 2.0 Hz, CHO); 13C 
NMR (75MHz, CDC13): 8  14.5 (CH3), 22.5 (CH2), 23.1 (CH2), 29.6 (CH2), 29.7 (CH2),
29.8 (CH2), 29.9 (CH2), 30.0 (CH2), 30.1 (CH2), 32.3 (CH2), 44.3 (CH2), 203.4 (HCO); IR 
(thin film) vmax (cm*1): 1728 (C=0)
Hexadecanal, 325
According to general procedure 6.2.11, employing 1-hexadecanol (0.5 g, 2.06 mmol) in 
DCM (60 mL) and pyridinium chlorochromate (0.89 g, 4.12 mmol), hexadecanal 325 
(0.48 g, 99%) was prepared as an off white solid which could be used crude in subsequent 
reactions.
mp 40 -  41 °C; *H NMR (300MHz, CDC13): 8  0.87 (3H, t, J = 8.5 Hz, CH3), 1.35 (24H, m, 
Ci2H24), 1.53 (2H, m, CH2), 2.37 (2H, td, J = 7.0, 2.0 Hz, CHOCi/2), 9.72 (1H, t, J = 2.0 
Hz, CHO); 13C NMR (75MHz, CDC13): 8  14.5 (CH3), 22.5 (CH2), 23.1 (CH2), 29.6 (CH2),
29.8 (CH2), 29.9 (CH2), 30.0 (CH2), 30.0 (CH2), 30.1 (CH2), 30.1 (CH2), 32.3 (CH2), 44.3 
(CH2), 203.4 (HCO); IR (KBr disc) vmax (cm'1): 1726 (C=0)
Octadecanal, 326
According to general procedure 6.2.11, employing 1-octandecanol (0.5 g, 1.85 mmol) in 
DCM (60 mL) and pyridinium chlorochromate (0.79 g, 3.70 mmol), octadecanal 326 
(0.47 g, 96%) was prepared as an off white solid which could be used crude in subsequent 
reactions.
mp 57 -  58 °C; ‘H NMR (300MHz, CDC13): 8  0.88 (3H, t, J = 8.5 Hz, CH}), 1.35 (28H, m, 
C 14H 2s) ,  1.55 (2H, m, CH2), 2.38 (2H, td, J = 7.0, 2.0 Hz, CHOCft), 9.71 (1H, t, J = 2.0 
Hz, CHO); 13C NMR (75MHz, CDCI3): 6  14.5 (CH3), 22.5 (CH2), 23.1 (CH2), 29.6 (CH2),
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29.8 (CH2), 29.8 (CH2), 29.9 (CH2), 30.0 (CH2), 30.0 (CH2), 30.1 (CH2), 30.1 (CH2), 32.3 
(CH2), 44.3 (CH2), 203.3 (HCO); IR (KBr disc) vmax (cm'1): 1728 (C=0)
6.2.12 Typical procedure for the (S)-4-methyl-oxazolidin-2-one mediated syn- 
aldol reaction
A solution o f  iV-acylated 4-methyl-oxazolidinone (1 eq.) in DCM was cooled to 0 °C in an 
ice bath and 9-BBNOTf (1.1 eq., 0.5 M solution in hexanes) added dropwise. The mixture 
was left stirring for 30 min at 0 °C before addition o f  diisopropylethylamine (1.3 eq.) and 
stirring for a further 40 min. The reaction was then cooled to -  78 °C in an acetone-dry ice 
bath before addition o f  the aldehyde (1.1 eq.) in DCM and stirring for 1 hr at -  78 °C 
followed by 1 hr at 0 °C. The mixture was allowed to warm to room temperature, pH 7 
phosphate buffer added and stirred for 5 min before addition o f  2:1 hydrogen 
peroxide:methanol (v/v) and stirring for 16 hrs. The bulk o f the solvent was removed in 
vacuo and the resulting slurry partitioned between water and diethyl ether. The combined 




U  IN  T '
K  1
According to general procedure 6.2.12, employing (5)-4-methyl-3-propiony loxazo lidin-2 - 
one 323 (0.13 g, 0.83 mmol) in DCM (6  mL), 9-BBNOTf (1.82 mL, 0.5 M, 0.91 mmol), 
diisopropylethylamine (0.19 mL, 1.08 mmol) and tetradecanal 324 (0.19 g, 0.91 mmol) in 
DCM (2.5 mL), the crude product was prepared as a dark yellow oil. Purification by 
column chromatography afforded (iS)-3-((25,3/?)-3-hydroxy-2-methyl-hexadecanoyI)-4- 
methyl-oxazolidin-2-one 327 (0.25 g, 81%) as a yellow oil.
[afn + 40.0 ° (c 0.60, CHC13); ]H NMR (CDC13, 300 MHz): 5 0.81 (3H, t, CH2CH3, J =
6.4 Hz), 1.14 (3H, d, OOCHCffc, J = 7.2 Hz), 1.15 -  1.31 (24H, m, Ci2H24), 1.34 (3H, d, 
CHCH3, J = 6.4 Hz), 2.82 (1H, broad s, OH), 3.68 (1H, qd, C=OC//CH3, J = 7.2, 2.6 Hz),
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3.85 (1H, broad td, C//OH, J = 6.4, 1.6 Hz), 3.94 (1H, dd, OCi/^HB, J = 3.0, 8.7 Hz), 4.38 
(1H, apparent t, OCi^HB, J = 8.7 Hz), 4.52 (1H, m, CHN); 13C NMR (CDC13, 75 MHz): 8
9.7 (CH3), 13.5 (CH3), 18.5 (CH3), 22.1 (CH2), 25.4 (CH2), 28.8 (CH2), 29.0 (CH2), 29.0 
(CH2), 29.1 (CH2), 31.3 (CH2), 33.2 (CH2), 41.4 (CH), 49.8 (CH), 68.4 (CH20 ), 70.7 
(CHOH), 152.2 (0C =0), 176.5 (NC=0); IR (thin film) v^x (cm-1): 3428 (broad OH), 1781 




According to general procedure 6.2.12, employing (5)-4-methyl-3-propionyloxazolidin-2- 
one 323 (0.89 g, 5.67 mmol) in DCM (50 mL), 9-BBNOTf (12.5 mL, 0.5 M, 6.24 mmol), 
diisopropylethylamine (1.3 mL, 7.37 mmol) and hexadecanal 325 (1.50 g, 6.24 mmol) in 
DCM (5 mL), the crude product was prepared as a dark yellow oil. Purification by column 
chromatography afforded (*S)-3-((2*S',3/2)-3-hydroxy-2-methyl-octadecanoyl)-4-methyl- 
oxazolidin-2-one 328 (1.96 g, 87%) as a pale yellow oil.
[a f t  + 25.6 ° (c 0.39, CHC13); JH NMR (CDC13, 300 MHz): 6  0.87 (3H, t, CH2CH3, J =
6 .8  Hz), 1.21 (3H, d, C=OCHC7/3, J = 7.2 Hz), 1.23 -  1.30 (28H, m, CuH28), 1.40 (3H, d, 
NCHCH3, J = 6.4 Hz), 2.89 (1H, broad s, OH), 3.74 (1H, qd, C=OC7/CH3, J = 7.2, 2.6 Hz),
3.92 (1H, m, CHOU), 4.00 (1H, dd, OCHaHb, J = 3.0, 8 .6  Hz), 4.44 (1H, apparent t, 
OCHaHb, J = 8 .6  Hz), 4.59 (1H, m, CHN)\ 13C NMR (CDC13, 75 MHz): 5 10.2 (CH3),
14.1 (CH3), 19.1 (CH3), 22.7 (CH2), 26.0 (CH2), 29.3 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 
(CH2), 31.9 (CH2), 33.8 (CH2), 41.9 (CH), 50.4 (CH), 68.9 (CH20 ) , 71.3 (CHOH), 153.0 
(OC=0), 177.7 (NC=0); IR (thin film) vmax (cm'1): 3425 (O-H), 1781 (C=0), 1703 (C=0); 




According to general procedure 6.2.12, employing (S)-4-methyl-3-propionyloxazolidin-2- 
one 323 (0.40 g, 2.55 mmol) in DCM (12 mL), 9-BBNOTf (5.56 mL, 0.5 M, 2.81 mmol), 
diisopropylethylamine (0.57 mL, 3.32 mmol) and octadecanal 326 (0.75 g, 2.81 mmol) in 
DCM (5 mL), the crude product was prepared as a yellow oil. Purification by column 
chromatography afforded (5)-3-((25',3i?)-3-hydroxy-2-methyl-icosanoyl)-4-methyl- 
oxazolidin-2-one 329 (0.87 g, 80%) as a pale yellow oil.
[afo + 23.5 ° (c 0.4, CHC13); *H NMR (CDC13, 300 MHz): 5 0.87 (3H, t, CH2CH3, J = 6 .8  
Hz), 1.21 (3H, d, C=OCHCH3, J = 7.2 Hz), 1.23 -  1.30 (32H, m, CJ6H32), 1.40 (3H, d, 
NCHCtfi, J = 6.4 Hz), 2.89 (1H, broad s, OH), 3.74 (1H, qd, C=OC//CH3, J = 7.2, 2.6 Hz),
3.92 (1H, m, C//OH), 4.00 (1H, dd, OCHAHB, J = 3.0, 8 .6  Hz), 4.44 (1H, apparent t, 
OCHaHb, J = 8 .6  Hz), 4.59 (1H, m, CHN); 13C NMR (CDC13, 75 MHz): 6  10.2 (CH3),
14.1 (CH3), 19.1 (CH3), 22.7 (CH2), 26.0 (CH2), 29.3 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 
(CH2), 31.9 (CH2), 33.8 (CH2), 41.9 (CH), 50.4 (CH), 68.9 (CH20 ), 71.3 (CHOH), 153.0 
(OC=0), 177.7 (NC=0); IR (thin film) vmax (cm'1): 3412 (O-H), 1788 (C=0), 1700 (C O );  
HRMS: m/z (ES) [M+H]+ requires 426.3578, found 426.3582
6.2.13 Typical procedure for the potassium terf-butoxide elimination of syn-
4-Methyl-oxazolidin-2-one syn-aldol (1 eq.) in THF is cooled to -  78 °C in an acetone/dry 
ice bath. Potassium ferf-butoxide (1 eq.) is added in one portion and the reaction allowed to 
warm to room temperature over 20 hours. The solvent is removed in vacuo and the residue 
redissolved in DCM, washed with brine, dried (MgSCL) and the solvent removed in vacuo 
to afford the crude product.








According to general procedure 6.2.13, employing (5)-3-((25',3/?)-3-hydroxy-2-methyl- 
hexadecanoyl)-4-methyl-oxazolidin-2-one 327 (50 mg, 0.14 mmol) in THF (1 mL) and 
potassium te/7-butoxide (15 mg, 0.14 mmol) the crude product was prepared as a 
colourless oil. Purification by column chromatography afforded (£)-2-methyl-hexadec-2- 
enoic acid ((S)-2-hydroxy-l-methyl-ethyI)-amide (semiplenamide C) 330 (34 mg, 74%) 
as a colourless oil, with spectroscopic data essentially identical to the literature 
compound. [2051
[afo - 8.0 ° (c 0.61, CHC13) [lit. -  5.0 0 (c 0.30, CHC13)]; ’H NMR (CDC13, 300 MHz): 5 
0.81 (3H, t, CH2C//j, J = 6 .6  Hz), 1.14 (3H, apparent d, CHCH3, J = 7.2 Hz), 1.19 -  1.27 
(22H, m, CuH22), 1.78 (1H, broad s, OH), 2.07 (2H, apparent q, J = 7.2 Hz, CH2CU=C), 
3.50 (1H, dd, C/^HbOH, J = 6.4, 10.9 Hz), 3.65 (1H, dd, CHA/ / 5 0H , J = 10.9, 3.4 Hz),
4.07 (1H, m CHCH3), 5.74 (1H, broad s, NH), 6.32 (1H, apparent dt, CH2CH=C, J = 7.2,
1.1 Hz); 13C NMR (CDC13, 75 MHz): 5 10.8 (CH3), 12.9 (CH3), 15.9 (CH3), 2 1 .1  (CH2),
26.8 (CH2), 27.1 (CH2), 27.9 (CH2), 28.2 (CH2), 28.5 (CH2), 28.7 (CH2), 28.8 (CH2), 29.3 
(CH2), 31.0 (CH2), 47.3 (CHN), 66.5 (CH2OH), 129.1 (C=CH), 136.3 (C=CH), 169.4 
(C=0); IR (thin film) vmax (cm 1): 3280 (broad OH), 1621 (C=0); HRMS: m/z (ES) 
[M+H]+ requires 326.3054, found 326.3052
(£)-2-Methyl-octadec-2-enoic acid ((iS)-2-hydroxy-l-methyI-ethyl)-amide, 331
According to general procedure 6.2.13, employing (1S)-3-((25',3R)-3-hydroxy-2-methyl- 





potassium te/7-butoxide (23 mg, 0.20 mmol) the crude product was prepared. Purification 
by column chromatography afforded (Zs)-2-methyl-octadec-2-enoic acid ((S)-2-hydroxy-
l-methyl-ethyl)-amide 331 (56 mg, 79%) as a pale yellow oil.
[a]2* - 7.2 ° (c 0.5, CHC13); ]H NMR (CDC13, 300 MHz): 5 0.88 (3H, t, CH2CH3, J = 6.4 
Hz), 1.15 (3H, d, CHCH3, J = 7.2 Hz), 1.25 (24H, m, CnH24\  1.42 (2H, m, CH2), 2.13 
(2H, m, CH2CH=C), 3.56 (1H, dd, C/^HBOH, J = 10.9, 6.4 Hz), 3.71 (1H, dd, CHAi / 50H, 
J = 10.9, 3.4 Hz), 4.10 (1H, m, CtfCH3), 5.83 (1H, broad s, NH), 6.38 (1H, dt, C=CH, J = 
7.5, 1.5 Hz); 13C NMR (CDC13, 75 MHz): 6 10.1 (CH3), 12.5 (CH3), 14.0 (CH3), 22.6 
(CH2), 26.8 (CH2), 28.3 (CH2), 28.5 (CH2), 28.7 (CH2), 28.8 (CH2), 29.3 (CH2), 29.6 
(CH2), 31.8 (CH2), 47.7 (CHN), 71.6 (CH2OH), 130.2 (C=CH), 137.0 (C=CH), 170.0 
(C=0); IR (thin film) v™* (cm'1): 3676 (N-H), 3448 (O-H), 1740 (C=0); HRMS: m/z (ES) 
[M+H]+ requires 354.3368, found 354.3366
(£)-2-Methyl-icos-2-enoic acid ((S)-2-hydroxy-l-methyl-ethyI)-amide, 332
o
H(3
According to general procedure 6.2.13, employing (5)-3-((2S',3R)-3-hydroxy-2-methyl- 
icosanoyl)-4-methyl-oxazolidin-2-one 329 (129 mg, 0.30 mmol) in THF (2 mL) and 
potassium fert-butoxide (34 mg, 0.30 mmol) the crude product was prepared. Purification 
by column chromatography afforded (Zs)-2-methyI-icos-2-enoic acid ((S)-2-hydroxy-l- 
methyl-ethyl)-amide 332 (85 mg, 74%) as a colourless oil.
[a]„ - 7.5 0 (c 0.50, CHC13); JH NMR (CDC13, 300 MHz): 5 0.88 (3H, t, CH2CH3, J = 7.0 
Hz), 1.21 (3H, apparent d, C i/3CH, J = 7.0 Hz), 1.21 -  1.35 (30H, m, C]5H30\  1.42 (1H, 
broad s, OH), 2.13 (2H, apparent q, CH2CH=C, J = 7.0 Hz), 3.56 (1H, dd, CHA/ / BOH, J =
11.0, 6.0 Hz), 3.71 (1H, dd, C //AHBOH, J = 11.0, 3.5 Hz), 4.12 (1H, apparent qd, CtfCH3, 
J = 6.5, 3.5 Hz), 5.83 (1H, broad s, NH), 6.37 (1H, apparent td, CH=C, J = 7.5, 1.5 Hz); 
13C NMR (CDCI3, 75 MHz): 5 11.7 (CH3), 13.1 (CH3), 16.1 (CH3), 21.7 (CH2), 27.4 
(CH2), 27.8 (CH2), 28.3 (CH2), 28.4 (CH2), 28.5 (CH2), 28.6 (CH2), 28.7 (CH2), 29.3 
(CH2), 30.9 (CH2), 47.1 (CHN), 66.7 (CH2OH), 129.2 (C=CH), 136.1 (C=CH), 169.3
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(C=0); IR (thin film) (cm 1): 3286 (broad OH), 1627 (C=0); HRMS: m/z (ES) 
[M+H]+ requires 382.3680, found 382.3678
6.2.14 Typical procedure for 0-acylation of 2-hydroxy amides
Unsaturated hydroxy amide (1 eq.) in acetic anhydride and pyridine is stirred for 20 hours 
before evaporating in vacuo. The residue is redissolved in DCM, washed with water and 
brine, dried (MgS0 4 ), filtered and the solvent removed in vacuo to afford the crude 
product.




According to general procedure 6.2.14, employing (£)-2-methyl-icos-2-enoic acid ((S)-2- 
hydroxy-l-methyl-ethyl)-amide 332 (100 mg, 0.26 mmol) in acetic anhydride (1 mL) and 
approximately 5 drops o f pyridine, the crude product is prepared. Purification by column 
chromatography afforded acetic acid (5)-2-((E)-2-methyl-icos-2-enoylamino)-propyl 
ester (semiplenamide D) 333 (101 mg, 92%) as a colourless oil, with spectroscopic data 
essentially identical to the literature compound.[205]
[a]2* - 10.0 ° (c 0.15, CHC13) [lit. -  10.6 0 (c 0.15, CHC13)]; lU NMR (CDC13, 300 MHz): 
5 0.89 (3H, t, CU2CH3 , J = 6.0 Hz), 1.20 (3H, d, CHCH3, J = 7.0 Hz), 1.25 -  1.29 (28H, 
broad m, (2H, m, C //2CH2CH), 1.82 (3H, s, CH=CCi/5), 2.08 (3H, s,
C =0CH3\  2.13 (2H, m, C//2CH=C), 4.05 (1H, dd, CHAHbO, J = 5.5, 4.0 Hz), 4.20 (1H, 
dd, CUaHbO , J = 5.5, 5.8 Hz), 4.33 (1H, m, CHN), 5.82 (1H, broad s, NH), 6.33 (1H, tm, 
C//=C, J = 7.0 Hz); 13C NMR (CDC13, 75 MHz): 5 13.0 (CH3), 14.6 (CH3), 17.5 (CH3),
20.9 (C=OCH3), 23.0 (CH2), 23.1 (CH2), 28.7 (CH2), 29.0 (CH2), 30.5 (CH2), 32.2 (CH2),
45.2 (CHNH), 67.7 (CH20 ), 131.8 (C= CH), 137.0 (C=CH), 169.3 (NC=0), 171.8
(OC=0); IR (thin film) VmaX (cm*1): 3279 (N-H), 1721 (C=0), 1655 (C=0); HRMS: m/z 
(ES) [M+H]+ requires 424.3712, found 424.3710
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According to general procedure 6.2.14, employing (is)-2-methyl-octadec-2-enoic acid ((5)-
2-hydroxy-l-methyl-ethyl)-amide 331 (107 mg, 0.30 mmol) in acetic anhydride (1.5 mL) 
and approximately 5 drops o f pyridine, the crude product is prepared. Purification by 
column chromatography afforded acetic acid (*S)-2-((£)-2-methyl-octadec-2- 
enoylamino)-propyl ester (semiplenamide E) 334 (112 mg, 94%) as a colourless oil, 
with spectroscopic data essentially identical to the literature compound.[2051
[afn - 26.7 ° (c 0.15, CHC13) [lit. - 7 .1 ° ( c  0.28, CHC13)]; *H NMR (CDC13, 300 MHz): 5 
0.87 (3H, t, CH2C i/i, J = 6.0 Hz), 1.19 (3H, d, CHCH3, J = 7.0 Hz), 1.22 -  1.29 (24H, 
broad m, CnH24) ,lA 0  (2H, m, C //2CH2CH), 1.81 (3H, s, CH=CCi/3), 2.07 (3H, s, 
C =0CH3), 2.12 (2H, m, C //2CH=C), 4.02 (1H, dd, C7^ H bO, J = 5.5, 4.0 Hz), 4.18 (1H, 
dd, CHa//sO , J = 5.5, 5.8 Hz), 4.33 (1H, m, CHN), 5.85 (1H, broad s, NH), 6.32 (1H, tm, 
CH=C, J = 7.0 Hz); ,3C NMR (CDC13, 75 MHz): 6 13.0 (CH3), 14.5 (CH3), 17.8 (CH3),
21.3 (C=OCH3), 23.0 (CH2), 28.8 (CH2), 29.5 (CH2), 29.7 (CH2), 29.9 (CH2), 30.1 (CH2),
32.3 (CH2), 45.1 (CHNH), 67.4 (CH20), 130.8 (C=CH), 137.1 (C=CH), 169.3 (NC=0),
171.8 (OC=0); IR (thin film) Vn« (cm’1): 3676 (N-H), 1735 (C=0), 1660 (C=0); HRMS: 
m/z (ES) [M+H]+ requires 396.3472, found 396.3470
6.2.15 Typical procedure for the epoxidation of unsaturated amides
3-Chloroperoxybenzoic acid (11.6 eq.) was added to the desired unsaturated amide (1 eq.) 
in DCM and left to stir at room temperature for 20 hours. The reaction mixture is washed 




2-Methyl-3-pentadecyl-oxirane-2-carboxylic acid ((S)-2-hydroxy-l-methyl-ethyI)- 





According to general procedure 6.2.15, employing (£)-2-methyl-octadec-2-enoic acid ((5)- 
2-hydroxy-l-methyl-ethyl)-amide 331 (10 mg, 0.028 mmol) in DCM (5 mL) and 3- 
chloroperoxybenzoic acid (57 mg, 0.328 mmol), the crude product was prepared as a 
colourless oil. Purification by column chromatography afforded a 45:55 mixture o f  
diastereomers 335a and 335b (9.3 mg, 90%) as a cloudy oil.
[afo + 0.3 ° (c 0.20, CHC13); NMR (CDC13, 300 MHz): 5 0.88 (6H, t, 335a CH2CH3 
and 335b CH2CH3, J = 6.4 Hz), 1.16 (3H, d, 335a CHCH3, J = 7.2 Hz), 1.18 (3H, d, 335b 
CHCH3, J = 6.8 Hz), 1.25 -  1.32 (48H, m, 335a Ci2H24 and 335b Ci2H24\  1.43 (4H, 
overlapping m, 335a CH2CH3 and 335b CH2CH3), 1.55 (6H, s, 335a CH3CO and 335b 
CH3CO), 1.57 (4H, overlapping m, 335a CH2CHO and 335b CH2CHO), 2.86 (1H, t, 335b 
CH2C //0 , J = 5.6 Hz), 2.89 (1H, t, 335a CH2C/70, J = 6.2 Hz), 3.52 (2H, apparent d, 335b 
CH2O, J = 5.3 Hz), 3.68 (2H, dd, 335a CH2O, J = 4.9, 1.1 Hz), 4.03 (2H, m, 335a CHNH 
and 335b CHNH), 6.40 (1H, broad s, NH), 6.45 (1H, broad s, NH); 13C NMR (CDC13, 75 
MHz): 6 12.8 (CH3), 14.1 (CH3), 17.3 (CH3), 23.7 (CH2), 26.6 (CH2), 28.3 (CH2), 29.6 
(CH2), 30.0 (CH2), 31.0 (CH2), 31.9 (CH2), 47.5 (CHN), 60.1 (CH3CO), 63.8 (CH2CHO),
67.7 (CH20), 173.3 (0 = 0 ) all peaks exhibit a corresponding peak for 335b; IR (thin film) 




Acetic acid (*S)-2-[(2-methyl-3-pentadecyl-oxiranecarbonyl)-amino]-propyl ester 336a 
(Semiplenamide G) and 336b
336a
336b
According to general procedure 6.2.15, employing acetic acid (5)-2-((E)-2-methyl-octadec- 
2-enoylamino)-propyl ester (semiplenamide E) 334 (10 mg, 0.025 mmol) in DCM (5 mL) 
and 3-chloroperoxybenzoic acid (50 mg, 0.29 mmol) the crude product was prepared. 
Purification by column chromatography afforded a 45:55 mixture o f 336a and 336b (10 
mg, 95%) as a cloudy oil.
[ a g  + 0.5 ° (c 0.20, CHC13); lH NMR (CDC13, 300 MHz): 5 0.87 (6H, t, 336a CH2CH3 
and 336b CH2CH3, J = 6.4 Hz), 1.12 (3H, d, 336a CHCH3, J = 7.2 Hz), 1.17 (3H, d, 336b 
CHCH3, J = 6.8 Hz), 1.23 -  1.32 (48H, m, 336a Ci2H24 and 336b CnH24), 1.46 (4H, 
overlapping m, 336a CH2CH2 and 336b CH2CH3), 1.50 (6H, s, 336a CH3CO and 336b 
CH3CO), 1.55 (4H, overlapping m, 336a CH2CHO and 336b CH2CRO), 2.06 (3H, s, 336b 
C =0CH3), 2.08 (3H, s, 336a C =0CH3), 2.81 (1H, t, 336b CH2C //0 , J = 5.6 Hz), 2.83 (1H, 
t, 336a CUiCHO, J = 6.2 Hz), 3.99 (2H, apparent d, 336b CH2O, J = 5.3 Hz), 4.03 (2H, dd, 
336a CH2O, J = 4.9, 1.1 Hz), 4.20 (2H, m, 336a CHNH and 336b CHNH), 6.37 (1H, broad 
s, NH), 6.42 (1H, broad s, NH); 13C NMR (CDC13, 75 MHz): 6 12.9 (CH3), 14.1 (CH3),
17.2 (CH3), 20.8 (C=OCH3), 22.7 (CH2), 26.2 (CH2), 28.1 (CH2), 29.3 (CH2), 29.6 (CH2),
31.0 (CH2), 31.9 (CH2), 43.6 (CHN), 60.0 (CH3CO), 63.8 (CH2CHO), 66.7 (CH20 ), 171.2 
(C=0), 173.3 (C=0) all peaks exhibit a corresponding peak for 336b; IR (thin film) Vmax 




6.2.16 Procedures for the synthesis of (^ -^ benzyl-S^ -d im ethyl-oxazolid in^ - 
one (SuperQuat auxiliary), 344
(S)-Phenylalanine methyl ester, 347
o
NH.
Thionyl chloride (33.1 mL, 0.45 mol) was added dropwise to a stirred suspension of (L)- 
phenylalanine (50 g, 0.30 mol) in methanol (500 mL) at 0 °C. The reaction was allowed to 
warm to room temperature and stirred for 30 hrs. The solvent was removed in vacuo to 
give (5)-phenylalanine methyl ester 347 (58 g, 90%) with 'H NMR spectroscopic data 
essentially identical to the literature compound.[234] The crude product was used in the next 
step without further purification.
'H NMR (CDC13, 300 MHz): 5 2.87 (1H, dd, CHAHBPh, J = 13.5, 5.0 Hz), 3.07 (1H, dd, 
CHA/ / BPh, J = 13.5, 5.0 Hz) 3.71 (3H, s, CH3O), 3.75 (1H, dd, CHN, J = 8.0, 5.0 Hz), 7.24 
-  7.35 (5H, broad m, Ph)
(iS)-7V-Boc-phenylalanine methyl ester, 348
To a stirred solution of (5)-phenylalanine methyl ester 347 (65.4 g, 0.30 mol) in ethanol 
(500 mL) at 0 °C was added NaHCC>3 (76.42 g, 0.90 mol) and Boc anhydride (69.50 g, 
0.32 mol). The reaction was allowed to warm to room temperature and stirred for 48 hrs. 
The mixture was filtered through Celite, washed with diethyl ether and the filtrate 
evaporated in vacuo. The residue was redissolved in diethyl ether, filtered through Celite 
and evaporated in vacuo to yield (5)-A^-Boc-phenylalanine methyl ester 348 (69.6 g,
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83%) with 'H NMR spectroscopic data essentially identical to the literature compound.[234] 
The crude product was used in the next step without further purification.
*H NMR ( C D C I 3 ,  300 MHz): 5 1.34 (9H, s, r-Bu), 3.01 (2H, m, CH2Ph), 3.64 (3H, s, 
CH3O), 4.53 (1H, m, CHNH), 4.89 (1H, m, NH), 7.00 -  7.07 (2H, m, Ph), 7.14 -  7.25 (3H, 
broad m, Ph)
te/’f-Butyl-(S)-3-hydroxy-3-methyl-l-phenylbutan-2-ylcarbamate, 349
Methyl iodide (1 mL) was added dropwise to a suspension o f magnesium turnings (3.48 g, 
0.14 mol) in diethyl ether (40 mL), until the reaction sustained a gentle reflux. Methyl 
iodide (8.91 mL, 0.14 mol) in ether (65 mL) was added dropwise over a period of 30 
minutes. The solution was allowed to cool to room temperature, before (S)-/V-Boc- 
phenylalanine methyl ester 348 (10 g, 0.036 mol) in ether (40 mL) was added dropwise to 
the reaction over a period of 30 minutes. The reaction was stirred for 48 hours, quenched 
with saturated ammonium chloride solution and hydrochloric acid (20 mL, 1 M solution in 
water), filtered through Celite and washed with ether. The solvent was removed under 
reduced pressure, dissolved in ether, washed with brine and dried (MgSCL). The solvent 
was removed in vacuo to give te/*/-butyl-(S)-3-hydroxy-3-methyl-l-phenylbutan-2- 
ylcarbamate 349 as an off white solid which was used in the next step without further 
purification.
mp 101 -  103 °C; [a]% - 44.8 0 (c 1.00, CHC13); 'H NMR (CDC13, 300 MHz): 5 1.20 (9H, 
s, t-Bu), 1.22 (6H, s, {CH3)2\  2.51 (1H, m, C/^HfiPh), 3.02 (1H, dd, CHAHB?h, J = 14.0,
3.5 Hz), 3.61 (1H, m, CHN), 4.47 (1H, d, NH, J = 9.0 Hz), 7.08 -  7.25 (5H, m, Ph); 13C 
NMR ( C D C I 3 ,  75 MHz): 6 26.8 (CH3), 27.5 (CH3), 28.4 (CH3), 36.3 (CH2Ph), 60.7 
(CHNH), 73.4 (Q , 79.5 (Q , 126.4 (phenyl CH), 128.6 (phenyl CH), 129.3 (phenyl CH),
139.3 (phenyl Q ,  156.8 (C=0); IR (KBr disc) vmax (cm 1): 3475 (O-H), 3379 (N-H), 1662 
(C=0); HRMS: m/z (ES) [M+H]+ requires 280.1907, found 280.1911.
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(5)-4-Benzyl-5,5-dimethyl-oxazolidin-2-one (SuperQuat auxiliary), 344
o
To a stirred solution of ^r/-butyl-(*S)-3-hydroxy-3-methyl-1 -phenylbutan-2-ylcarbamate 
349 (4.0 g, 14.32 mmol) in THF (70 mL) at 0 °C was added potassium /ert-butoxide (1.6 g, 
15.75 mmol) in one portion. After 30 minutes the solvent is evaporated in vacuo and the 
residue dissolved in ethyl acetate, washed with brine, dried (MgSCL) and evaporated in 
vacuo to afford the crude product. Recrystallisation (ether, petrol) afforded (-S)-4-benzyl-
5,5-dimethyl-oxazoiidin-2-one (SuperQuat auxiliary) 344 (3.55 g, 95%) as a white solid 
with spectroscopic data essentially identical to the literature compound.[207] 
mp 64 -  65 °C [lit. 59 °C]; [a fj - 119.5 0 (c 0.80, CHC13) [lit. -  103.5 ° (c 0.60, CHC13)]; 
'H NMR (CDC13, 300 MHz): 5 1.33 (6H, s, C(CH3)2), 2.59 (1H, dd, CHA/ / flPh, J = 4.3,
13.6 Hz), 2.72 (1H, dd, CHAHBPh, J = 13.6, 10.2 Hz), 3.59 (1H, apparent dd, CHN, J =
10.2, 3.8 Hz), 5.35 (1H, broad s, NH), 7.07 - 7.33 (5H, m, Ph); 13C NMR (CDC13, 75 
MHz): 6 22.3 (CH3), 28.0 (CH3), 37.5 (CH2Ph), 63.4 (CHN), 83.5 (C(CH3)2), 127.6 
(phenyl CH), 129.3 (phenyl CH), 129.5 (phenyl CH), 137.3 (phenyl Q , 158.2 (C=0); IR 
(KBr disc) vmax (cm 1): 3379 (N-H), 3475 (O-H), 1662 (C=0)
6.2.17 Typical procedure for the TV-acylation o f (5)-4-benzyl-5,5-dim ethyl- 
oxazolidin-2-one (SuperQuat auxiliary) 344
(5)-4-Benzyl-5,5-dimethyl-oxazolidin-2-one 344 (1 eq.) in dry THF was cooled to -  78 °C 
before addition of butyl lithium (1.01 eq., 2.5 M solution in hexanes) slowly over a 10 
minute period followed by the acid chloride (1.1 eq.). The mixture was left stirring at - 78 
°C for 45 min before warming to room temperature whilst stirring for 1 hour and excess 
acid chloride quenched by addition o f aqueous ammonium chloride. Most of the THF and 
hexane was removed by evaporation in vacuo and the organics extracted with DCM. The
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combined organic extracts were washed with 1 M NaOH and brine, dried (MgS0 4 ), 





According to general procedure6.2.17, employing (S)-4-benzyl-5,5-dimethyl-oxazolidin-2- 
one 344 (1.0 g, 4.87 mmol) in THF (15 mL), butyl lithium (1.97 mL, 2.5 M solution, 4.92 
mmol) and propionyl chloride (0.59 mL, 5.36 mmol) the crude product was prepared as a 
colourless oil. Purification by column chromatography afforded (5)-4-benzyl-5,5- 
dimethyl-3-propionyl-oxazolidin-2-one 346 (1.08 g, 85%) as a white solid, 
mp 60 -  62 °C; [arg - 30.0 ° (c 0.87, CHC13); *H NMR (CDC13, 300 MHz): 5 1.18 (3H, t, 
CHS, J = 7.5 Hz), 1.33 (3H, s, C(CH3)2), 1.35 (3H, s, C(CH3)2), 2.89 (3H, overlapping m, 
CH2CH3 and CHA//*Ph), 3.12 (1H, dd, C//„HBPh, J = 14.5, 4.0 Hz), 4.50 (1H, dd, CHN, J 
= 9.5, 4.0 Hz), 7.18 -  7.32 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 9.0 (CH3), 22.7 
(C(CH3)2), 29.1 (C(CH3)2), 29.8 (CH2), 35.8 (CH2Ph), 63.9 (CHN), 82.6 (C(CH3)2), 127.2 
(phenyl CH), 129.1 (phenyl CH), 129.4 (phenyl CH), 137.2 (phenyl Q ,  152.9 (OC=0),
173.9 (NC=0); IR (KBr disc) vmax (cm*1): 1770 (C=0), 1700 (C=0); HRMS : m/z (ES) 




According to general procedure 6.2.17, employing (5)-4-benzy 1-5,5-dimethyl-oxazolidin-
2-one 344 (1.0 g, 4.87 mmol) in THF (15 mL), butyl lithium (1.97 mL, 2.5 M solution,
4.92 mmol) and isovaleryl chloride (0.65 mL, 5.36 mmol) the crude product was prepared 
as a colourless oil. Purification by column chromatography afforded (5)-4-benzyl-5,5- 
dimethyl-3-(3-methyl-butyryl)-oxazolidin-2-one 355 (1.11 g, 79%) as a colourless oil. 
[afn - 33.9 ° (c 0.60, CHC13); 'H NMR (CDC13, 300 MHz): 5 0.95 (6H, apparent d, 
CH{CH3)2, J = 7.2 Hz), 1.33 (3H, s, C(C//j)2), 1.34 (3H, s, C(C//j)2), 2.13 (1H, m, 
C//(CH3)2), 2.78 (2H, apparent d, C //2-'Pr, J = 6.5 Hz), 2.86 (1H, apparent dd, CHAHB?h, J 
= 14.5, 9.6 Hz) 3.11 (1H, dd, CHAHBPh, J = 14.5, 4.0 Hz), 4.50 (1H, dd, CHN, J = 9.6, 4.0 
Hz), 7 .18-7 .31  (5H, m, Ph); ,3C NMR (CDC13, 75 MHz): 8 22.6 (CH3), 22.9 (CH3), 25.6 
(CH(CH3)2), 28.8 (C(CH3)2), 35.8 (CH2Ph), 44.5 (CH2-'Pr), 63.9 (CHN), 82.5 (C(CH3)2),
127.2 (phenyl CH), 129.2 (phenyl CH), 129.5 (phenyl CH), 137.3 (phenyl Q , 152.9 
(OC=0), 173.0 (NC=0); IR (thin film) vmax (cm’1): 1779 (C=0), 1699 (C=0); HRMS m/z 




According to general procedure 6.2.17, employing (S)-4-benzyl-5,5-dimethyl-oxazolidin-
2-one 344 (1.0 g, 4.87 mmol) in THF (15 mL), butyl lithium (1.97 mL, 2.5 M solution,
4.92 mmol) and phenyl acetyl chloride (0.71 mL, 5.36 mmol) the crude product was 
prepared as a colourless oil. Purification by column chromatography afforded (S)-4- 
benzyl-5,5-dimethyl-3-phenylacetyl-oxazolidin-2-one 356 (1.23 g, 78%) as a colourless 
oil.
[a]2* - 15.8 ° (c 0.50, CHC13); *H NMR (CDC13, 300 MHz): 5 1.33 (3H, s, C(CH3)2), 1.35 
(3H, s, C(CH3)2), 2.87 (1H, dd, CHA//*Ph, J = 14.5, 4.0 Hz), 3.12 (1H, dd, CHAHBPh, J =
14.5, 10.0 Hz), 4.28 (2H, apparent s, C=OCH2), 4.51 (1H, dd, CHN, J = 10.0, 4.0 Hz), 7.17 
-  7.38 (10H, m, Ph); ,3C NMR (CDC13, 75 MHz): 5 22.6 (C(CH3)2), 28.6 (C(CH3)2), 36.0 
(CH2), 42.3 (CH2), 64.2 (CHN), 82.9 (C(CH3)2), 127.2 (phenyl CH), 127.6 (phenyl CH),
129.0 (phenyl CH), 129.1 (phenyl CH), 129.6 (phenyl CH), 130.1 (phenyl CH), 134.1 
(phenyl C), 137.2 (phenyl C), 153.3 (OC=0), 172.0 (NC=0); IR (thin film) vmax (cm 1): 
1777 (C=0), 1697 (C=0); HRMS m/z (ES) [M+H]+ requires 324.1594, found 324.1594
6.2.18 Typical procedure for the SuperQuat mediated syw-aldol reaction
A solution of A-acylated oxazolidinone (1 eq.) in DCM is cooled to 0 °C in an ice bath and 
9-BBNOTf (1.1 eq., 0.5 M solution in hexanes) added dropwise. The mixture is left 
stirring for 30 min at 0 °C before addition o f diisopropylethylamine (1.3 eq.) and stirring 
for a further 40 min. The reaction is then cooled to -  78 °C in an acetone-dry ice bath 
before addition o f the aldehyde (1.1 eq.) and stirring for 1 hr at -  78 °C followed by 1 hr at 
0 °C. The mixture is allowed to warm to room temperature, pH 7 phosphate buffer added 
and stirred for 5 min before addition of 2:1 hydrogen peroxide:methanol (v/v) and stirring 
for 16 hrs. The bulk o f the solvent is removed in vacuo and the resulting slurry partitioned
2 1 2
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between water and diethyl ether. The combined organic extracts are washed with 5 % 




According to general procedure 6.2.18, employing (S)-4-benzyl-5,5-dimethyl-3-propionyl- 
oxazolidin-2-one 346 (2.5 g, 9.57 mmol) in DCM (100 mL), 9-BBNOTf(21.05 mL, 0.5 M, 
10.52 mmol), diisopropylethylamine (2.17 mL, 12.44 mmol) and 2-methylene-octanal 283 
(1.48 g, 10.52 mmol) the crude product was prepared as a pale yellow oil. Purification by 
column chromatography afforded (5)-4-benzyl-3-((2iS,,3*5)-3-hydroxy-2-methyl-4- 
methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 350 (3.20 g, 83%) as a colourless 
oil.
[a]2* - 27.8 ° (c 1.15, CHC13); ‘H NMR (CDC13, 300 MHz): 5 0.87 (3H, t, CH2CH3, J = 6 . 8  
Hz), 1.11 (3H, d, CHCH3, J = 7.2 Hz), 1.28 (6 H, m, CH2), 1.37 (3H, s, C(CH3)2), 1.39 (3H, 
s, C(C//i)2), 1.45 (2H, m, CH2), 1.98 (2H, m, CH2C=C), 2.76 (1H, broad s, OH), 2.90 (1H, 
dd, C/^HePh, J = 14.3, 9.0 Hz), 3.08 (1H, dd, CHA/ / 5Ph, J = 14.3, 4.5 Hz), 3.95 (1H, qd, 
CHCH3, J = 7.2, 3.4 Hz), 4.38 (1H, d, CHOU, J = 3.4 Hz), 4.53 (1H, dd, C//N, J = 9.0, 4.5 
Hz), 4.96 (1H, m, C=CHAHB), 5.15 (1H, apparent s, C=CHAHB), 7.19 - 7.33 (5H, m, Ph); 
,3C NMR (CDC13, 75 MHz): 6  10.6 (CH3), 14.1 (CH3), 22.2 (C(CH3)2), 22.6 (CH2), 27.8 
(CH2), 28.4 (C(CH3)2), 29.1 (CH2), 31.7 (CH2), 32.6 (CH2), 35.3 (CH2Ph), 40.5 (CHCH3),
63.4 (CHN), 73.3 (CHOH), 82.3 (C(CH3)2), 110.4 (C=CH2), 126.9 (phenyl CH), 128.6 
(phenyl CH), 129.1 (phenyl CH), 136.6 (phenyl C), 148.3 (C), 152.2 (Q , 177.3 (NC=0); 
IR (thin film) vmax (cm 1): 3499 (O-H), 1780 (C=0), 1700 (C=0); HRMS m/z (ES) [M+H]+ 






According to general procedure 6.2.18, employing (S)-4-benzyl-5,5-dimethyl-3-(3-methyl- 
butyryl)-oxazolidin-2-one 355 (0.30 g, 1.02 mmol) in DCM (15 mL), 9-BBNOTf (2.24 
mL, 0.5 M, 1.12 mmol), diisopropylethylamine (0.23 mL, 1.33 mmol) and 2-methylene- 
octanal 283 (0.16 g, 1.12 mmol) the crude product was prepared as a pale yellow oil. 
Purification by column chromatography afforded (5)-4-benzyl-3-((25,35)-3-hydroxy-2- 
isopropyI-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 357 (0.35 g, 79%) as a 
pale yellow oil.
[a]2* - 25.9 ° (c 1.16, CHC13); lU NMR (CDC13, 300 MHz): 5 0.85 (3H, m, CH2CH3), 0.99 
(3H, d, CH(CH3)2, J = 6 . 8  Hz), 1.02 (3H, d, CH(C//3)2, J = 7.2 Hz), 1.27 (H12, m, C3H6 
and C(CH3)2), 1.41 (2H, m, C //2), 1.91 ( 1H, d, OH, J = 4.9 Hz), 2.06 (2H, m, CH2C=C),
2.30 (1H, m, C//(CH3)2), 2.82 (1H, dd, C//„HBPh, J = 14.3, 10.2 Hz), 3.11 (1H, dd, 
CHA/ / 5 Ph, J = 14.3, 3.6 Hz), 4.32 (1H, dd, Gtf-'Pr, J = 8.7, 4.8 Hz), 4.39 (1H, dd, C//OH, J 
= 8 .8 , 4.8 Hz), 4.48 (1H, dd, CHN, J = 10.2, 3.8 Hz), 4.85 (1H, m, C=C//„HB), 5.08 (1H, 
apparent s, C=CHAHB), 7.16 -  7.31 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 14.1 
(CH3), 18.6, 20.8, 22.2, 22.6 (CH2), 27.8 (CH2), 28.1, 28.3, 29.1 (CH2), 31.7 (CH2), 32.6 
(CH2), 35.5 (CH2Ph), 50.7 (CH-'Pr), 63.6 (CHN), 74.4 (CHOH), 81.7 (C(CH3)2), 111.2 
(C=CH2), 126.8 (phenyl CH), 128.6 (phenyl CH), 129.0 (phenyl CH), 136.9 (phenyl Q ,
151.0 (C), 152.5 (C), 173.8 (N C O ); IR (thin film) v™* (cm 1): 3494 (O-H), 1777 (C=0), 






According to general procedure 6.2.18, employing (S)-4-benzyl-5,5-dimethyl-3- 
phenylacetyl-oxazolidin-2-one 356 (0.35 g, 1.08 mmol) in DCM (15 mL), 9-BBNOTf 
(2.38 mL, 0.5 M, 1.19 mmol), diisopropylethylamine (0.25 mL, 1.40 mmol) and 2- 
methylene-octanal 283 (0.17 g, 1.19 mmol) the crude product was prepared as a yellow oil. 
Purification by column chromatography afforded (S ) -4 -b e n z y l-3 -( (2 S ,3 S )-3 -h y d r o x y -4 -  
methylene-2-phenyI-decanoyl)-5,5-dimethyl-oxazolidin-2-one 358 (0.35 g, 70%) as a 
pale yellow oil.
[of* - 56.2 ° (c 1.05, CHC13); !H NMR (CDC13, 300 MHz): 6  0.87 (3H, t, CH2CH3, J = 6 . 8  
Hz), 1.25 - 1.37 (6 H, broad m, C3H6), 1.30 (3H, s, C(CH3)2), 1.34 (3H, s, C(C//3)2), 1.53 
(2H, m, CH2), 2.12 (2H, m, CH2\  2.14 (1H, d, OH, J = 3.4 Hz), 2.69 (1H, dd, C/^HePh, J 
= 14.7, 9.2 Hz), 2.89 (1H, dd, CHA//*Ph, J = 14.7, 4.1 Hz), 4.49 (1H, dd, CHN, J = 9.0, 4.1 
Hz), 4.74 (1H, dd, CHOH, J = 7.9, 3.0 Hz), 4.91 (1H, m, C C /^ H B), 5.04 (1H, apparent s, 
C=CHaHb), 5.34 (1H, d, CH?h, J = 7.9 Hz), 7.08 -  7.19 (5H, m, Ph), 7.30 -  7.38 (3H, m, 
Ph), 7.42 -  7.47 (2H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 14.1 (CH3), 22.1 (CH3), 22.6 
(CH2), 27.8 (CH2), 28.3 (CH3), 29.2 (CH2), 31.7 (CH2), 32.4 (CH2), 34.9 (CH2Ph), 53.2 
(CHPh), 63.2 (CHN), 75.9 (CHOH), 82.1 (C(CH3)2), 111.9 (C=CH2), 126.7 (phenyl CH),
127.9 (phenyl CH), 128.6 (phenyl CH), 128.6 (phenyl CH), 128.9 (phenyl CH), 129.8 
(phenyl CH), 134.3 (phenyl C), 136.5 (phenyl Q , 149.1 (C=CH2), 152.0 (OC=0), 172.5 
(NC=0); IR (thin film) v^x (cm 1): 3511 (O-H), 1777 (C=0), 1692 (C=0); HRMS m/z 
(ES) [M+Na]+ requires 486.2615, found 486.2611
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6.2.19 Typical procedure for the hydrogenation o f SuperQuat aldols
A: Using the Endeavour catalyst screening system, unsaturated aldol (1 eq.) was dissolved 
in DCM in a dry reaction tube and placed in the hydrogenator at 25 °C. The sealed vessel 
was purged three times with nitrogen before injection o f the hydrogenation catalyst in 
DCM and pressurising with hydrogen to the required pressure. After 24 hours the crude 
mixture was removed from the hydrogenator and filtered through a plug of silica, washed 
with methyl ter/-butyl ether and evaporated in vacuo.
B: Using the Parr pressure vessel, unsaturated aldol (1 eq.) was dissolved in DCM and 
added to the vessel under a nitrogen atmosphere at room temperature. The hydrogenation 
catalyst in DCM was added under nitrogen before sealing of the vessel and pressurising 
with hydrogen to the desired pressure. After 24 hours the crude mixture was filtered 




According to general procedure 6.2.19 B, employing (5)-4-benzyl-3-((25,3,S)-3-hydroxy-2- 
methyl-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 350 (50 mg, 0.125 mmol) in 
DCM (0.5 mL) the crude product was prepared as a pale yellow oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25,3/?,4/?)-3-hydroxy-2,4-dimethyl- 
decanoyl)-5,5-dimethyl-oxazolidin-2-one (4R)-351a as an off white solid, 
mp 84 -  8 6  °C; [a]% - 19.2 ° (c 1.30, CHC13); *H NMR (CDC13, 300 MHz): 6  0.87 (6 H, m, 
CH2CH3 and CHC//?), 1.15 (3H, d, C=OCHCH3, J = 7.2 Hz), 1.27 (8 H, m, CaH*), 1.38 
(3H, s, C(C//j)2), 1.40 (3H, s, C(CH3)2), 1.55 (2H, m, CH2), 1.71 (1H, m, C//CH3), 2.83 
(1H, broad s, OH), 2.90 (1H, dd, CHAHBPh, J = 14.3, 9.0 Hz), 3.06 (1H, dd, CHA//sPh, J = 
14.3, 4.5 Hz), 3.56 (1H, dd, CHOH, J = 8.7, 2.6 Hz), 3.92 (1H, qd, C=OC//CH3, J = 7.2,
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2.6 Hz), 4.54 (1H, dd, CHN, J = 9.0, 4.5 Hz), 7.19 -  7.34 (5H, m, Ph); ,3C NMR (CDC13, 
75 MHz): 5 10.1 (CH3), 14.1 (CH3), 15.3 (CH3), 22.2 (C(CH3)2), 22.6 (CH2), 26.7 (CH2),
28.4 (C(CH3)2), 29.7 (CH2), 31.9 (CH2), 32.5 (CH2), 35.4 (CH2Ph), 35.6 (CHCH3), 39.6 
(C=OCHCH3), 63.2 (CHN), 75.2 (CHOH), 82.2 (C(CH3)2), 126.9 (phenyl CH), 128.6 
(phenyl CH), 129.1 (phenyl CH), 136.6 (phenyl Q , 152.0 (0 0 = 0 ), 178.1 (NC=0); IR 
(KBr disc) vmax (cm 1): 3471 (0-H), 1774 (C=0), 1676 (C=0); HRMS m/z (ES) [M+H]+ 
requires 404.2795, found 404.2797
(S)-4-Benzyl-3-((2iS,3/?,4S)-3-hydroxy-2,4-dimethyl-decanoyl)-5,5-dimethyl- 
oxazolidin-2-one, (4S)-351b
According to general procedure 6.2.19 B, employing (5)-4-benzyl-3-((25',35)-3-hydroxy-2- 
methyl-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 350 (50 mg, 0.125 mmol) in 
DCM (0.5 mL) the crude product was prepared as a colourless oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((25',3/?,45)-3-hydroxy-2,4-dimethyl- 
decanoyl)-5,5-dimethyl-oxazolidin-2-one (4S)-351b as an off white solid.
mp 78 -  83 °C; [erg - 14.6 ° (c 1.30, CHC13); ‘H NMR (CDC13, 300 MHz): 6  0.88 (3H, m, 
CH2CH3), 0.95 (3H, d, CHCH3, J = 6 . 8  Hz), 1.18 (3H, d, C=OCHC//3, J = 7.2 Hz), 1.26 
(8 H, m, C4H8\  1.37 (3H, s, C(CH3)2), 1.39 (3H, s, C(CH3)2), 1.58 (3H, overlapping m, 
CHCH3 and CH2), 2.49 (1H, broad s, OH), 2.91 (1H, dd, C//„HBPh, J = 14.3, 9.0 Hz), 3.06 
(1H, dd, CHA//fiPh, J = 14.3, 4.5 Hz), 3.62 (1H, dd, C//OH, J = 7.2, 4.1 Hz), 3.95 (1H, qd, 
C=OC//CH3, J = 6 .8 , 4.1 Hz), 4.52 (1H, dd, CHN, J = 9.0, 4.5 Hz), 7.20 -  7.34 (5H, m, 
Ph); ,3C NMR (CDC13, 75 MHz): 5 11.6 (CH3), 14.1 (CH3), 14.9 (CH3), 22.2 (C(CH3)2),
22.6 (CH2), 26.8 (CH2), 28.4 (C(CH3)2), 29.4 (CH2), 31.8 (CH2), 33.0 (CH2), 35.4 
(CH2Ph), 35.6 (CHCH3), 40.1 (C=OCHCH3), 63.3 (CHN), 75.4 (CHOH), 82.2 (C(CH3)2),
126.9 (phenyl CH), 128.6 (phenyl CH), 129.1 (phenyl CH), 136.6 (phenyl Q , 152.2
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According to general procedure 6.2.19 A, employing (S ')-4 -b e n z y l-3 -( ( iT )- (2 /? ,3 6 ') -3 -  
hydroxy-2,4-dimethyl-dec-4-enoyl)-5,5-dimethyl-oxazolidin-2-one 363 (50 mg, 0.125 
mmol) in DCM (0.5 mL) (S')-4-benzyl-3-((2J/?,3/?,4/?)-3-hydroxy-2,4-dimethyl- 
decanoyl)-5,5-dimethyl-oxazolidin-2-one (4/?)-362a was prepared in 85% d.e. as a pale 
yellow oil.
‘H NMR (CDC13, 300 MHz): 5 0.86 (6 H, m, CH2CH3 and CHC//j), 1.12 (3H, d, 
C=OCHCH3, J = 6 . 8  Hz), 1.24 (8 H, m, C4H8), 1.33 (3H, s, C(CH3)2), 1.40 (3H, s, 
C(CH3)2), 1.58 (2H, m, CH2), 2.44 (1H, apparent d, CHCH3, J = 9.0 Hz), 2.85 (1H, dd, 
C/^HePh, J = 14.7, 9.8 Hz), 3.18 (1H, dd, CHAHB?h, J = 14.7, 3.4 Hz), 3.60 (1H, dt, 
C//OH, J = 8.7, 3.0 Hz), 4.02 (1H, m, C=OC//CH3), 4.48 (1H, dd, CHN, J = 10.2, 3.4 Hz), 
7.14 -  7.32 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 10.8 (CH3), 14.5 (CH3), 14.9 
(CH3), 22.4 (C(CH3)2), 22.5 (CH2), 26.7 (CH2), 28.2 (C(CH3)2), 29.5 (CH2), 32.1 (CH2),
32.3 (CH2), 35.0 (CH2Ph), 36.1 (CHCH3), 40.1 (C=OCHCH3), 63.3 (CHN), 75.4 (CHOH),
82.2 (C(CH3)2), 126.8 (phenyl CH), 128.6 (phenyl CH), 129.1 (phenyl CH), 136.7 (phenyl 







According to general procedure 6.2.19 A, employing (,S)-4-benzyl-3-((2/?,3‘S)-3-hydroxy- 
2-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 359 (50 mg, 0.125 mmol) in 
DCM (0.5 mL) (S)-4-benzyl-3-((2/?,3i?,45)-3-hydroxy-2,4-dimethyI-decanoyl)-5,5- 
dimethyl-oxazolidin-2-one (45)-362b was prepared in 96% d.e. as a pale yellow oil.
*H NMR (CDC13, 300 MHz): 5 0.86 (6 H, m, CH2CH3 and CHC//*), 1.20 (3H, d, 
C=OCHC//*, J = 7.2 Hz), 1.24 (8 H, m, C M ),  1.33 (3H, s, C(CH3)2), 1.40 (3H, s, 
C(C//j)2), 1.58 (2H, m, CH2), 2.71 (1H, apparent d, CHCH3, J = 9.8 Hz), 2.87 (1H, dd, 
C/^HePh, J = 14.5, 9.6 Hz), 3.13 (1H, dd, CHAHB?h, J = 14.5, 3.9 Hz), 3.39 (1H, m, 
C//OH), 4.02 (1H, m, C=OC//CH3), 4.48 (1H, dd, CHN, J = 10.2, 3.4 Hz), 7.13 -  7.32 
(5H, m, Ph); 13C NMR (CDC13, 75 MHz): 6  9.4 (CH3), 14.2 (CH3), 15.1 (CH3), 22.2 
(C(CH3)2), 22.5 (CH2), 26.7 (CH2), 28.3 (C(CH3)2), 29.3 (CH2), 32.4 (CH2), 32.5 (CH2),
35.2 (CH2Ph), 36.3 (CHCH3), 39.8 (C=OCHCH3), 63.5 (CHN), 75.3 (CHOH), 82.2 
(C(CH3)2), 127.4 (phenyl CH), 128.8 (phenyl CH), 129.3 (phenyl CH), 136.1 (phenyl Q ,
152.4 (OC=0), 177.8 (NC=0); IR and mass spec data identical to (S)-4-Benzyl-3- 
((2S,3R,4R)-3-hydroxy-2,4-dimethyl-decanoyl)-5,5-dimethyl-oxazolidin-2-one 351
6.2.20 Typical procedure for the retro-aldol reaction
LHMDS (1.1 eq., 1M solution) was added dropwise to a stirred solution o f hydrogenated 
aldol (1 eq.) in toluene at 0 °C. After stirring for 2 hours at 0 °C the reaction was quenched 
with a few drops of pH 7 buffer, dried (MgS0 4 ), filtered and evaporated in vacuo to afford 






According to general procedure 6.2.20, employing (5)-4-benzyl-3-((2,S,3/?,4/?)-3-hydroxy-
2,4-dimethyl-decanoyl)-5,5-dimethyl-oxazolidin-2-one (4R)-351a (15 mg, 0.04 mmol) in 
toluene (0.7 mL) and LHMDS (0.04 mL, 0.04 mmol) (/?)-2-methyl-octanal (7?)-340a was 
prepared in 96% e.e. (determined by subsequent derivatisation with DMPEDA) as a 
colourless liquid.
[afo - 17.4 ° (c 8.0, CHC13, 96% e.e.); *H NMR (CHCI3, 300 MHz): 5 0.84 (3H, t, 
CH2 CH3 , J = 6.0 Hz), 1.05 (3H, d, CHC//3, J = 6.2 Hz), 1 .10 -1 .37  (8 H, m, C M ),  1.64 
(2H, m, CH2 C H \ 2.24 (1H, m, CHCH3), 9.55 (1H, s, HC=O); ,3C NMR (CDC13, 75 
MHz): 5 14.2 (CH3), 15.7 (CH3), 22.9 (CH2), 26.8 (CH2), 29.6 (CH2), 30.4 (CH2), 32.7 
(CH3), 48.4 (CHCH3), 203.6 (HC=O); IR (thin film) vmax (cm 1) 1723 (C=0 )
6.2.21 Typical procedure for the derivatisation o f aldehydes with DM PEDA
According to procedure 6.2.20, the crude reaction mixture (1 eq.) is redissolved in ether 
before addition o f molecular sieves and DMPEDA (1.1 eq.). After stirring at room 
temperature for 2  hours the reaction mixture is filtered and evaporated in vacuo to yield the 









'H NMR (C6D6, 300 MHz): 5 0.99 -  1.38 (26H, m, (R)-353a CeH13 and (S)-353b Co/Z/i), 
1.20 (3H, d, (S)-353b CHCH3, J = 6.8 Hz), 1.21 (3H, d, (R)-353a CHCH3, J = 6.8 Hz), 
1.94 (2H, m, (R)-353a C//CH3 and (S)-353b CHCH3), 2.22 (3H, s, (R)-353a NCH3\  2.25 
(3H, s, (S)-353b NCH3), 2.32 (3H, s, (5)-353b NCH3), 2.35 (3H, s, (R)-353a NCH3), 3.66 
(2H, d, (R)-353a CH?h and (S)-353b CH?h, J = 8.5 Hz), 3.78 (1H, d, (S)-353b NC//N, J =
1.9 Hz), 3.92 (1H, d, (R)-353a NCHN, J = 1.9 Hz), 4.04 (1H, d, (R)-353a C//Ph, J = 8.5 
Hz), 4.14 (1H, d, (5)-353b CH?h, J = 8.5 Hz), 6.89 -  7.22 (10H, m, Ar)
6.2.22 Typical procedure for the SuperQuat mediated anti-a\do\ reaction
To a solution of TV-acylated SuperQuat oxazolidin-2-one (1 eq.) in dry ethyl acetate was 
added magnesium chloride (0.2 eq.), triethylamine (2 eq.), chlorotrimethylsilane (1.5 eq.) 
and the desired aldehyde (1.2 eq.). The reaction mixture was stirred at room temperature 
for 24 hours before the resultant orange slurry was filtered through a plug o f silica and 
washed with diethyl ether. The filtrate was concentrated in vacuo before the addition o f 
methanol and trifluoroacetic acid. The mixture was stirred for a further 30 minutes, the 






According to general procedure 6.2.22, employing (5)-4-benzyl-5,5-dimethyl-3-propionyl- 
oxazolidin-2-one 346 (100 mg, 0.38 mmol), magnesium chloride (7.3 mg, 0.076 mmol), 
triethylamine (0.11 mL, 0.76 mmol), chlorotrimethylsilane (0.07 mL, 0.57 mmol) and 2- 
methylene octanal 283 (64 mg, 0.46 mmol), the crude product was prepared as a yellow
oil. Purification by column chromatography afforded (S)-4-benzyl-3-((2/?,3S)-3-hydroxy- 
2-methyl-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 359 (84 mg, 55%) as a 
colourless oil.
[a]2* - 40.9 ° (c 1.15, CHC13); *H NMR (CDC13, 300 MHz): 5 0.86 (3H, t, CH2CH3, J = 6 . 8  
Hz), 1.13 (3H, d, CHCH3, J = 6.4 Hz), 1.28 (6 H, m, C3H6), 1.32 (3H, s, C(CH3)2), 1.33 
(3H, s, C(CH3)2), 1.46 (2H, m, CH2), 2.00 (1H, m, C//^HBC=CH2), 2.11 (1H, m, 
CHAHBC=CH2), 2.77 (1H, broad s, OH), 2.83 (1H, dd, C//^HBPh, J = 14.7, 9.8 Hz), 3.16 
(1H, dd, CHA//flPh, J = 14.7, 3.4 Hz), 4.14 (2H,overlapping m, CHOH and CHCH3), 4.48 
(1H, dd, CHN, J = 9.8, 3.4 Hz), 4.91 (1H, m, C=CHAHB), 5.02 (1H, apparent s, 
C=CHaHb), 7.16 -  7.31 (5H, m, Ph); ,3C NMR (CDC13, 75 MHz): S 14.1 (CH3), 15.0 
(CH3), 22.3 (C(CH3)2), 22.6 (CH2), 27.9 (CH2), 28.5 (C(CH3)2), 29.2 (CH2), 31.0 (CH2),
31.8 (CH2), 35.1 (CH2Ph), 40.9 (CHCH3), 64.1 (CHN), 78.7 (CHOH), 82.3 (C(CH3)2),
112.0 (C=CH2), 126.7 (phenyl CH), 128.7 (phenyl CH), 129.0 (phenyl CH), 137.1 (phenyl 








According to general procedure 6.2.22, employing (5)-4-benzy 1-5,5-dimethyl-3-(3-methyl- 
butyryl)-oxazolidin-2-one 355 (200 mg, 0.69 mmol), magnesium chloride (13 mg, 0.14 
mmol), triethylamine (0.19 mL, 1.38 mmol), chlorotrimethylsilane (0.13 mL, 1.04 mmol) 
and 2-methylene octanal 283 (116 mg, 0.83 mmol), the crude product was prepared as a 
yellow oil. Purification by column chromatography afforded (5)-4-benzyl-3-((2/?,35)-3- 
hydroxy-2-isopropyl-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 360 (104 
mg, 35%) as a colourless oil.
[afo - 11.4 ° (c 0.79, CHCb); ‘H NMR (CDC13, 300 MHz): 5 0.85 (3H, t, CH3C //3, J = 6 . 8  
Hz), 0.93 (3H, apparent dd, CH(C//j)2, J = 6.4, 1.3 Hz), 0.96 (3H, d, CH(CH3)2, J = 6 . 8  
Hz), 1.10 (3H, d, J = 6 . 8  Hz), 1.27 (6 H, m, C3H6), 1.32 (3H, d, J = 4.5 Hz), 1.42 (2H, m, 
CH2), 2.07 (2H, m, CH2C=CH2), 2.28 (1H, m, C//(CH3)2), 2.71 (1H, dd, C /^ H BPh, J = 
14.7, 10.5 Hz), 3.06 (1H, dd, CHA/ / fiPh, J = 14.7, 1.8 Hz), 4.15 (1H, dd, C//-'Pr, J = 9.8, 
3.4 Hz), 4.31 (1H, broad dd, C//OH, J = 10.2, 3.4 Hz), 4.49 (1H, m, CHN), 4.83 (1H, s, 
C=CHaHb), 4.99 (1H, s, C=CHaHb), 7.15 -  7.31 (5H, m, Ph); ,3C NMR (CDC13, 75 MHz): 
5 14.5 (CH3), 20.7, 21.2, 22.6, 23.1, 28.2, 29.4, 32.2, 32.9, 35.6 (CH2Ph), 50.8 (CH-'Pr),
64.2 (CHN), 73.3 (CHOH), 82.2 (C(CH3)2), 109.9 (C=CH2), 127.2 (phenyl CH), 129.1 
(phenyl CH), 129.4 (phenyl CH), 137.6 (phenyl C), 151.1 (Q , 153.2 (Q , 177.5 (NC=0); 




6.2.23 Procedures for the derivatisation of chiral aldehyde 340 
2-((/?)-l-methyl-heptyl)-[l,3]dithiane, 364
According to general procedure 6.2.20, employing (5)-4-benzyl-3-((25,3/?,4/?)-3-hydroxy-
2,4-dimethyl-decanoyl)-5,5-dimethyl-oxazolidin-2-one (4i?)-351a (150 mg, 0.372 mmol) 
in toluene (7.5 mL) and LHMDS (0.41 mL, 0.409 mmol). The crude mixture was 
redissolved in DCM ( 6  mL), cooled to 0 °C before addition of propane-1,3-dithiol (0.06 
mL, 0.558 mmol) and boron trifluoride diethyletherate (0.09 mL, 0.744 mmol) and stirring 
for 1.5 hours. The reaction was quenched with saturated NaHCC>3 and extracted with 
DCM. The combined organic extracts were washed with NaHCCb, dried (MgSCL), filtered 
and evaporated in vacuo to afford the crude product as a yellow oil. Purification by column 
chromatography afforded 2-((/?)-l-methyl-heptyl)-[l,3]dithiane 364 (67 mg, 78%) as a 
yellow oil, with spectroscopic data essentially identical to the literature compound.[235]
[a}2» + 8.0 ° (c 3.00, ether) [lit. + 8.3 ° (c 3.00, ether)]; *H NMR (CDC13, 300 MHz): 5
0.87 (3H, t, CH2CH3, J = 6 . 8  Hz), 1.07 (3H, d, CHC//j, J = 6 . 8  Hz), 1.23 -  1.36 (10H, m, 
CsH jo), 1.78 -  1.91 (2H, m, C //2CH2S), 2.07 -  2.15 (1H, m, CHCH3), 2.80 -  2.85 (4H, m, 
SC//2CH2C //2S), 4.14 (1H, d, SCH, J = 4.1 Hz); 13C NMR (CDC13, 75 MHz): 5 14.1 
(CH3), 17.0 (CH3), 22.7 (CH2), 26.4 (CH2), 27.3 (CH2), 29.3 (CH2), 30.9 (CH2), 31.2 
(CH2), 31.8 (CH2), 34.0 (CH2), 38.5 (CHCH3), 55.7 (SCH)
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(£)-(/?)-4-methyl-dec-2-enoic acid methyl ester, 366
o
According to general procedure 6.2.20, employing (S)-4-benzyl-3-((2S',3/?,4R)-3-hydroxy-
2,4-dimethyl-decanoyl)-5,5-dimethyl-oxazolidin-2-one (4/?)-351a (100 mg, 0.248 mmol) 
in toluene (5 mL) and LHMDS (0.27 mL, 0.273 mmol). The crude mixture was redissolved 
in DCM (5 mL) followed by addition o f (carbethoxymethylidene)triphenylphosphorane 
(91 mg, 0.273 mmol) and stirring at room temperature for 16 hours. Evaporation in vacuo 
afforded the crude product as a colourless oil. Purification by column chromatography 
afforded (£)-(/?)-4-methyl-dec-2-enoic acid methyl ester 366 (45 mg, 92%) as a 
colourless oil.
[afp - 27.5 ° (c 0.40, CHC13); *H NMR (CDC13, 300 MHz): 5 0.87 (3H, t, CH2CH3, J = 6.6 
Hz), 1.03 (3H, d, CHC//?, J = 6.7 Hz), 1.21 -  1.38 (10H, m, C5H10), 2.28 (1H, m, C//CH3), 
3.72 (3H, s, OCH3), 5.77 (1H, dd, C=OC//=CH, J = 15.8, 1.1 Hz), 6.86 (1H, dd, 
C=OCH=CH, J = 15.8, 7.9 Hz); ,3C NMR (CDC13, 75 MHz): 5 14.5 (CH3), 19.8 (CH3),
23.0 (CH2), 27.6 (CH2), 29.7 (CH2), 32.2 (CH2), 36.4 (CH2), 37.0 (CHCH3), 51.8 (OCH3),
119.5 (C=OCH=CH), 155.6 (C=OCH=CH), 167.8 (C=0); IR (thin film) vmax (cm 1): 1728 
(C=0); HRMS: m/z (NH3C1+) [M+NH4]+ requires 216.1958, found 216.1960
(/?)-2-Methyl-octan-l-ol, 367
According to general procedure 6.2.20, employing (5)-4-benzyl-3-((2S',3R,4R)-3-hydroxy-
2,4-dimethyl-decanoyl)-5,5-dimethyl-oxazolidin-2-one (4R)-351a (80 mg, 0.20 mmol) in 
toluene (4 mL) and LHMDS (0.22 mL, 0.22 mmol). The crude mixture was redissolved in 
diethylether (2 mL) before addition o f borane dimethylsulfide (0.09 mL, 1.00 mmol) and 
stirring at room temperature for 4 hours. The reaction was quenched with a couple o f drops 




product as a yellow oil. Purification by column chromatography afforded (/?)-2-methyl- 
octan-l-ol 367 (22 mg, 75%) as a colourless liquid with spectroscopic data essentially 
identical to the literature compound.[218]
[a]“  + 10.0 ° (c 1.0, CHC13) [lit. + 10.3 0 (c 1.00 CH2C12)]; 'H NMR (CDCI3, 300 MHz): 
5 0.86 (3H, t, CH2C //1, J = 7.0 Hz), 0.89 (3H, d, CHCHh  6 . 8  Hz), 1.10 (2H, m,
1.30 (8 H, m, C4 Hs), 1.61 (1H, m, C//CH3), 1.89 (1H, broad s, 3.38 (1H, dd, 
C//„HBOH, J = 10.4, 6.5 Hz), 3.45 (1H, dd, CHA/ / sOH, J = 10.4, 6.5 Hz); l3C NMR 
(CDCb, 75 MHz): 8  14.0 (CH3), 16.1 (CH3), 22.6 (CH 26.5 (CH2), 29.4 (CH2), 31.7 
(CH2), 33.1 (CH2), 35.7 (CHCHj), 68.3 (CH2OH); IR (thin fdm) vm( (cm 1): 3355 (O-H)
6.2.24 Typical procedure for the palladium catalysed isomerisation reaction
To a solution of methylene substituted aldol (1 eq.) in DCM was added either 3 mol% 
palladium on carbon or 3 mol% palladium (II) acetate in one portion under nitrogen. The 
vessel was sealed and pressured to the required pressure with hydrogen gas. The reaction 





According to general procedure 6.2.24, employing (5)-4-benzyl-3-((25',35)-3-hydroxy-2- 
methyl-4-methylene-decanoyl)-oxazolidin-2-one 282 (50 mg, 0.134 mmol) in IPA (1 mL), 
palladium on carbon (4.3 mg, 10% Pd, 0.0040 mmol) and 1 bar hydrogen pressure, the 
crude product is prepared as a colourless oil. Purification by column chromatography 
afforded (5)-4-benzyl-3-((E)-(25,35)-3-hydroxy-2,4-dimethyl-dec-4-enoyl)-oxazolidin- 
2-one 285 (49 mg, 97%) as a colourless oil.
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[a]2* + 41.7 ° (c 1.2, CHC13); 'H NMR (CDC13, 300 MHz): 5 0.83 (3H, t, CH2C //3, J = 6.8 
Hz), 1.13 (3H, d, CHCH3, J = 7.2 Hz), 1.19 - 1.35 (6H, broad m, (C //2)3), 1.55 (3H, s, 
CCH3), 1.99 (2H, m, C=CHCH2), 2.74 (2H, m, CHAHBPh and OH), 3.21 (1H, dd, 
CHA/ / fiPh, J = 13.6, 3.4 Hz), 3.93 (1H, qd, C//CH3, J = 6.8, 3.8 Hz), 4.15 (2H, m, CH2O),
4.30 (1H, d, C//OH, J = 3.0 Hz), 4.63 (1H, m, CHN), 5.50 (1H, apparent tt, C=CH, J = 7.4,
1.3 Hz), 7.13 -  7.32 (5H, broad m, Ph); 13C NMR (CDC13, 75 MHz): 5 10.5 (CH3), 13.3 
(CH3), 14.0 (CH3), 22.5 (CH2), 27.5 (CH2), 29.1 (CH2), 31.5 (CH2), 37.7 (CH2Ph), 40.4 
(CHCH3), 55.3 (CHN), 66.1 (CH20), 75.3 (CHOH), 126.6 (C H C ), 127.4 (phenyl CH),
128.9 (phenyl CH), 129.4 (phenyl CH), 133.2 (C), 135.1 (C), 153.00 (0C =0), 177.0 
(NC=0); 1R (thin film) Vmax (cm'1): 3393 (O-H), 1780 (C=0), 1709 (C=0); HRMS: m/z 




According to general procedure 6.2.24, employing (5)-4-benzyl-3-((2/?,35)-3-hydroxy-2- 
methyl-4-methylene-decanoyl)-5,5-dimethyl-oxazolidin-2-one 359 (100 mg, 0.25 mmol) in 
IPA (2 mL), palladium on carbon (8.0 mg, 10% Pd, 0.0075 mmol) and 5 bar hydrogen 
pressure, the crude product is prepared as a colourless oil. Purification by column 
chromatography afforded (5)-4-benzyl-3-((£)-(2/?,35)-3-hydroxy-2,4-dimethyl-dec-4- 
enoyl)-5,5-dimethyl-oxazolidin-2-one 363 (97 mg, 97%) as a colourless oil.
[a]2* - 15.3 0 (c 1.00, CHCI3); ’H NMR (CDC13, 300 MHz): 5 0.87 (3H, t, CW2CH3, J = 6.8 
Hz), 1.04 (3H, d, CHCH3, J = 6.4 Hz), 1.28 (3H, s, CH3C=CH), 1.36 (6H, m, C3H6), 1.60 
(3H, s, C(C//i)2), 1.66 (3H, s, C(CH3)2), 2.03 (2H, m, CH2CH=C), 2.47 (1H, broad s, OH), 
2.88 (1H, dd, C/Z^HbPH, J = 14.7, 9.8 Hz), 3.21 (1H, dd, CHA//*Ph, J = 14.7, 3.4 Hz), 4.08 
(2H, overlapping m, CHCH3 and C//OH), 4.52 (1H, dd, CHN, J = 9.8, 3.4 Hz), 5.44 (1H, 
apparent td, C=CH, J = 7.2, 1.5 Hz), 7.19 -  7.34 (5H, m, Ph); ,3C NMR (CDC13, 75 MHz):
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5 10.8 (CH3), 14.0 (CH3), 14.8 (CH3), 22.2 (C(CH3)2), 22.5 (CH2), 28.5 (C(CH3)2), 29.0 
(CH2), 29.5 (CH2), 31.5 (CH2), 35.2 (CH2Ph), 40.9 (CHCH3), 64.1 (CHN), 81.3 (CHOH),
81.9 (C(CH3)2), 126.7 (phenyl CH), 128.6 (phenyl CH), 129.0 (phenyl CH), 130.1 
(C=CH), 134.0 (C=CH), 137.2 (phenyl Q , 152.2 (0C =0), 177.1 (NC=0); IR (thin film) 




According to general procedure 6.2.24, employing (5)-4-benzyl-3-((25,35)-3-hydroxy-2,5- 
dimethyl-4-methylene-hexanoyl)-oxazolidin-2-one 378 (50 mg, 0.14 mmol) in I PA (1.5 
mL), palladium (II) acetate (1.0 mg, 0.0042 mmol), at 5 bar hydrogen pressure the crude 
product is prepared as a grey oil. Purification by column chromatography afforded (S)-4- 
benzyl-3-((25',3iS)-3-hydroxy-2,4,5-trimethyl-hex-4-enoyl)-oxazolidin-2-one 380 (20
mg, 40%) as a colourless oil.
[afn + 27.4 ° (c 0.73, CHC13); 'H NMR (CDC13, 300 MHz): 5 1.34 (3H, d, CHCHS, J =
6.8 Hz), 1.65 (6H, s, C=C(CH3)2\  1.71 (3H, s, CH 3 C=C), 2.76 (1H, dd, C/^HePh, J =
13.6, 9.4 Hz), 3.23 (1H, dd, CHA//*Ph, J = 13.6, 3.4 Hz), 4.03 (1H, apparent pentet, 
C/ZCH3, J = 6.8 Hz), 4.16 (2H, m, CH2O), 4.60 (1H, m, CHN), 4.87 (1H, dd, C//OH, J = 
6.8, 3.4 Hz), 7.18 -  7.37 (5H, m, Ph); 13C NMR (CDC13, 75 MHz): 5 13.0 (CH3), 13.7 
(CH3), 20.2 (CH3), 21.2 (CH3), 37.7 (CH2Ph), 41.9 (CHCH3), 55.3 (CHN), 66.0 (CH20),
71.9 (CHOH), 127.4 (phenyl CH), 128.9 (C=C), 128.9 (phenyl CH), 129.4 (phenyl CH),
129.6 (C=C), 135.1 (phenyl C), 152.9 (OC=0), 176.1 (NC=0); IR (thin film) vmax (cm 1): 
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